Microarray-based expression profiling: improving data mining and the links to biological knowledge pools by Giles, Peter James
Microarray-based expression profiling: 
Improving data mining and the link to biological 
knowledge pools
A thesis submitted in partial 
satisfaction o f the requirements for the degree of 
Doctor o f Philosophy by:
Peter James Giles
Department of Pathology 
School of Medicine, Cardiff University 
June 2005
UMI Number: U200552
All rights reserved
INFORMATION TO ALL USERS  
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U200552
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition ©  ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Declaration
This work has not been previously accepted in substance for any degree and is not 
being concurrently submitted in candidature for any degree.
Signed: y  *__________________________  (candidate)
Date: 21 June 2005___________________________
Statement 1
The thesis is the result of my own investigations, except where otherwise stated. 
A bibliography is attached.
Signed:   (candidate)
Date: 21 June_2005___________________________
Statement 2
I hereby give consent for my thesis, if accepted, to be available for photocopying and for 
inter-library loan, and for the title and summary to be made available to outside 
organisations.
Signed: ^ __________________________  (candidate)
Date: 21 June 2005
2
Abstract
Microarray based expression profiling provides a useful research tool to gain new 
insights into biological systems. Data analysis methods are in their infancy, with the 
answers to many basic questions shadowed by work on more complex computational 
and statistical methods. Understanding the fundamental concepts is essential in the 
application of statistical tests and to underpin work aiming to link microarray data to 
its biological annotation.
Centring on the detection of differential gene expression, the work presented in this 
thesis explores the effect of different statistical testing approaches and different 
expression metrics in their ability to correctly identify known changes in a dataset over 
a range of experimentally plausible sample sizes. Whilst certain combinations of 
methods are shown to have additional detection power in comparison to others, the 
results suggest that sample size, along with variability between samples, are probably the 
most important factors in analysis outcomes.
Having identified differentially regulated genes, the final and most labour intensive 
part of the analysis process is drawing biological conclusions and hypothesises about 
the data. A novel solution is presented which combines experimental data with a 
curated annotation sources along with analysis tools to assist the researcher in 
exploring the information contained within their dataset.
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Chapter One 
Introduction
In this Chapter, the concepts, technology and implementation of gene expression 
profiling are introduced and explored. Section 1.1 introduces functional genomics and 
the biological importance of gene expression. Section 1.2 introduces the techniques of 
microarray expression measurement and compares different technological approaches. 
Section 1.3 introduces the Affymetrix GeneChip system, the design and manufacture of 
a GeneChip, and the technological process in transferring a biological sample into 
experimental data. Section 1.4 discusses the analysis stages required to convert the 
scanned microarray image into a numerical result and the type of analysis that can 
subsequently be applied to the data to enable biological understanding.
1.1 Gene expression profiling
Significant advances in molecular biology have occurred as a result of the application of 
high-throughput techniques to experimental problems. Application of these 
technologies has accelerated the achievements in genome sequencing over the last few 
years and contributed to the completion of many sequencing projects including many 
microbial genomes, a few from higher organisms, as well as substantial parts of other 
eukaryotic genomes.
To biomedical researchers, the draft release of the human genome sequence (Lander, et 
al., 2001; Venter, et al., 2001) is purported to form the firm foundation for biomedical 
research in the decades ahead, allowing for further study into the mechanisms of 
human biology and the study of inherited disease.
However, the genome sequence only is only the start of the biological process and can 
be thought of as representing the “parts list” for an organism (Skolnick and Fetrow, 
2000). To realize the full potential of the sequencing accomplishment, the information 
must be taken forward to assist in the understanding of how genomes function and to 
study the many interactions within an organism.
The ability to monitor the expression of many genes simultaneously at the transcript 
level has become possible due to the advent of DNA microarray technologies (Pease, et 
al., 1994; Schena, et al., 1995). Microarrays provide the possibility for examination of 
the expression patterns of many previously uncharacterised genes and may provide 
clues to their possible function by comparison analysis.
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Combinations of this information allow for the formulation of metabolic schemas to 
understand how pathways are changed under varying conditions a cell is exposed to. 
Advancements in the application of these high-throughput technologies is set to allow 
data collection on a scale previously unparalleled and will allow for the comparative 
study of entire genomes and their resultant elements between species as well as 
characterise the mechanisms behind individual variations and the complex interplay 
that allows an organism to function.
1.2 Introduction to microarray technologies
Microarray technology makes use of the sequence resources created by the genome 
projects and other sequencing efforts to measure the cellular transcription of many 
genes simultaneously based on the principle of hybridisation. Hybridisation has been 
in use for many years in molecular biology and forms the basis of the established 
techniques of Northern and Southern Blotting.
1.2.1 Evolution of the microarray
In Southern blotting, a short labelled nucleic acid probe (either DNA or RNA) is used to 
hybridise to complementary fragments of DNA that have been separated according to 
size by gel electrophoresis. Radio-labelling of the oligonucleotide enables visualisation 
using photographic film sensitive to radiation (Southern, 1975). Northern blotting is 
similar but oligonucleotides bind to mRNA run through a gel and transferred to a 
membrane. The intensity of any resultant band on the film is a semi-quantitative 
measure of the amount of DNA or mRNA present, in comparison to a known standard.
Evolving from the insight that labelled nucleic acid molecules could be used to 
interrogate nucleic acid molecules attached to a solid support, arrays are based on the 
ideas of a mass parallel version of these blotting techniques (Lander, 1999). The 
principle difference between blotting techniques and arrays is the immobilisation of the 
probe to the substrate in a microarray. Evolution of the technique from blotting first 
lead to the development of “m acroarrays”, which explored expression levels by 
hybridizing mRNA to cDNA libraries gridded on nylon filters.
Technical improvements lead to the development of the microarray, which utilises a 
non-porous solid support. In addition to the miniaturisation opportunities the rigid 
substrate offers, a technical advantage is obtained due to the fact that neither the target 
nucleic acids (normally cDNA) nor the post-hybridisation wash solutions are required 
to permeate into nitrocellulose pores, and therefore the rates of the hybridisation and 
washing steps are increased (Southern, et al., 1999).
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1.2.2 Overview of microarray technology
Microarrays exploit the binding of complementary single-stranded nucleic acid 
sequences. Whereas a Southern blot utilises on only one probe, in a microarray, 
thousands of known probes are fabricated onto a solid substrate (e.g. a glass slide) in a 
specified order. There may be tens of thousands of spots on an array, each containing 
a huge number of identical DNA molecules or fragments of molecules, with lengths 
from twenty to hundreds of nucleotides.
Whilst there are differing implementations of the fundamental ideas behind microarray 
technology, the stages of production and experimentation are common between the 
different methodologies. Firstly the microarray must be designed and produced. DNA 
complementary to genes of interest is generated and laid out in microscopic quantities 
on solid surfaces at defined positions according to the array design. In the design stage, 
attention must be given to the sequences identifying genes of interest to overcome 
issues of families of similar genes sharing sequence and the effects of splice variants.
The next stage of experimentation converts the expression mRNA into a labelled 
complementary DNA, enabling it to be eluted over the surface and form 
complementary DNA binds. The presence of bound DNA is detected by fluorescence 
following laser excitation and then used to form an estimate of the relative level of gene 
expression.
Whilst the basic technology is the same, differences exist in the types of microarray 
available to the researcher based on the form of sequence used for detection, and the 
methods by which the sequence is applied to a solid substrate. The sequence can be 
applied to the slide using a robot to spot previously produced sequences to the array, or 
synthesized by photo-lithography or by ink-jet printing technologies.
The second difference is in the length of DNA sequences that are laid down on the 
array. Either full length complementary cDNA sequence or a particular segment in the 
form of a unique oligonucleotide sequence is placed on the slide to enable expression 
specific hybridisation.
Techniques involving oligonucleotide sequences and photo-lithographic production 
methods are generally the proviso of commercial microarray systems whereas the full 
length cDNA arrays are within the remit of the researcher to design and produce the 
array slides (e.g. Cheung V.G, et al. 1999) and as such are normally a cheaper solution.
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1.2.2.1 cDNA microarrays
cDNA microarrays use robotic techniques to spot glass slides at precise points with 
complete gene/EST sequences in the form of a pre-synthesised cDNA to generate a 
probe. As a result of the circular probe formation left on the chip and the process of the 
applying liquid droplets of cDNA to the slide, these arrays are often termed spotted 
arrays. cDNA arrays offer a high degree of flexibility and can be designed and 
implemented using off the shelf hardware in a typical research environment, allowing 
the researcher complete control over the array design and features (Schulze and 
Downward, 2001). In addition the technology is sequence independent making it ideal 
for species with limited genome sequence availability (Chen, et al., 2004).
Experimentally cDNA arrays are normally subjected to differential expression by use of 
simultaneous, two-colour fluorescence hybridisation. Fluorescent probes are prepared 
from two mRNA sources to be compared one channel comprising of a green dye (Cy3) 
and the other a red dye (Cys). The probes are mixed and then eluted over the 
microarray slide for an extended period to allow hybridisation to occur.
As a result of the simultaneous two-channel experimentation, complex issues of 
experimental design have evolved to overcome dye-biases and the general effects of 
simultaneous processing. It is generally accepted that cyclic design incorporating dye- 
swaps between channels is the optimal solution, but this has the limitation of closing 
the experimental loop and makes extension studies more difficult to plan (Churchill, 
2002). Potential problems in the use of cDNA technologies include the maintenance of 
cDNA libraries needed for probe manufacture, and the occasional misidentification of 
probe sequences (Warner and Dieckgraefe, 2002).
1.2.2.2 High-density oligonucleotide arrays
In contrast to the high level of control the researcher has over the type, number, and 
identity of probes when using cDNA microarray systems, high-density oligonucleotide 
arrays are generally purchased as ‘off the shelf solutions with chips representing a 
standard range of probe sets (Lipshutz, et al., 1995). Custom designed arrays are 
available, and have been successfully developed by consortiums of researchers working 
on organisms for which catalogue arrays are not available, however for the average 
biological researcher the additional development and production costs for this form of 
array will most likely prove prohibitive to a customised design. However, the large 
number of probe sets (>47,000 on the HG-U133+ chip) incorporated on the chips 
compensates for this limitation.
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Oligonucleotide arrays are manufactured using a combination of photolithographic and 
combinatory chemistry techniques (Lipshutz, et al., 1999), resulting in an extremely 
high feature density with complete control of the sequence laid down on the array. 
Typically, a set of unique oligonucleotide probes form a probe set providing 
information to represent a gene or expressed sequence tag (EST). However the array 
design requires sequence data to allow probe design, and there is a risk of uneven 
performance by individual array elements dependant on the rules used for oligo 
selection.
Despite potential issues of low specificity and sensitivity in short oligonucleotides and 
the converse issues of higher cost in purchase of large number of long oligonucleotides, 
high-density arrays offer a much more integrated system for experimental workflow by 
virtue of the commercial production of arrays and eliminate the potentially error-prone 
and time-consuming process of handling cDNA resources. Further details of the 
Affymetrix high-density oligonucleotide array system and the stages of experimental 
processing and analysis are described in Section 1.3
1.2.3 Application of microarray technology
Microarrays provide information on the relative expression levels of thousands of genes 
simultaneously. The information that such an experiment obtains can be used for a 
variety of purposes supporting research from the basic sciences, through 
pharmacocgenomic drug testing to applications in clinical diagnosis (Debouck and 
Goodfellow, 1999). Within the basic sciences microarrays provide the ability to explore 
the gene expression between differing cell types over time and in response to differing 
disease states. They also provide a potential mechanism for the development of 
interaction maps between genes and the downstream effects these produce (Clarke, et 
al., 2001).
Within pharmacogenomics, microarrays can assist in drug discovery by identifying the 
exact targets and actions of drugs and provide information of toxicological effects 
within the cell (Ivanov, et al., 2000; Nees and Woodworth, 2001). Clinically, 
microarrays have presented as a method to improve the pathological classification of 
disease and provide the potential for patient specific treatment derived from the results 
of identified bio-markers (Perez, et al., 2004). Microarrays have been shown to be 
effective in this regard with the identification of additional classes of breast cancer 
subgroups, which whilst appearing phenotypically identical, present with different 
transcription profiles (Hedenfalk, et al., 2003).
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1.2.4 Limitations of microarray technology
Whilst microarrays are a powerful tool to enable a snapshot of the transcription events 
with a cell, they do present with limitations in their scope and of the information the 
technique can provide. The key proviso of the techniques is that the physiological state 
of an organism may not be reflected by gene expression or RNA levels. The amount of 
mRNA may not correlate with amount of translated protein and the expression of a 
protein may not always produce a detectable physiological activity or response.
In addition, mRNA is an unstable molecule, with the half lives of the messenger varying 
considerably. This makes the reproducible extraction of mRNA difficult. For mRNA 
that has been extracted without due care, all that may remain after extraction is the 
stable mRNA, which have not been subject to degradation and may not provide as 
much insight into the experimentally important transcription changes.
In Section 1.1.1 the concept of alternative splicing was introduced. Within the context 
of a microarray experiment, the researcher must consider to what extent changes in 
observed signal from a messenger are due to alternative splicing rather than a change 
in transcript abundance. Current knowledge of alternative splicing is limited, making 
array design to explore and account for this effect problematic. However, in theory the 
multiple probes present for each gene within high-density oligonucleotide systems 
should be able to reveal alternative splicing if probes span an alternative splice junction 
(Lee and Roy, 2004). However, looking for changes in the relative intensity of probes 
across a gene might reveal this but it doesn’t  exclude the possibility of changes in cross­
hybridisation for some of the probes within a gene.
Technically quantification of transcription requires additional knowledge of how well 
each probe binds to its target before it can be used to deduce anything about the 
absolute mRNA concentration present in the cell. This can be achieved by using known 
concentrations of mRNA to calibrate each probe set. However, this is a labour 
intensive task if working with more than a few mRNAs. Whilst purists may argue that 
microarrays are therefore limited to measurements of whether a mRNA is present or 
not above the detection threshold, many researchers prefer to consider the microarray 
as a *!snapshot view " of the current cellular transcription, one that can be used for 
hypothesis generation and is often supplemented with more accurate complimentary 
experiments (e.g. quantitative RT-PCR).
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1.3 Affymetrix GeneChip technology
The Affymetrix GeneChip system is a commercial microarray system based on 
oligonucleotide array targets synthesised by a photolithographic process. The design 
and verification of the array is done commercially and is shipped as a plastic cassette 
containing the array, in which all hybridisation reactions occur (Lipshutz, et al., 1999). 
It is data from this microarray system that forms the basis for the work presented in 
this thesis.
1.3.1 Overview of technology features and production
Each gene is represented on the array by a series of different 25-mer oligonucleotide 
probes, which are directly synthesized onto the array. At the time of writing, each array 
contains up to 1.3 million different oligonucleotide probes (HG-U133+ array) with 
millions of oligonucleotide copies at a location on the array. The Affymetrix GeneChip 
design implements probes in pairs, consisting of a perfect match oligonucleotide and a 
mismatch oligonucleotide. The perfect match probe has a sequence exactly 
complimentary to the particular gene and thus measures the expression of the gene. 
The mismatch probe differs from the perfect match probe by a single base substitution 
at the centre base position.
The presence of the mismatch probe is argued to disturb the binding of the target gene 
transcript, help to determine the background signal and help control for any non­
specific hybridisation that contributes to the signal measured for the perfect match 
oligonucleotide.
GeneChip arrays are commercially manufactured using a combination of 
photolithographic and combinatorial chemistiy techniques building many arrays 
simultaneously on a 5-inch square quartz glass wafer.
In manufacture, linker molecules are applied to the glass wafer to form a covalently 
linked molecule-matrix which enables the synthesis of oligonucleotide strands onto the 
array. This process proceeds in a parallel process with the addition of A, C, T, or G 
nucleotides to multiple chains growing simultaneously by the programmed application 
of photolithographic masking techniques which expose or protect the linkers on each 
strand.
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1.3.2 Chip Design
The design of each oligonucleotide arrays is reliant on the availability of accurate 
sequence information. Early chip designs (e.g. Hu68oo) were based on sequence 
information obtained from GenBank exemplar sequences (a single sequence that 
represents a cluster of different sequences) from preliminary UniGene clusters. This 
was improved on in the design of the U95 chip series with the alignment of UniGene 
data using a cluster and alignment tool to form a consensus sequence where each base 
had agreement from 75% of the aligned sequences. The most recent design 
methodology for the latest U133 chips improved on previous practice and utilised 
sequence information from UniGene, dbEST, WUSTL, GenBank and RefSeq to form a 
the consensus sequence to which probes were then designed.
The probe spacing in early chip designs was approximately equal along an expressed 
sequence. However, the U133 design involved spacing to favour high quality 
independent probes in an attempt to ensure that multiple probes give measurements 
independent of the target (Affymetrix, 2001a). Probe uniqueness is required in order to 
minimise cross hybridisation to similar targets from unintended sequences. The 
Hu68oo and U95 chips were designed with probes that have 21 or more bases (out of 
25) matching those in other probes excluded, as they were deemed too similar. In the 
design of the U133 chips the criteria were altered to exclude probes with two 8mer 
matches (including at least one with a I2mer match).
F igure 1.2
5' 3'
Probes
TGTACCTAGTACTACTGGCTAGTAAGCCGTCTATCGGTATC Genome Sequnce
CATGATGACCGA TCATTCGGCAGAT Perfect Match Sequence
CATGATGACCG2 ACATTCGGCAGAT Mismatch Sequence
Figure 1.2 -  Overview of probe location and design in relation to the genomic 
sequence
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Mismatch probes are identical to the perfect match ones, but with an alteration of the 
middle (13th) base to be different to that expected from the expressed sequence, thus 
forming a mismatched hybridisation. A summary of the probe makeup of a probe set is 
shown in Figure 1.2. As part of the design process, probes for a given probe set are 
randomly assigned locations on the chip in an attempt to avoid location effects during 
the hybridisation process.
Improvements in the design algorithms and probe quality have allowed for a decrease 
in the number of probes in probe set from 16-20 down to 11 which has allowed for 
greater information density. The combination of fewer probes, along with a decrease in 
probe feature size on the array from 20 microns to 18 and most recently down to 11 
microns, means that many more probe sets can be fitted onto a single array.
1.3.3 Sample processing
The experimental stages required to extract RNA from samples and hybridise these to 
GeneChips varies according to the experimental organism (Affymetrix, 2004). In 
eukaryotic samples, the process begins with total RNA isolated from cells (e.g. a tissue 
sample or cell line). The total RNA is reverse transcribed in two separate stages to 
produce double-stranded cDNA before a cleanup procedure is then carried out on the 
cDNA. The next stage involves the amplification of the cDNA into biotin labelled anti­
sense cRNA which is also subjected to a cleanup procedure before fragmentation into 
segments typically 25-200 bases long.
At this stage, a number of controls are added which are used to locate the edges and 
comers of the array (oligo B2), along with control that can provide information on the 
hybridisation, washing and staining procedures (E-coli genes; BioB, bioC, bioD and 
ere). An additional five genes from B. subtilis, (dap, thr, trp, phe and lys) are also 
present on the chip, which are used by some researchers as additional controls or 
features used from normalisation between arrays (Hill, et al., 2001).
The fragmented biotin-labelled cRNA, along with the controls are mixed to form a 
hybridization cocktail which is inserted into the array cartridge before being placed in a 
hybridization oven for 16 hours, during which time the sample is eluted over the chip at 
optimal hybridisation temperatures. During hybridisation, the fragmented cRNA and 
controls bind to the oligonucleotides on the array utilising the complementary binding 
properties of DNA.
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Following hybridisation, non-hybridised cRNA is removed from the cartridge and the 
array is placed in a “fluidics station”, where a series of washing and staining steps are 
applied to the array including the addition of a fluorescent staining agent streptavidin- 
phycoerythrin (SAPE) which binds with the biotin labelling on the cRNA.
After the washing and staining process the array is removed from the fluidics station 
and placed in a laser scanner. Laser light is applied to the array which excites the 
fluorescent staining agent. At locations where more cRNA is hybridised a brighter 
signal is observed. Each probe array is scanned twice, taking up to ten minutes, 
depending on the array format. The software calculates an average of the two images, 
defines the probe cells and computes an intensity for each cell. The double scan 
improves assay sensitivity and reduces background noise. The amount of signal 
emitted is recorded as a value in 16 bits, with many pixels comprising a single probe. 
The Affymetrix control software stores this image as a DAT file.
The final stage in the experimental processing is the application of a grid to the array 
according to the signal obtained from the corner and edge controls. These are used to 
superimpose and align a grid upon the image which is then used to produce a single 
expression value for each probe using the 75th percentile of the pixel intensities for 
each probe cell. The probe intensity values are then written into a CEL file. This CEL 
file forms the bases of the majority of data analysis options which are explored further 
in the course of this thesis.
1.4 Interpretation of microarray data
There have been several studies undertaken to validate the technology and explore the 
biological meanings of the resultant data. Chudin et al. compared signal level relative 
to spiked in transcript concentration as a sensitivity study and found linearity over the 
middle range of signal values with deviation at the extremes (Chudin, et al., 2002). 
Naef at al., undertook experiments to characterise the expression to noise ratio and 
found a relationship between the standard deviation of values and noise and an 
intensity dependence of the standard deviation of the resultant data (Naef, et al., 
2002).
Li et al. examined the sensitivity and specificity between the Affymetrix oligonucleotide 
microarray systems and cDNA arrays and found large differences in the values 
produced for allegedly comparable data. They concluded that oligonucleotide 
microarrays is more reliable for interrogating changes in gene expression than data 
from long cDNA microarrays (Li, et al., 2002).
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The central concept of any microarray data analysis is one of data reduction. If we look 
at a single Affymetrix U133A chip the values for millions of oligonucleotides are 
reduced to a single value for each of the 267,397 probes. The data obtained from each 
set of (on average) eleven probes is then used to calculate a score for each of 22283 
probe sets representing a transcript. This is then repeated across a number of chips 
presenting a researcher with somewhere in the region of a quarter of a million data 
values for further analysis, from a 10 array experiment.
Dependent on the type of experiment being undertaken, the next stage in the analysis 
process may be the further reduction of this data to a list of significant changes within 
the dataset Due to the volume of data being produced in the course of an experiment, 
the analysis stages undertaken during data reduction are an essential process to make 
data both comparable and usable.
1.4.1 Computing expression values from image data
The first important analysis step in any microarray experiment (both cDNA and high- 
density oligonucleotide) is the conversion of the image file representing the scanned 
array to a numerical representation of transcript expression. As part of this process 
various potential experimental artefacts in the data must be tackled in an attempt to 
overcome experimental variation and make data comparable between identical 
experiments. This is achieved with the application of normalisation and scaling 
methodologies.
Concentrating on the analysis of data from the Affymetrix GeneChip system, the first 
stage of analysis after the initial reduction of the full image to a representative CEL file 
image (see Section 1.3.4) are a number of stages resulting in the production of 
expression values for each probe set present on the chip. As each transcript is 
represented by a number of probes on the chip, these must be combined and reduced to 
form a single value for gene expression.
The production of an expression value requires the integration of data from numerous 
perfect match and mismatch probes representing both a measure of actual transcript 
expression and a component indicating the non-specific binding to the probes. In 
addition to the two methodologies for this process provided by Affymetrix within 
versions of their Microarray Suite software, numerous alternative methods of 
computing expression values have been proposed. Popular alternatives include the 
Model Based Expression Index (MBEI) (Li and Hung Wong, 2001a; Li and Wong, 
2001b), the Robust Multi-chip Average (RMA) (Irizarry, et al., 2003) and an improved 
RMA version using sequence information in the analysis named gcRMA (Wu, et al., 
2004).
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Common to all these methods is a three stage analysis approach. Stage one applies a 
background correction to the array to make data comparable across the array and 
identification of the detection threshold. Stage two incorporates varying methodologies 
for the incorporation of the probe data into an expression value. Some of these 
methods follow a heuristic approach whilst others are strongly statistical, whilst others 
incorporate all the probe data and other disregard mismatch data. Stage three, 
overcoming data variability, is discussed in Section 1.4.2.
The varying methods for the low-level analysis of high-density oligonucleotide arrays 
all have a common goal; to produce biologically meaningful expression values by 
application of a specific blend of data manipulation and modelling of the probe 
intensity data. Rajagopalan compared the relative performance of different expression 
metrics for their accuracy in producing concentration curves and correct fold-change 
detection within the Affymetrix Latin square dataset. Rosetta Resolver and MAS 5.0 
were found to out perform the dChip PM-Only model (Rajagopalan, 2003).
Optimally, the resultant expression values should be both precise (low variance 
between observations) and accurate. Chapters Three and Four concentrate on a 
comparison of these different expression metrics, and the ability of each to correctly 
identify changes within a dataset.
1.4.2 Issues of data variability and normalisation
Bakay et al. assessed the sources of variability in experimentation and experimental 
design using clinical biopsies and concluded that inter-patient differences were the 
most variable effect, with only a minor contribution from experimental variation 
(Bakay, et al., 2002).
However, scaling and normalisation steps are essential to overcome the effects of 
technical variation and systematic experimental error and aim to produce data that is 
comparable between arrays. Normalisation can summarised as a focused goal of 
getting numbers from one chip to mean the same as numbers from another chip.
Normalisation for microarrays generally makes the biological assumption that the vast 
majority of genes on the array are unchanged; however, some researchers have chosen 
to implement normalisation based on a selection of known invariant control genes or 
use a set of “housekeeping genes” whose expression are believed to remain constant 
and are used to scale the other expression values accordingly (Geller, et al., 2003).
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Normalisation steps can be applied at many differing stages of the analysis process, and 
are key to the methodologies for many expression metrics; however they can also be 
applied post-expression analysis to overcome remaining issues of dissimilarity between 
biologically identical chips (Bolstad, et al., 2003; Durbin, et al., 2002). Investigations 
into the effect of post expression analysis normalisation are discussed and explored 
further in Chapter Five.
1.4.3 Experimental approaches using microarrays
Analysis of the expression values obtained from a series of experiments can be split into 
two main areas, pattern recognition (clustering and learning techniques) and detection 
of differential gene expression (Nadon and Shoemaker, 2002).
Pattern recognition involves the application of cluster analysis or class discovery, which 
results in grouping of chips and probe sets according to the experimental data. This 
can then be compared to clinical phenotype data for the purposes of identifying the 
genetic patterns (or fingerprint) of a given clinical condition. There are a variety of 
techniques available for the supervised and unsupervised clustering of data including 
hierarchical clustering, k-means clustering, self-organising maps and principal 
components analysis (Dudoit and Fridlyand, 2002; Knudsen, 2002).
For the biological researcher, however, many microarray experiments are of an 
exploratory nature, conducted to generate hypotheses to guide future research. 
Experiments of this type can include prior knowledge evaluation where a researcher is 
examining a wide series of effects within a known system of interest and inferring new 
information from the results, or more generic “gene fish ing” experiments where a 
researcher is looking for new interesting results to potentially explain the phenotypic 
differences observed in the laboratory.
The common feature between these approaches is the desire to identify differentially 
regulated genes that may be of interest The process of data analysis is typically 
concerned with the reduction of this data to a fist of “significant” findings for follow up 
using complementary validation techniques (e.g. RT-PCR). This analysis stage forms 
yet another data reduction process, where the results for many probe sets across many 
chips are processed to a smaller list for further examination.
In many respects, data analysis methods are in their infancy, with the answers to many 
basic questions shadowed by work on more complex computational and statistical 
methods. Understanding the fundamental concepts is essential in the application of 
statistical tests and to underpin future work aiming to link microarray data to its 
biological annotation.
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As Quackenbush comments, “Sophisticated computational tools are available but the 
methods that are used to analyse data can have a profound influence on the 
interpretation of the results. A basic understanding of these computational tools is 
therefore required” (Quackenbush, 2001).
1.4.4 Techniques to identify differential gene expression
The aim of all experiments and subsequent analysis is to make the strongest possible 
conclusion from limited amounts of data. Biological variability and differences in 
experimental accuracy can make it difficult to separate real differences from those 
occurring due to random variability.
The human brain has an exceptional ability for pattern recognition, even from random 
data. It is natural to conclude that these observed differences are real effects and to 
exclude the possibility for random variation from our judgement. Analysis techniques 
and statistics exists to prevent this occurring and add a degree of certainty to any 
conclusions reached as well as allowing for the efficient analysis of the vast volumes of 
data a microarray experiment produces.
1.4.4.1 Non-specific filtering techniques
After normalization and estimation of the expression levels some anomalies may exist. 
For example there are sometimes estimated expression levels that are negative or ones 
that are much too high. In addition, data obtained from the early versions of 
Affymetrix Microarray Suite software (prior to version five) and from certain dChip 
models (Li and Hung Wong, 2001a; Li and Wong, 2001b) contained some negative 
intensity scores in the output.
Negative numbers cause issues when working out ratios and applying transforms to 
data so it became customary to shift these values to positive numbers. Examples of 
approaches used to overcome this include the addition of a shifting factor to all signal 
values or the replacement of all numbers less than 20 with a signal value of 20. Whilst 
this overcomes the problem presenting, it also has the effect of changing the 
distribution of the data, and may change the outcome of analyses further downstream.
Other non-specific techniques are used to reduce the amount of data for downstream 
analysis, in many cases to remove potentially problematic data prior to the application 
of fold-change calculations (Kersten, et al., 2001; Teague, et al., 1999).
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As a comprehensive example of the types of filtering that can be applied to a data set, 
Golub et al. (Golub, et al., 1999) pre-processed their data in three stages. First 
thresholds were applied to the data, removing the upper and lower most values. 
Secondly genes were removed from analysis where the maximum minus the minimum 
intensity of a gene across arrays was less than a pre-determined figure and those where 
the ratio of maximum intensity divided by minimum intensity was less than a defined 
threshold.
Finally Golub et al. transformed their data by taking base ten logarithms of the raw 
data. The application of a transform as part of analysis has been employed by many 
researchers, for a variety of heuristic reasons (Grant, et al., 2002; Katsuma, et al., 2001; 
Virtaneva, et al., 2001). Virtaneva comment the reasons for application of a log 
transform to their data was to “reduce skew  and the desired variability properties”. 
An investigation of the application of these techniques and specifically transformation 
is addressed in Chapters Three and Four.
1.4.4.2 Identification of differentially regulated genes
Early work on microarray data involved the application of non-specific filtering 
techniques (the removal of probe sets that fail to adhere to a set of arbitrary rules 
(Golub, et al., 1999) and analysis of the ratio of gene expression between various 
grouped samples (Bowcock, et al., 2001; Cao, et al., 2001; Jiang, et al., 2001; Luthi- 
Carter, et al., 2000; Newton, et al., 2001; Porter, et al., 2001; Sandberg, et al., 2000; 
Unger, et al., 2001). Other researchers (Svaren, et al., 2000) simply chose the fifty 
highest expressed transcripts in their resultant dataset.
The limitation of this approach is a lack of a confidence measurement in any 
observation obtained from a microarray experiment. For example two genes which are 
both very low expressed in terms of their signal measurement may be identified as 
significant, whilst moderate changes in the measurement of a higher expressed gene 
may be deemed insignificant.
Scientists are often presented with data with small differences in the observations 
compared to experimental imprecision and biological variability and large variances in 
their observations. Statistical methods have been designed to deal with each of these 
problems and provide a robust measurement of any differences present Application of 
non biased statistical tests give both access to information of which genes are likely to 
be differentially expressed, , but also provide a score for confidence in any result 
identified.
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In the early days of statistics, it was assumed that most analyses would deal with large 
datasets and small samples were too small to be of any value. Opinion has gradually 
changed with the realisation that differences in large datasets are most often obvious. 
It is the smaller sample size that warrants the attention of statistical investigation in 
order to extract reliable conclusions from limited amounts of data.
Deterred by the cost of replication of comparatively expensive microarray experiments, 
some researchers have attempted to develop and apply techniques to minimise the 
requirement for experimental replication. Ron et al. reported good results when 
comparing the Affymetrix change p-values to the t-test and concluded this was a good 
method of reducing the requirement for replication (Ron, et al., 2003), whilst Kamb 
and Ramaswami used the technique of difference averaging to avoid multiple replicates 
(Kamb and Ramaswami, 2001).
Most statistical tests have been designed for situations where the number of 
observations exceeds the number of factors that may influence the result. 
Unfortunately microarray experiments consist of a large number of parallel 
observations. Wolkenhauer termed this issue in relation to microarrays as “the curse o f  
dimensionality” (Wolkenhauer, et al., 2002).
Despite issues with the application of statistics to microarrays, they have proven a 
popular and ultimately useful tool for the identification of differentially expressed 
genes.
Many classic statistical techniques have been applied in the identification of 
differentially regulated genes in microarray data sets, including several variants of 
Student’s t-test (Baldi and Long, 2001; Dow, 2003; Kooperberg, et al., 2002; Korn, et 
al., 2002; Lonnstedt and Speed, 2002; Tusher, et al., 2001) and ANOVA, an extension 
of the t-test for multiple groups of data. (Kerr, et al., 2000; Pavlidis and Noble, 2001). 
Non-parametric equivalents of these tests have also been utilised (McKay, et al., 2004).
Other researchers have chosen to undertaken analysis using multiple statistical 
techniques and then integrate the results to draw conclusions about the changes in 
their data. Welsh et al. employed a variety of methods including difference of mean, 
fold-change, t-test and clustering methods (Welsh, et al., 2001), Wang et al. combined 
results from the t-test and Westfall and Young permutation t-test for multiple 
correction (Wang, et al., 2002), whilst Tan et al. used the t-test and Mann-Whitney test 
to analyse their data for differential gene expression (Tan, et al., 2002).
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The t-test and SAM technique (Tusher, et al., 2001) which implements a more robust 
version of the t-test have also proven popular analysis techniques (Mootha, et al., 2003; 
Tudor, et al., 2002).
In addition to the application of these more traditional testing approaches, research has 
developed novel techniques for the detection of differential gene expression. Jenssen et 
al. developed and applied a log rank test (Jenssen, et al., 2002), Jain et al., developed a 
local pooled error method and compared results versus the t-test and Westfall and 
Young permutation t-test (Jain, et al., 2003). Li et al. developed a rank method based 
on the sums of detection calls (absent /  marginal /  present) (Li, et al., 2002b). Other 
researchers (Hatfield, et al., 2003; Saidi, et al., 2004; Tong, et al., 2001) have 
implemented the Baldi and Long Bayesian t-test framework (Baldi and Long, 2001).
A variety of permutation techniques have also been developed for application to 
microarray data including Permax, which assigns a limited number of permutations to 
the dataset (Martin, et al., 2001; Mutter, et al., 2001). Pan utilised various 
permutations of simulated dataset utilising ROC curves to access performance of a 
variety of methods including non-parametric techniques, SAM and an empirical Bayes 
method (Pan, 2003). Xu and Li reported the application of a permutation method 
applied to dChip data and made comparisons of gene ranks in the output compared to 
non-parametric methods (Xu and Li, 2003) and Park et al. developed and applied a 
permutation based ANOVA test (Park, et al., 2003).
However, the use of statistical techniques to analyse microarrays have often been 
applied in a somewhat ad-hoc fashion, often due to a lack of options available to 
validate the application of a technique to a dataset, with many researchers choosing to 
implement multiple tests in order to obtain a consensus confidence in the results 
obtained. Chapters Three to Seven are concerned with the validation of statistical 
methodologies and their application to Affymetrix GeneChip arrays. The investigations 
have followed a "back to basics” approach in an attempt to overcome the hurdle of 
understanding and infer maximum significance from minimum resources.
1.4.5 Making sense of microarray experimental findings
Most important biological activities are not the result of a single molecular activity, and 
generally result from choreographed activities of multiple molecules often acting as 
functional pathways. To fully understand how organisms function we will have to 
understand the relevant pathways for that organism.
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The parallelization of experimentation within a microarray experiment provides the 
information required to attempt conclusion about gene interaction by relation of the 
levels of many genes simultaneously.
The results of a statistical analysis may typically return a list of between 200 and 1000 
genes tagged as significant. Practically a molecular biologist might consider following 
up around twenty genes and thus a list of 500 genes with no clue to relative priority 
may be of little help to guide future experiments. An important, but often overlooked 
final stage of a microarray experiment is the annotation of the data, allowing for 
functional links between findings to be made. Techniques and tools for the effective 
annotation and exploration of experimental findings are discussed in detail in Chapter 
Seven.
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Chapter Two 
Data distributions and their effect on analysis 
options
In this Chapter the issue of data distributions of microarray datasets is explored. 
Section 2.1 introduces the importance of data distributions and the effect these have n 
the choice of statistical test that can be applied to a dataset. Section 2.2 reviews the 
methods used to investigate the normality of data from a variety of expression metrics. 
Section 2.3 explores the data distributions of six expression metrics using a variety of 
techniques and investigates the effect of data transformations on data distribution. 
Section 2.4 discusses the results and observations regarding the observed data 
distributions and the effects these have on the use of statistical tests in an analysis.
2.1 Introduction
The importance of investigating differential gene expression is evident from the various 
cell types in an organism that all contain the same genetic information, but are 
phenotypically very different from each other in function and appearance. Many of 
these differences are fundamentally due to differences in gene expression between 
different cells.
The mass-parallelisation of techniques able to detect gene transcription provides 
potential insight into the full pattern of gene expression in a cell rather than the study 
of single genes and messengers. To the clinician the characterisation of patterns within 
a dataset can yield classification information for disease, such as the determination of 
transcriptional signatures that predict outcomes in breast cancers (Perou, et al., 1999).
2.1.1 Introduction to differential gene expression
However, to the laboratory-based researcher, the experimental goal may be centred 
more on determining the basic processes that control an organism’s functioning or 
looking for malfunctions that may result in disease. At this level the focus may be 
identifying changes in gene expression between only two or three different states in 
order to yield potential useful information about groups of genes implicated in the 
phenotypic differences observed. In their simplest and most common application, 
microarrays experiments are focused on the detection of differences between two 
different types of sample, such as differences between diseased and normal states or 
between treated and untreated groups.
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Analysis of the amount of data an experiment that just a simple experiment produces is 
not a trivial task due to both the amount of data a researcher is required to analyse in 
parallel, combined with the potential complexity of tools available (Quackenbush,
2001). It is the understanding of the tools available and the aim of determining best 
practice in analysis that forms the basis of the investigations undertaken and reported 
in this thesis.
2.1.2 Application of statistical techniques to microarray data
The aim of all experiments and subsequent analysis is to make the strongest possible 
conclusion from the available data. Biological variability and differences in 
experimental accuracy can sometimes make it difficult to separate real differences from 
those occurring due to random variability. The human brain has an exceptional ability 
for pattern recognition, even from random data. It is natural to conclude that these 
observed differences are real effects and to exclude the possibility for random variation 
from our judgement. Analytical methods exist to prevent this occurring and add a 
degree of certainty to any conclusions reached.
In the early days of the development of microarray technologies analytic methods were 
often based on pair-wise comparison between chips, often using the ratio of expression 
signal between two samples (the “fo ld  change”) as the method for determining 
differential expression of a gene between samples. Fold change however, is limited by 
it failing to account for technical and biological variability and processing each data 
point as an exact value contributing to the overall result and a single extreme outlying 
value could results in a result being returned as significant. Statistical tests present as a 
solution to this problem and can provide results which identify which probe sets are 
significant along with a value indicating the confidence of a result being true.
Many different statistical approaches have been explored to identify differential gene 
expression (Kerr, et al., 2000; Miller, et al., 2001; Nadon and Shoemaker, 2002). 
However, few guidelines exist based on the comparative performance of each test in 
relation to each other, regarding which is best at extracting meaningful biological 
knowledge from a microarray experiment. An important avenue of research thus 
presents in undertaking a uback to basics” approach to the analysis of microarray data, 
building analysis methodologies with sound theoretical and empirical grounding in 
contrast to an ad hoc analysis decision making process.
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The review of any basic statistics book on the subject of determining differences 
between groups of data yields a series of additional questions about the data in contrast 
to a unified solution to the most applicable statistical test. A summary of some of the 
questions typically encountered and the resultant suggestion for most applicable 
statistical test is shown as a flow chart in Figure 2.1.
Figure 2.1
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Figure 2.1 -  Flow chart o f typical questions encountered in the quest fo r  a statistical 
test looking fo r  differences between two groups o f  data. Interval and ratio data are 
continuous data where the differences are interpretable. Ratio data also contains a 
natural zero, allowing fo r  interpretation o f  the ratios. Ordinal data are categorical 
and contain a logical ordering to the categories. Nominal data is categorical data 
where the order o f  the categories is arbitrary.
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2.1.3 Reviewing key statistical assumptions and their relation to 
Affymetrix Gene Chip data
Each of the questions posed leads to the researcher making statements about the 
nature of their data; to a statistician, these answers are termed assumptions. There are 
very few large-scale validation datasets that have been made available by the companies 
that developed the technologies. As a result, researchers are often left attempting to 
solve issues of assumptions using real-world datasets which are limited in size and 
usually contain no “known truth” to test the outcomes of differing answers to these 
assumption questions.
Review of the questions posed in Figure 2.1 with the analysis of a microarray dataset in 
mind highlights the issue of whether the data meets parametric assumptions as a key 
question/assumption without an answer. This parametric assumption is concerned 
with the question of whether the distribution of the data is comparable to a distribution 
of which the equation is known. Applied to statistical techniques in which sampling is 
involved, this comparison is usually made to the normal (or Gaussian) distribution.
2.1.4 Application of parametric testing to microarray data
Parametric statistical tests are popular as a method of identifying differentially 
regulated genes in microarray datasets partially as result of small experiment size due 
to the associated cost considerations or the limitations of sample availability. A variety 
of parametric tests have been developed for the identification of differentially regulated 
genes in microarray datasets, including several variants of Student’s t-test (Baldi and 
Long, 2001; Kooperberg, et al., 2002; Lonnstedt and Speed, 2002; Tusher, et al., 2001) 
and ANOVA (Kerr, et al., 2000).
These statistical tests have superseded earlier empirical methods that were often based 
on the magnitude of expression ratios, in combination with other heuristic filtering 
rules (Golub, et al., 1999; Knudsen, 2002). However, the majority of classical statistical 
tests have been designed for situations where the number of observations exceeds the 
number of factors that may influence the result.
Although increasingly sophisticated parametric techniques are being developed, many 
share the common assumption that the data (comprising the repeated measurement of 
the same gene across many chips) are drawn from a normal (Gaussian) distribution. As 
the researcher is unable to determine the answer to this question with the data from a 
typical microarray experiment, a logical approach is to consider the application of non- 
parametric testing.
35
2.1.5 Application of non-parametric testing to microarray data
Because of the lack of knowledge regarding data distributions resulting from the 
analysis of Affymetrix microarray data, statistical guidance would therefore suggest 
non-parametric tests as the analysis method of choice for the determination of 
differential gene expression. Non-parametric tests make fewer assumptions about the 
distribution of data (for example the requirement that the data comes from a Gaussian 
distribution). However, non-parametric tests are less powerful than their parametric 
equivalent, which assume the data distribution follows a known form.
Overall, it has been calculated that non-parametric tests require only 5% more 
observations in order to have the same power as parametric tests if the distribution is 
truly normal. If the sample is large then there is little difference between parametric 
and non-parametric tests, however at smaller sample sizes, to reach an identical 
statistical conclusion with the same confidence level, nonparametric tests require 
anywhere from 5% to 35% more data than parametric tests (Bethea and Rhinehart, 
1991).
A typical exploratory microarray experiment may comprise of as little as three or four 
chips and unfortunately non-parametric testing provides insufficient power and 
resolution at this sample size and hence may not produce a useable result at this small 
sample size (Good, 2000; Grant, et al., 2002). Molutsky (Motulsky, 1999) states that 
with less than 7 samples it is impossible to get a p-value of less than 0.05, a commonly 
used confidence value.
Non-parametric tests have been used to provide such p-values (Troyanskaya, et al.,
2002), but although they make no assumptions regarding the underlying data 
distribution, their use can be restricted by their relatively poor power when applied to 
small-scale, exploratory microarray datasets.
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The major problem for a researcher designing a microarray experiment is one of cost. 
Current Affymetrix GeneChip experiments cost around £500 per sample. The 
researcher must be guided on dividing a limited resource between replicating 
experiments in order to calculate a statistical significance of the results, and 
undertaking another experiment. The view of an average researcher can be 
summarised in a quote by David Botstein “I f  I  had to replicate m y experiments, I  could 
only do ha lf as much” (Churchill, 2001).
2.1.6 Data distributions and Affymetrix microarray data
For researchers using Affymetrix GeneChip technology, the assumption of normality 
has been difficult to address, with the majority of extant datasets that are sufficiently 
large to critically investigate the issue of normality being confounded by underlying 
biological variability.
Inspection of existing Affymetrix datasets suggests that significant deviations from 
normality can occur. For example, when analysing the well-studied AML/ALL dataset 
(Golub, et al., 1999) one study found both normal and non-normal data, including bi- 
modal and tri-modal distributions (Grant, et al., 2002). A separate study profiling 
prostate cancers reported highly skewed distributions, with both positive and negative 
skew, leading the researchers to take the square root of each expression value in an 
attempt to control for this (Stamey, et al., 2001).
The limitation of these studies is the difficulty of separating the data distribution 
resulting from the analytical technology from that associated with biological variability. 
Indeed, for many of the large-scale cancer studies (Alon, et al., 1999; Golub, et al., 
1999), the nature of the underlying biology would make it surprising if significant 
deviations from normality were not found. Fortunately, such datasets are large in scale 
(often in excess of fifty chips), and in these cases non-parametric testing would have the 
power to circumvent the problems raised by data that do not follow a normal 
distribution.
In contrast, well-designed small-scale exploratory experiments, involving as few as 3 or 
4 chips in each sample group, usually do not suffer the same problems of genetic, 
patient and disease heterogeneity. Due to this small sample size and the limitations of 
non-parametric testing, we must look towards the application of parametric 
techniques, which offer increased power with smaller datasets. However, to achieve 
confidence in any result obtained, there is a need to review the nature of the data 
distributions obtained from microarray technology, and any address necessity to 
transform data prior to the application of parametric tests.
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2.2 Technical Methodology
To address issues of data distributions and the assessment as to whether Affymetrix 
microarray data is suitable for parametric testing requires investigations applied to a 
dataset with sufficient replicates to explore these distribution issues in the absence of 
biological variance.
2.2.1 Experimental approach
As part of their software development cycle, Affymetrix made publicly available, a 59- 
chip “spike-in” dataset based on hybridisation of the same human pancreatic cRNA, 
together with various transcripts spiked-in at known concentrations, onto Affymetrix 
U95A GeneChips (Affymetrix, 2001b).
The original motivation for the production of this dataset was to address the 
experimental response to known transcript concentrations. However, removal of the 
spiked genes produces a dataset comprising 59 replicates from the same sample, large 
enough to enable exploration of the sample population, and to address whether the 
data follow a normal distribution and thus allows the valid application of a parametric 
test. Further details on the dataset can be found in Section 9.2.1
The dataset comprised the results from an experiment with 14 spiked-in probe-sets set 
against a complex background of human pancreatic mRNA hybridised onto U95A 
GeneChips containing 12559 probe-sets. Experimental details from Affymetrix are 
limited but it is believed that each of the 59 chips was hybridised with a technical 
replicate of the same mRNA. Removal of these 14 spikes thus leaves a dataset of 59 
replicates which contain only experimental and technical variation.
2.2.2 Analysis with a series of expression metrics
Six different algorithms were applied to extract expression values for each probe set 
(generally comprising a series of sixteen probe pair intensities) from the image data. 
The data was analysed using Affymetrix Microarray Suite versions 4.0 (MAS 4.0) and 
5.0 (MAS 5.0), the model based expression indices (MBEI) of Li and Wong (Li and 
Wong, 2001) calculated using two different models (PMMM and PM-Only) within the 
dChip software package, and the RMA (Irizarry, et al., 2003) and gcRMA (Wu, et al., 
2004) algorithms released as part of the Bioconductor project (Gentleman, et al., 
2004). Each of these analysis methods produced a single value for each probe set for 
each chip within the dataset. Further details of these expression metrics are contained 
in Section 9.2.2.
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In addition to a quantitative expression value, four of the analysis methods (all MAS 
and dChip models) provide a qualitative measurement indicating if the transcript is 
detected (Present), not detected (Absent), or marginally detected (Marginal). These 
data were also extracted where present.
2.2.3 Post-analysis filtering
The expression values and calls for relative gene expression (Absent, Present or 
Marginal) were exported from each package into delimited text files. Data from the 
fourteen spiked-in genes (37777_at, 684_at, i597_at, 38734_at, 39058_at, 363ii_at, 
36889_at, I024_at, 36202_at, 36o8s_at, 40322_at, 407_at, I09i_at, I708_at) and 67 
control probe sets (with AFFX prefix) were removed, leaving 12545 probe sets for 
further analysis.
2.2.4 Technical Methodology
Normality testing using the Shapiro-Wilks (Shapiro and Wilks, 1965) test was 
undertaken using the R statistical language (Dudoit, et al., 2002; Ihaka and Gentleman, 
1996). Futher insight into data normality was obtained by calculating the Pearson’s 
correlation coefficient from a normal Quantile-Quantile (Q-Q) plot (Filliben, 1975) 
implemented using R. Measurements of the skew coefficient (Press, et al., 1993) were 
implemented within R using the ei07i library (Dimitriadou, et al., 2004). Box-Cox 
normality plots were implemented using R in combination with Microsoft Excel.
Datasets to be used for the investigation of data distributions were produced by 
extracting the expression values from the 59 CEL comprising the Affymetrix U95A 
Latin Square experiment. The CEL files were analysed using six different expression 
metrics, Affymetrix Microarray Suite versions 4.0 and 5.0, two dChip model based 
expression algorithms, and two variants of the RMA methodology. The resultant data 
was then processed to remove the 14 spiked-in genes and control probe sets (see 
Materials and Methods).
The expression matrix outputted from each analysis method comprised columns, 
relating to each GeneChip, with a row for each probe set. All the subsequent tests for 
normality refer to the data distribution for each row of data, comprising the 59 
expression values for a single gene. This is distinct from analysing intra-chip 
distributions (Hoyle, et al., 2002), where a dataset would be a single column 
comprising the expression of many different genes
39
2.3 Results and Explorations
2.3.1 Statistical Normality Testing
The statistical assumption key to the application of parametric testing is the 
requirement for the data to follow a normal distribution. To test this assumption 
applied to Affymetrix microarray data, the normality of the data for each probe set was 
assed within the 59 chip Latin Square dataset (9.2.2)
Many statistical tests exist for the analysis of the distribution of a dataset, specifically 
the conformation to a normal distribution. The default test offered by many statistical 
packages (e.g. SPSS, SAS) is the Kolmogorov-Smimov test. However, D'Agostino and 
Stephens have argued that "the Kolmogorov-Smimov test is only a historical curiosity 
- it should never be used". In choosing a test to assess the normality of the exemplar 
dataset from Affymetrix, the issue of limited sample size restricted the choices of 
suitable tests; for example, the Kolmogorov-Smimov test was designed for use against 
much larger sample sizes (D'Agostino and Stephens, 1986).
Formal testing of normality was undertaken by application of the Shapiro-Wilks test 
for normality to each probe set within the dataset from each of the six expression 
metrics under review. The Shapriro-Wilks test was chosen for its suitability for small 
and medium samples and ability to show good power across a range of non-normal 
distributions (Shapiro and Wilks, 1965).
The number of non-normal genes (scoring a p-value less than 0.05) for each of the four 
datasets is shown in Table 2.1. A large number of normal genes are observed within 
each of the expression metrics; however MAS 5.0 and gcRMA show a significantly 
increased level of non-normality when compared to the other four metrics.
Whilst this observation does not provide confidence in the application of parametric 
tests to these datasets, with 59 samples the Shapiro-Wilks test has the power to detect 
even small deviations from normality and score them as significant. In addition the 
nature of the analysis of the answers with a probe set either passing or failing the test 
for normality does not provide information regarding the magnitude of deviation from 
normality. It could be that many probe sets have only a modest deviation from 
normality, one that would not be a barrier to the application of a t-test (or similar).
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T a b l e  2 .1
Analysis Method Number of probe sets deviating from normality (p<o.os from SW test)
MAS 4.0 3521 (28%)
dChip PM-MM 2213 (18%)
dChip PM-Only 2544 (20%)
MAS 5.0 5799 (46%)
RMA 3075 (25%)
gcRMA 6371 (51%)
Table 2.1 -  Results fro m  Shapiro-Wilks tests fo r  normality.
Guidance about how much deviation can tolerated is hard to come by. However, 
Motulsky commented that “many parametric tests, such as the t-test, are resistant to 
moderate deviations from normality, although the degree to which such deviations are 
tolerated is dependent upon the shape of the distribution and the degree of deviation” 
(Motulsky, 1999). It is thus desirable to assess the degree of deviation from normality 
and investigate the nature of deviation observed.
2.3.2 Assessing the degree of deviation from normality
Investigations into the degree that each probe-set deviated from normality was 
addressed using normal Quantile-Quantile (Q-Q) plots. Q-Q plots are a graphical 
method for examining data distributions, showing the ordered data for each probe set 
plotted against the standard quantiles of the normal distribution. They provide a 
simple and effective visualisation of the data distribution, and any deviation from 
normality. For a perfect normal distribution a Q-Q plot would show data points in a 
straight line with a positive gradient (Hyndman and Fan, 1996). As an illustration, 
normal Q-Q plots for a typical reasonably-expressed probe set (322o8_at) called 
Present in all six datasets is shown in Figure 2.1.
Since the visualisation of plots for over twelve thousand genes is impractical, the 
Pearson’s correlation coefficient (R2) for each Q-Q plot was calculated, to assess how 
close the data fit to a straight line, and thus normality. Any deviation from normality 
results in a correlation coefficient value significantly less than unity (Filliben, 1975). 
Frequency histograms of the correlation coefficient when compared to normality (R2) 
for each of the datasets are shown in Figure 2.2.
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Figure 2.1 - Normal Q-Q plots for probe set 322o8_at, which shows a good 
correlation to normality in all six datasets.
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Figure 2.2 -  Histograms showing the correlation to normality (Rp) extracted from  
normal Quantile-Quantile plots for individual probe sets.
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The majority of probe sets from both dChip models, MAS 4.0 and RMA show a strong 
correlation with normality, with most probe sets scoring over 0.9. Interestingly, the 
MAS 5.0 dataset shows a pronounced tail to the histogram, with a significant number of 
probe sets with a low correlation value (3165 probe sets where R2 <0.95). A similar 
effect is seen with data from gcRMA which displays an increase in tail density coupled 
with fewer probe sets scoring with a correlation coefficient value close to unity (R2 
>0 .975).
Whilst the histogram plots are informative in producing information about the number 
of probe sets which present with differing degrees of correlation to normality, they do 
not provide information regarding the data distributions for the probe sets in each bin 
that result in non-normality. To investigate this issue further the correlation coefficient 
values from the Q-Q plots for each probe set were plotted against the mean expression 
signal for each probe set (Figure 2.3).
The majority of data from both dChip models and MAS 4.0 (Figures 2.3.a, 2.3.b and 
2 .3 .C ) group close to unity, with no apparent pattern to the expression levels of probe 
sets scoring as non-normal. The data distributions for a large proportion of RMA data 
correlates well to normality (Figure 2 .3 .e ) .  However, a small group of low expressed 
probes show moderate deviation from normality and a few very low expressed probes 
show marked deviation from normality.
In contrast, MAS 5.0 and gcRMA (Figures 2.3.d and 2.3.f) show a large number of low 
expressed probe sets showing deviation from normality. Analysing the MAS 5.0 plot 
shows the majority of the poorly scoring probe sets have a relative expression level of 
less than 100 forming a pronounced tail to the plot. gcRMA shows a similar tail to the 
plot until reaching the very low expressed values, where their correlation to normality 
approaches unity again.
2.3.2.1 Comparison of correlation to normality and Shapiro-Wilks p-values
If the results of the Shapiro-Wilks test for normality are plotted against mean 
expression level a similar structure is seen to that visible in R2 from Q-Q plots, versus 
expression plots (Figure 2.4). As both metrics address the degree of normality of the 
data, such a similarity could be expected, with any difference being attributed to 
differences in linearity and scaling of the normality data between methods. The use of 
the p-values to stratify data and look for more interpretation, whilst commonly done, is 
technically an incorrect use for the results of the test. In the strict statistical use of the 
Shapiro-Wilks test, an alpha level should be set prior to testing and the results 
interpreted as passing or failing at this level.
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Figure 2.3 - Plots showing correlation to normality (R2) versus mean expression 
signal for each probe set.
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Figure 2.4 -  Plot of mean expression signal from the MAS 5.0 dataset plotted against 
the p-value from Shapiro-Wilks test for normality for each probe set
2.3.3 Investigating normality on a stratified MAS 5.0 dataset
Analysis using Affymetrix Microarray Suite provides an additional piece of information 
regarding each probe set, a detection call regarding the likely expression of a probe set. 
Each probe set is given a call of Absent, Marginal or Present derived from the resultant 
expression signal when compared to the background signal. Using this information, 
the R2 data from the Q-Q analysis of MAS 5.0 data was stratified for re-analysis on the 
basis of the detection call.
Two groups were defined, one containing the data from probe sets called Absent in all 
samples, and the other where at least one sample was given a detection call of Present 
or Marginal. As shown in Figure 2.5, this somewhat arbitrary subdivision is 
nevertheless effective at separating the data into one group that is largely non-normal 
(the Absents) and another that is largely normal (the Present/Marginal probe sets). 
The difference in normality between the groups was scored highly significant using the 
Mann-Whitney test (p < 2.2 x 1016).
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Figure 2.5 -  Plots showing correlation to normality (R2) versus mean expression 
signal for each probe set split according to the detection call from MAS 5.0 analyses. 
2.5.a shows the data subset where at least one sample was given a detection call of 
Marginal or Present and 2.5b shows the subset of data where all samples were called 
as Absent.
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2.3.4 Characterising the nature of the data distributions leading 
to deviations from normality in the MAS 5.0 dataset
To investigate the nature of the deviation from normality in those MAS 5.0 probe sets 
with low normality correlation values, Q-Q plots were inspected. These suggested the 
presence of a strong positive skew in many cases (data not shown). As an example, 
Figure 2.6 shows probe set 3i929_at which shows a normal distribution in the MAS 
4.0, dChip and RMA datasets, but is markedly non-normal in the MAS 5.0 dataset
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Figure 2.6 - Normal Q-Q plots for probe set 3i929_at which shows a strong positive 
skew in the MAS 5.0 dataset.
Review of the Q-Q plots suggests evidence of positive skew in many probe sets 
presenting with a non-normal distribution. Skewness characterizes the degree of 
asymmetry of a distribution around its mean. Graphically a distribution is described as 
having either positive or negative skew describing the direction that the data is skewed 
in.
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Due to the number of probe-sets under consideration a more numerical measure of 
skew is required in order to characterise different degrees of skewness. Numerically, 
skewness is defined in such a way as to make it non-dimensional. As such, skewness is 
defined in a way which characterises only the shape of the distribution, with the 
magnitude of a normally distributed dataset presenting with skew within the +2 to -2 
range when the data are normally distributed (Press, et al., 1993).
Skew was calculated for each probe set in each of the six expression metrics using the 
ei07i library (Dimitriadou, et al., 2004). The skew coefficient for each probe set was 
plotted against the R2 value obtained from the Q-Q plot of the data (Figure 2.8). For 
comparison the data was compared to a similar plot obtained by calculating the 
correlation to normality and skewness for 12000 normally distribution datasets with 59 
values (Figure 2.7).
Figure  2 .7
Skewness
Figure 2.7 -  Plot showing the correlation to normality and skewness for 12000 
normally distributed datasets with 59 values.
The MAS 4.0 and both dChip datasets have few non-normal probe sets, with an even 
spread of skew scores (Figures 2.8.a, 2.8.b and 2.8.c). In contrast, the MAS 5.0, RMA 
and gcRMA datasets contains a large number of non-normal probe sets with a marked 
positive skew (Figures 2.8.d, 2.8.e and 2.8.f). In addition, there is strong correlation 
between the strong positive skew and a poor correlation to normality.
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Figure 2.8 -  Plots showing the correlation to normality (R2 value) and skewness for 
each probe set.
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2.3.5 The effect of data transformation filtering techniques
In light of the observations of non-normality in Absent called probe sets in MAS 5.0 
data, gene filtering based on excluding all Absent calls would be extremely effective in 
removing the group of non-normal probe sets, and such an approach is commonly used 
by research prior to other analyses (e.g. clustering). However, there may be occasions 
when there is a desire to apply a statistical test to a gene called Absent in some samples, 
and present in others, such as an off-on regulation signal. Such a situation causes 
comparison to be made between data sets with very different distributions.
Functions can be applied to datasets that result in a transformation of the data 
distribution. An appropriate transformation of a dataset can often result in a dataset 
that approximately follows a normal distribution. Application of this technique can 
increase the number of tests available when their raw data does not meet the 
assumptions of standard tests.
Driven by the requirement of parametric tests to have data that follow a normal 
distribution, the question of whether skewed probe sets could be converted to 
normality by the application of a standard mathematical transformation was addressed. 
Examples of such transformations worthy of consideration include logarithmic, square 
root and inverse function since these can often correct the positively skewed data such 
as that presented by the MAS 5.0, RMA and gcRMA expression metrics.
2.3.5 Application of a logarithmic transform to correct non- 
normality in MAS 5.0, RMA and gcRMA datasets
Log2 transformation is common with users of two-channel cDNA microarray systems in 
order to make fold changes symmetrical. In the case of Affymetrix data, many 
researchers have chosen to log transform their data to overcome distributional 
problems (Golub, et al., 1999; Katsuma, et al., 2001; Virtaneva, et al., 2001). In 
addition, it should be noted that the expression metrics RMA and gcRMA include a log 
transformation as the final step in their analysis algorithm.
However, the validity of such a transformation is unclear with many researchers 
justifying its use by commenting on the prevalence of log2 data in biological data 
(Affymetrix, 2001b). The effect of log2 transformation was investigated using Shapiro- 
Wilks testing and correlation to normality from Q-Q plots (Sections 2.3.1 and 2.3.2).
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2.3.5.1 Logarithmic transformation of MAS 5.0 data
Shapiro-Wilks testing of log transformed MAS 5.0 data yielded 7047 probe sets 
deviating from normality (pco.os), compared to 5799 in the un-transformed data. 
Comparison of the Rp data plotted versus mean (Figure 2.9) with that from the 
untransformed data (Figure 2.2d) showed a loss of the pronounced tail to the plot. 
However, the probe sets showing lack of correlation to normality has shifted from the 
low expressed probes to the mid-expressed probe sets.
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Figure 2.9 -  R2 from Q-Q plotted against mean expression value for log2 transformed 
MAS 5.0 data
A  plot comparing the correlation to normality values from the untransformed versus 
transformed data (Figure 2.10) shows that the majority of non-normal probe sets in the 
untransformed data have had their correlation to normality improved as a result of the 
transformation. In addition it shows that there are not a group of probe sets which are 
impossible to transform towards a normal distribution by application of a 
transformation. However, the plot also shows a number of probe set which correlated 
highly to normality in the untransformed have been moved away from unity in the 
transformed data. This suggests that the transformation may have corrected the 
normality for the non-normal low expressed probes, but altered the normality for a 
large number of mid to high expressed probe sets.
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Figure 2.10 -  Plot showing the correlation to normality scores for each probe set in 
untransformed and log2 transformed MAS 5.0 datasets.
2.3.5.2 Logarithmic transformation of RMA and gcRMA data
RMA and gcRMA already incorporate a log2 transformation as part of the default 
analysis algorithm. To facilitate meaningful comparison to other data, the 
transformation was removed using power transformation and the results compared to 
that from the default analysis.
_ _  ' J  x  transformed
untransformed
Review of the R2 versus Q-Q plots for each expression metric reveals very little change 
to the data distributions observed (for RMA compare Figure 2.11 to 2.2.e and for 
gcRMA compare Figure 2.12 to 2.2.f). Review of the Shapiro-Wilks data highlights 
some differences between the normality of the transformed to un-transformed data 
with RMA showing 3322 probe sets deviating from normality compared to 3075 in the 
default data. gcRMA yielded 7508 probe sets deviating from normality compared to 
6371 in the untransformed data.
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Figure 2.11 -  R2 from Q-Q plotted against mean expression value for power 
transformed (2*x) RMA data
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Figure 2.12 - R2 from Q-Q plotted against mean expression value for power 
transformed (2*x) gcRMA data
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2.3.6 Application of a Box-Cox transformation
Extending the possibilities of data transformation to improve the normality of resulting 
datasets the logical extension from the ad hoc application of a test and examination of 
the effects on normality is a systematic search for the optimal transformation. Box and 
Cox (Box and Cox, 1964) suggest a series of power transformation can be useful in 
determination of the ideal data transformation for correlation to normality using the 
transform:
Y ' = Y X
The lambda value of a Box-Cox transformation correlates with other data 
transformations as follows; X=i = no transform; A,=o.5 = square root transform; >.=-1 = 
inverse transform. To eliminate the problem of Y° = 1, the transformation is replaced 
with log(Y) when X=o.
Given the results of a particular transformation it is helpful to define a measure of the 
normality of the resulting transformation. The R2 correlation value from a standard Q- 
Q plot can be used to determine which transform to apply to a dataset in order to 
transform its distribution as close to normal as possible.
A wide range of different transformations were applied to the MAS 5.0, RMA and 
gcRMA datasets (lambda range -2 to 2 in steps of 0.1). For each probe set the value of 
lambda which produced data that was the most normal, as judged by the Rp/Q-Q plot 
method described above, was recorded.
F igure 2.13
800 
700 
600 
>.500o
|  400 
S?
^  300 
200 
100 
0
Figure 2.13 -  Histogram of highest scoring transform value following Box-Cox 
normality plots of MAS 5.0 data.
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Figure 2.13 shows a histogram of these optimal transformation values for each probe 
set for the MAS 5.0 dataset. The histogram suggests the presence of a bimodal 
distribution is observed with one distribution centred around X = -0.2 (close to a log 
transformation) and another near A. = 1 (no transformation).
When the data were stratified into Present and Absent groups as before, this biphasic 
distribution was resolved into two separate monophasic distributions (Figure 2.14). 
Probe sets called Present require no transformation, which provides further support for 
the normality of these probe sets. In contrast, and as may be expected by the positive 
skewness observed in many of the probe sets, the optimal transformation for the 
Absent group is somewhere between a log and square root.
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Figure 2.14 -  Histogram of highest scoring transform value following Box-Cox 
normality plots o f MAS 5.0 data split by MAS 5.0 detection call.
Results from the application of Box-Cox normality plots to the RMA and gcRMA data 
did not reveal any structure to the data. Even with the extension of the bin range, no 
obvious structure was observed with the majority of values falling outside of the -3 to 3 
range. Within the -3 to 3 range a similarly small number of probes were observed in 
each histogram bin (range of 50-150).
The data indicates that there is no ideal transform that can move the dataset towards 
normality. Instead each probe set would require a differing transform when analysing 
RMA and gcRMA data. This would account for the marginal differences in normality 
observed between the untransformed data and default Log2 transformed data discussed 
in section 2.3.5.
■ Gene called absent in all samples
■ Gene called present/marginal in at least one sample
I
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2.4 Summary and Discussion
Statistical testing is becoming more common in the analysis of microarray datasets, but 
many parametric tests (assuming normality of the data) have been applied without 
knowledge of the underlying data distribution. In some cases Affymetrix microarray 
expression data has been transformed with little empirical justification, simply because 
of a lack of data to address these issues of data distribution.
Analysis of the Latin Square 59-chip dataset provides an unprecedented opportunity to 
address relatively straightforward but key questions regarding the resultant data 
distribution obtained using Affymetrix microarray technology. The use of a 
combination of formalised statistical testing, graphical visualisation of the correlation 
to the normal distribution, and assessment of distribution features such as skew, 
provides support for the normality of much of the data produced by six different 
algorithms commonly used for extracting expression values, and thus the application of 
parametric tests that assume normality.
Discussion of the features of the data distributions seen in each expression metric are 
best considered separately. However, in summary, the majority of expression metrics 
produce data that approximately follow a normal distribution, but with some low- 
expressed probe sets presenting as non-normal with two of the analysis metrics. 
Overall the analysis data provides little support of the application of data 
transformations prior to statistical analysis.
4.2.1 Distributions of MAS 4.0 and dChip models data
Analysis of data from MAS 4.0 and both dChip models suggests that for most genes, no 
transformation of expression data is required. This is an important issue, as some 
previous studies using datasets produced using Affymetrix MAS 4.0 software chose to 
transform their data, having identified the presence of positive skew in some probe sets 
(Gieseg, et al., 2002; Stamey, et al., 2001).
It can be suggested that the apparently skewed data that was seen in these previous 
studies reflects not the underlying data distribution, but rather the presence of outlying 
data points because of biological heterogeneity. A few such extreme values can alter the 
distribution of a dataset away from normality, and logarithmic transformations can 
indeed provide an ad hoc route to reducing the influence of extreme outlier values 
(Iglewicz and Hoaglin, 1993).
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The results from this Chapter suggest caution should be applied when applying 
transformations in such cases, because of the potential to distort the bulk underlying 
distribution. Instead, if outliers are an issue, consideration should be given to detection 
and accommodation of the outlying data points, using either more robust statistical 
tests (Lonnstedt and Speed, 2002) or by the use of more robust measures of location 
and spread such as the median or median absolute deviation (Iglewicz and Hoaglin, 
1993)* In contrast, there may be some special situations (e.g. variance stabilisation) 
when data transformation may be justified (Durbin and Rocke, 2003).
The analysis results suggest that datasets produced using dChip (either the PM or PM- 
MM model algorithms) and MAS 4.0 show a distribution close to normality that does 
not strongly violate the assumptions of classic parametric tests such as the t-test. It 
can, therefore, be argued that there is no a priori rationale for the application of a 
logarithmic (or any other) transformation to the expression values obtained from the 
analysis of Affymetrix image data prior to the use of parametric tests.
2.4.2 Distributions of MAS 5.0 data
Analysis of data generated using MAS 5.0 reveals an interesting situation. For probe 
sets identified as expressed (Present) by MAS 5.0, the outputted data appears normally 
distributed, making valid a t-test for a gene that is expressed in both groups.
However, a large number of low expressed genes, called as Absent by the package, 
instead follow a skewed distribution (e.g. Figure 2.6). This would compromise the use 
of the t-test without additional data transformation, although in practice it is unlikely 
that such a test would be applied to a gene that is not expressed in either sample. If 
necessary, something close to a log transformation may be suitable for such probe sets 
(see Figure 2.14). However, a generalised application of a log transformation to an 
entire MAS 5.0 dataset is not warranted, as for most genes this would distorts the data 
from the normal distribution (Figure 2.9)
It can only be speculated as to why MAS 5.0 is unique in distorting the data distribution 
of genes as they decrease in expression value. However, it is possible that it is the 
incorporation of the perfect match and mismatch probe information in combination 
with the background determination that result in the distortion observed; specifically 
how situations where the majority of mismatch probes score higher than the perfect 
match probes in a probe set.
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A review of the algorithms behind each analysis method (Affymetrix, 2002a; 
Affymetrix, 2002b; Li and Hung Wong, 2001a; Li and Wong, 2001b) shows that dChip 
and MAS 4.0 employ a single algorithm to deal with all data, and if MM values are used 
this can produce negative expression values. In contrast, MAS 5.0 uses a different 
approach to using both PM and MM values in the expression calculation, one that 
avoids the production of negative values.
Affymetrix argue that the MM signal contains most of the background cross- 
hybridisation and stray signal affecting the PM probe and if this value is less than the 
PM value it is a physically possible estimate for background. However if the MM value 
is larger than the PM value, then the estimate is physically impossible and an idealised 
value must be substituted from the data in the rest of the probe set.
MAS 5.0 employs a scenario-based approach to expression calculations, and a decision 
process is used when this PM>MM assumption is broken. Generally MM values that 
are larger than their PM counter parts are replaced with a value determined as 
representative from the rest of the probe set. However, when the data is too close to the 
PM value, a value slightly less than the PM value is substituted for the experimental 
signal reading. It is probable that the result of this step to avoid negative values that 
produces the side-effect of skewed distributions.
Such an abrupt switch between models clearly has the potential to produce apparently 
distorted data if, in some experiments, a probe set is analysed using one algorithm and 
in other experiments a different process is applied. This effect can be modelled by 
producing a dataset with a normal distribution with a mean of zero and then shifting all 
values less than zero to be zero. Figure 2.15 shows the resultant Q-Q plot for such a 
model, which shows close correlation to that obtained from skewed MAS 5.0 probe sets.
However as the replacement values are typically sampled from real probe sets values, 
the predicted effect would be an overall distribution that would appear to originate 
from two separate normal distributions. Indeed, visual inspection of the normal Q-Q 
plots reveals not a smooth skewed distribution, but rather an abrupt change in gradient 
of the slope, producing two straight lines, each equating to a normal distributed portion 
of the dataset (Figure 2.6).
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Figure 2.15 -  Modelling o f a normcdly distributed dataset w ith mean o f zero, whose 
values less than zero are shifted to zero. Note the sim ilarity to that shown fo r  the M AS 
5.0 dataset in Figure 2.6
2.4.3 Distributions of RMA data
Review of the data from RMA would suggest that application of parametric testing to 
these datasets would perform similarly to MAS 4.0 and dChip. There does not appear 
to be any pattern to the non-normality observed with these appearing in the very low 
expressed probe sets. One possible explanation for this observation is that it results as 
an artefact of determining real signal from background noise; RMA applies a single 
uniform background correction compared to a more complex zonal method employed 
in the Microarray Suite metrics.
Analysis of transformations applied to RMA data shows no benefit to the application of 
common transforms coerce the data into correlating better with normality. The data 
provides no support for the removal of the final stage log transformation from analysis 
using RMA.
2.4.4 Distributions of gcRMA data
Review of the gcRMA data indicates that the metric presents as the most problematic of 
all the expression metrics under consideration. Statistical testing for normality showed 
that 51% of probe sets present with a non-normal distribution and Rp from Q-Q plots 
versus mean expression show normality issues with many low to mid expression probe 
sets. Like the MAS 5.0 dataset the majority of these non-normal probes present with a 
positive skew.
1 S
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However, unlike the MAS 5.0 data there seems little discernable pattern to the non­
normality and no single transform could be identified to improve the normality of the 
whole dataset. The source of the problem may be as a result of the procedures the 
model uses to describe non-specific binding variation by integration of the MM probe 
data and sequence information into the background correction. Whilst the authors 
claim improvements in sensitivity and specificity of when compared to other methods, 
the evidence suggests that caution should be applied when considering the statistical 
analysis of image data analysed using gcRMA.
2.4.5 Conclusions
Overall the data provides strong support for the application of parametric statistical 
tests to data in four of the analysis algorithms (MAS 4.0, two dChip models and RMA).
Some care must be applied to certain probe sets called Absent in MAS 5.0 datasets 
when looking at differential gene expression situations presenting as on-off regulation 
using MAS 5.0 data due to apparent normality of one group and non-normality in the 
other. Control of the non-normality observed in the Absent group by application of a 
log transformation is one possible solution. However the transform degrades the 
normality seen in the Present group which is the data that a researcher may have the 
most confidence in experimentally. In this situation a researcher may wish to explore 
analysis methods that are more resilient to differences in the underlying data 
distribution and deviation from normality.
Further investigation is required to the suitability of data obtained with gcRMA. Whilst 
evidence for normality does not particularly support the use of parametric tests, gcRMA 
performs well when compared to other expression metrics across a range of 
performance indicators (Cope, et al., 2004).
With the exception of RMA and gcRMA data, where the application of transformation 
makes very little difference to the overall normality of the dataset, there is no evidence 
to suggest that application of a transformation improves a dataset, and in most cases 
actually makes the correlation with normality worse.
Although data distributions are an important issue when applying a statistical test, it 
should be considered that tests that violate assumptions perform perfectly adequately 
in the real world determining real biological differences. Further analyses of these 
expression metrics to address other related issues, such as sensitivity and bias, is 
therefore important (Lemon, et al., 2002).
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Chapter Three 
Statistical approaches to the detection of 
differentially regulated genes in Affymetrix 
datasets
In this Chapter the issue of applying statistical testing to microarray datasets is 
explored. Section 3.1 introduces key questions regarding basic data analysis, sample 
sizes, experimental design and the idea of developing best practice in analysis. Section 
3.2 reviews the methods used to investigate the effects differing combinations of 
statistical tests and expression metrics over a range of experimentally plausible sample 
sizes undertaken in Section 3.3 using the U95A Latin Square dataset. Section 3.4 
discusses the results and observations regarding the application of statistical tests 
within an analysis.
Conceptualisation and initial drafting of the FDR framework implemented in these 
explorations was undertaken by David Kipling.
3.1 Introduction
Over the last few years many funding bodies have invested heavily in projects using 
microarray technology and are in the process of producing very large quantities of 
experimental data. Despite this multi-million pound investment there remains a very 
real perceived weakness in our current ability to analyse these datasets: "If the 
collection, analysis and interpretation o f the data are flaw ed  then it may not only be a 
waste o f a valuable resource - we could draw fa u lty  conclusions and potentially risk 
our health and environm ent." Nick Fisher, President of the Statistical Society of 
Australia, quoted in (Tilstone, 2003).
In Chapter Two it was argued that, because of issues of small sample sizes, a researcher 
looking to apply statistical tests for differential gene expression should look towards 
parametric testing. However, these parametric tests typically come with the caveat that 
the data must follow a normal distribution, something that in general was met by each 
of the expression metrics reviewed, with the exception of some lower-expressed probe 
sets analysed using the MAS 5.0, RMA and gcRMA expression summaries.
However, these theoretical observations about which metric is “best”, looking purely 
from a viewpoint of the data distributions, may not necessarily identify the expression 
metric and test that is most powerful when it comes to identifying differentially 
expressed genes in an experiment.
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Similarly, even though the assumptions of a statistical test have been violated, or lower 
power can be inferred because of small sample size, the test may still be able to detect 
the differentially expressed genes of interest to the research.
This Chapter undertakes various investigations into the performance of each of the six 
expression metrics and investigates the “real-world” application of statistics to detect 
differentially regulated genes. Such data should provide guidance about the choice of 
methods for accurate microarray data analysis.
3.1.1 Defining “best practice” in data analysis
The idea of good analytical practice in microarray experiments is becoming well 
sounded in a variety of literature articles (Brazma, et al., 2001; Miller, et al., 2001; 
Tumor Analysis Best Practices Working Group, 2004). However, the majority of issues 
raised, and solutions proposed, are centred on complete annotation of experimental 
procedure and experimental design to allow comparative meta-analysis of data into the 
future.
In contrast, to date there has been relatively little guidance regarding “best practice” in 
the analysis of microarray data, with many researchers forced to choose a heuristic 
approach to the development of an analysis strategy due to a lack of firm evidence 
about the choices they should be making.
Miller makes comprehensive recommendations about the requirements for statistical 
analysis on microarray datasets, concluding that “Reports of differential gene 
expression should not be published unless they contain either significance tests or, at 
least, calculated estimates of the number of expected false positives”. He goes on to 
suggest that all research proposals should include a formal power analysis relating to 
the number of samples being run, and makes the case for archiving the results to form a 
public resource (Miller, et al., 2001).
3.1.2 Sample size and statistical power
The issue of sample size has been previously discussed, specifically with relation to the 
potential application of parametric testing (2.1.3). More generally the issue of sample 
size is of interest to statisticians in the context of power. Statistical power is the 
probability that meaningful difference will be detected if present within a dataset 
(Motulsky, 1999).
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In addition to sample size, other factors that influence the statistical power of a test 
include variability of the population, the desired detectable differences, the power of 
discrimination of a test and an acceptable error rate. In addition, experimental design, 
technical variability and data pre-processing play a role in the power of the statistical 
tests (Wei, et al., 2004). Interpretation of issues regarding sample size and power 
when applied to microarray data would appear to be even more difficult than simple 
estimation of each factor and their input to defined power calculations.
Tsai et al. raise the issue that current methods for power estimation do not consider the 
dependency of expression levels between genes (instead they are considered as un­
related observations) (Tsai, et al., 2004) and Wei et al. (Wei, et al., 2004) reported that 
fewer individuals are needed for the same statistical power when using inbred animals 
rather than unrelated human subjects.
Practically, Dow reported that a meta-analysis of a larger experiment revealed that a 
sample size less than ten impaired the capacity to detect differentially expressed genes. 
As many researchers are interested in running experiments with far fewer than this 
reported threshold, it is of interest to know how additional replicates influence power, 
and ultimately the correct identification of differentially regulated genes within a 
dataset (Dow, 2003).
3.1.3 Application of statistics in the determination of differential 
gene expression
Supporting the idea of good analytical practice in microarray experiments are the 
development of many academic and commercial packages for microarray analysis that 
provide some excellent statistical capabilities. Academic examples include MeV (Saeed, 
et al., 2003) Genesis (Stum, et al., 2002) and maxD (Hancock, et al., 2000), whilst 
popular commercial packages include GeneSpring (Silicon Genetics) and Rosetta 
Resolver (Rosetta Biosoftware).
However, where they often fall down is their all-encompassing, non-proscriptive 
nature; almost any test can be applied, irrespective of whether that is a sensible thing to 
do or not. Quackenbush describes this problem in detail, one where the sophistication 
of the computational tools often out-strips the understanding necessary to use them 
correctly (Quackenbush, 2001).
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In Chapter Two, parametric tests such as the classic t-test were introduced as potential 
tests of interest for application to the small sample sizes faced in typical microarray 
research. A variety of parametric tests have been developed for the identification of 
differentially regulated genes in microarray data sets, including several variants of 
Student’s t-test (Baldi and Long, 2001; Kooperberg, et al., 2002; Lonnstedt and Speed, 
2002; Tusher, et al., 2001) and ANOVA (Kerr, et al., 2000; Pavlidis and Noble, 2001). 
Pan (Pan, 2002) highlighted the problem in applying statistics to microarrays, in that a 
researcher must make assumptions about their data in order to select a test, and in 
situations where multiple tests are available, there is a lack of information about how 
the results of a test compare to each other. Breitling et al. (Breitling, et al., 2004) add 
to this argument, commenting that the reasons for differing performance from current 
statistical techniques is poorly understood.
Focusing in on the t-test, many different variants on the basis variety have been 
proposed; Thomas et al (Thomas, et al., 2001) proposed a variant based on regression 
modelling, Pan (Pan, 2002) suggested a mixed model approach and Baldi and Long 
(Baldi and Long, 2001) developed a Bayesian framework approach. Although attempts 
have been made to compare these different methods (Pan, 2002), they have 
concentrated on results of analysis on real biological datasets, and thus conclusions 
could only be based on comparison of ranks between tests and examination of 
significant gene lists.
In section 2.1.4 the potential limitation of non-parametric testing in light of small 
sample size was highlighted. As an example, Thomas et al. demonstrated the price paid 
with loss in power when applying a non-parametric test, with no genes being returned 
as significant after the application of the Mann-Whitney test (Thomas, et al., 2001). 
However, there is a point at which the power between non-parametric and parametric 
testing should converge, and at this point the additional resilience to outlying data 
points and deviations in distribution are of use to the researcher.
3.1.4 Comparisons of expression metrics
In addition to the effect on output from the application of differing statistical tests, the 
other key area for differences in the analysis of microarray data is the expression metric 
used to convert image data from the scanner into numerical representations for 
analysis. Each development in metrics attempt to make an improved calculation of the 
“truth” within a GeneChip and minimise variability between chips to enable easier 
comparison and subsequent analysis.
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Lemon et al. (Lemon, et al., 2002) made comparisons between MAS 4.0 and the dChip 
PMMM model using a variety of real-world and simulated datasets. Using a 
combination of analytical arguments, along with empirical data from data derived from 
spiked-in bacterial controls, they concluded that the model based expression metric 
(dChip) was the superior method. Cope et al. (Cope, et al., 2004) used the Affymetrix 
Latin Square dataset (9.1.2) along with a dilution dataset from GeneLogic to compare 
MAS 5.0 to dChip PMMM model and RMA and proposed a set of benchmark measures 
to judge expression metrics by. They concluded that RMA was the metric of choice for 
analysis of Affymetrix GeneChip data.
The common theme of both these studies was the application of a technique that 
examined sensitivity and specificity applied to a dataset with spiked-in data, providing 
known truth in the expected result. It is this methodology that will be built on, and 
extended, in the work presented within this Chapter.
3.1.5 Key questions regarding basic data analysis and 
experimental design.
Many of the issues that have been highlighted so far in the potential application of 
statistics and expression metrics can be reduced to a series of simple questions that a 
scientist new to microarrays would typically ask; *How m any chips do I  need to run?”, 
“Should I  log transform  m y data before analysis?”, “W hat statistical test should I  use 
to identify differential expressed genes?” and “W hat method should I  used to generate 
expression values?”.
In order to address these issues, methods to accurately make comparisons between 
differing analysis outcomes are needed. The major limitation of much published work 
on microarray analysis is that it applies novel techniques to “real world” datasets 
addressing biological problems. This presents two major problems, firstly separating 
the biological variation from any technical variability, and secondly knowing what is 
being looked for in an analysis method.
Extending the work published by Cope et al. (Cope, et al., 2004), which used the known 
truth in a dataset to compare the responses from different expression summaries 
applied to Affymetrix GeneChip data, a testing framework was developed to compare 
the responses from combinations of expression metrics and statistical tests against a 
background of known truth, across a range of experimentally plausible sample sizes.
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3.2 Technical Methodology
3.2.1 Overview
An integrated analysis script was written in R which took a subset of the Affymetrix 
U95A Latin Square dataset and produced a series of 20 replicates at a range of 3 to 12 
chips in each of two groups using the MAS 5.0, RMA and gcRMA expression metrics. 
Next the script took each of these indexed matrices, extracted the relevant data and 
then runs a series of statistical tests with twenty replicates over a range of ten sample 
sizes. The statistical tests chosen for these initial investigations were fold-change, un­
paired t-test, Welch’s variant of the t-test and the non-parametric Mann-Whitney test.
The output for each test was fed into an FDR function which extracted the location of 
the spikes from the ordered p-values and calculated the area under the FDR curve as 
previously described. The output for each test was exported into a summary matrix 
containing the area under the FDR curve (AUC) for each sampling, grouped by sample 
size. Summary plots were produced charting the average area under the curve (with 
standard error, error bars), across the range of sample size under consideration.
Figure 3.1
Data processing 
and filtering
Analysis
FDR Analysis
Select samples per group (n)
Store AUC value
Randomly sample n chips from each group
Apply expression metric to dataset
Apply statistical test
Note position of spiked in probe sets
Filter control probe sets
Order test results by significance (descending)
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Repeat for 3-12 
chips (n) per group 
with 20 samplings 
at each sample size
Figure 3.1 -  Analysis flow chart
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Datasets from MAS 4.0, MAS 5.0 and two dChip models were produced from the image 
CEL files using the stand-alone analysis package (as opposed to a Bioconductor 
implementation) and then split according to the samplings into indexed matrices using 
the R environment, totalling 200 datasets for analysis. The output from each run was 
formed into an indexed matrix for further analysis.
Full details of the technical methodology are given in Section 9.3.
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3.3 Exploration and Results
3.3.1 Investigations into the detection sensitivity of fold change
Fold change describes the ratio of intensity values between two groups and are often 
specified as cut-off criteria for finding differentially expressed genes. The issue of 
calculating fold change using just a simple A/B calculation is the issue of the highly 
asymmetric scale created between up-regulated and down regulated genes by the same 
magnitude. For example an experiment with no change results in a fold change of 1, a 
100 fold up regulation gives a fold change of 100, whilst a 100 fold down regulation 
gives a figure of o.oi.
To overcome this asymmetry, taking the log of the ratio gives a fold change value that is 
both symmetric and centred on zero. In addition, by taking the log2 of the data, each 
increment of the fold change figure represents a doubling of the fold change.
FoldC hange = log.
J
Experimentally it was of interest to examine the power of simple fold change to 
correctly identify the spiked in probe sets with the Latin Square dataset and compare to 
those from a standard statistical test based on detection of the difference between 
means. The statistical test chosen was the Welch variant of the t-test. This test is an 
impaired version of the t-test and does not assume heterogeneity of variance between 
the two sample groups.
Data from each of the 200 random sampling from the 24 chip Latin square experiment 
from each of the six expression metrics under consideration (MAS 4.0, MAS 5.0, dChip 
PMMM, dChip PM-Only, RMA and gcRMA) was analysed for the detection of the 
spiked in probe sets using fold change and the Welch t-test. The sensitivity and 
specificity of each test was examined using FDR curves.
The FDR curve implemented takes the p-values and orders them according to 
significance. A graph is then plotted working down the list of the first 200 probe sets in 
the list. For each probe set, the plot is advanced one mark horizontally with a plot of 
one mark vertically if the probe set is one of the spiked in transcripts (Figure 3.2). The 
larger the area under the curve (AUC) the more sensitive (the likelihood of detecting a 
true change in the dataset) and specific (the likelihood that observed results reflect true 
changes) the test is in the corrected identification of the spiked-in data. It is these AUC 
values that are returned to the framework for summation and interpretation.
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Figure 3.2 -  Example FDR graph showing the sensitivity and specificity of an 
analysis method to detect the spikes within the Latin square dataset.
A summary graph was then drawn representing the 200 area under the curve values 
resulting from each analysis. The mean AUC for each sample size was plotted along 
with error bars representing the standard error. By reducing the data to this summary 
plot it is possible to view the results for many tests simultaneously and determine 
differences in their response at different sample sizes. The results for the Welch t-test 
and fold change data is shown in Figure 3.3.
Review of the summary graphs (Figure 3.3) shows that the statistical technique out 
performs basic fold change by a large amount across each of the expression metrics 
under review. Detection of spikes from data analysed using MAS 4.0, MAS 5.0 and 
dChip PMMM algorithms is found to be near impossible using fold change alone. 
dChip PM, RMA and gcRMA fair better with fold change being able to pick up some of 
the two-fold change in expression of spikes between groups.
The models that are able to detect spikes using fold change are all perfect match only 
probe models where the mismatch information is either ignored of down played in the 
analysis algorithm. To further characterise the data, MVA plots were examined. MVA 
plots have become a widely used tool in microarray analysis, comprising a vertical axis 
representing the difference between the logarithms of the signal (the fold change) and 
the horizontal axis being formed as the average logarithm of the signal intensity (Smyth 
et al., 2003). MVA plots are only able to examine the variability between two chips at a 
time, so for the purposes of investigation here, just two chips in the sample group were 
chosen. MVA plots for each of the six expression metrics are shown in figure 3.4.
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Figure 3.3 -  Summary AUC plots for each of the six expression metrics, comparing 
the power of detection between fold change and the Welch t-test.
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It can be seen that each of the methods that give positive spike detection using fold 
change produce tight MVA plots with a tighter horizontal clustering to the graph. Fold 
change can be visualised onto these plots as the drawing of a horizontal line at a pre­
determined level on the y-axis -  in the case being considered here, each spike should be 
at +2. In both MAS models and dChip PMMM, the large cloud of highly variable probe 
sets at low expression values precludes the simple fold change threshold from detecting 
the spikes as many false positives are detected.
Whilst fold change can, to some extent, detect spikes in data analysed using dChip PM- 
Only, RMA and gcRMA expression metrics, the additional power achieved using a 
statistical technique suggest that whilst an intuitive technique, fold change is 
superseded in sensitivity by the statistical technique.
3.3.2 Does logarithmic transformation improve power of 
detection?
The application of logarithmic transformation was dealt with in the context of ensuring 
that the data complies with the assumption of normality for statistical testing in 
Chapter 2. Overall there seems little justification for the application of such a 
transformation prior to analysis, with the exception of RMA and gcRMA, where the 
application of a log2 transform did help conformation with normality to a very small 
extent.
However, the application of transforms is still a common experimental analysis 
proceeded and it was thus sought to investigate whether any advantage was achieved by 
the application of a loga transform.
Data outputted from each expression metric was loga transformed before analysis using 
Welch’s t-test across a range of sample sizes before comparison using the previously 
described FDR methods. In the case of RMA and gcRMA data, which are provided 
ready-transformed, the data was untransformed with the application of a power 
transform resulting in an equivalent raw dataset for comparison. Welch’s test was 
chosen as the safe variant of the t-test, making fewest assumptions about the data in 
exchange for a small reduction in power of detection. Summary FDR plots are shown 
in Figure 3.5.
79
F i g u r e  3 . 5
a)
b)
MAS 4.0
M axim um
C M
O
O
s
§o
Welch t-test
Welch t-test (Log2 Data)o
128 9 10 115 6 73 4
Replicates
dchip PMMM
8
8
CM
C M
§O
Welch t-test
Welch t-test (Log2 Data)o
10 11 123 5 6 7 8 94
Replicates
80
Ar
ea 
Un
de
r 
FD
R 
Cu
rv
e 
Ar
ea 
Un
de
r 
FD
R 
Cu
rv
e
F i g u r e  3 . 5  -  c o n t i n u e d
c)
dchip PM-Only
oQin
Welch t-test
Welch t-test (Log2 Data)o
6 7 8 10 11 123 4 5 9
Replicates
MAS 5.0
TT^^iUfDornurn
C O
CM
CSI
8in
Welch t-test
Welch t-test (Log2 Data)o
7 83 4 5 6 9 10 11 12
Replicates
81
F i g u r e  3 . 5  -  c o n t i n u e d
e)
RMA
Jtav^ dManmum
C M
©£3o
or5U.
1 0
to2<
Welch t-test (2A Data)
Welch t-test
3 4 5 6 7 8 9 10 11 12
Replicates
f)
gcRMA
CO
© OI o
o  CM
a.
e s.10
c
COc
<
Welch t-test (2A Data)
Welch t-test
3 4 5 6 7 8 10 129 11
Replicates
Figure 3.5 -  Summary AUC plots for each of the six expression metrics, comparing the 
power to detect between untransformed and log2 transformed data.
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Summarised data from the area under FDR each of the FDR curves generated shows 
little difference in the performance between log and transformed and untransformed 
datasets, with the exception of MAS 4.0 and dChip PMMM model (Figure 3.5). The 
dChip PM-Only data was the tightest, with virtually identical results achieved with 
either transformed or untransformed data.
3.3.2.1 Effect of logarithmic transformation applied to MAS 4.0 and dChip 
PMMM data
In the MAS 4.0 data there was a slight decrease in detection ability with log 
transformed data (Figure 3-5.a). With the dChip PMMM model a slight improvement 
in spike detection was observed with the log2 transformed dataset (Figure 3-5.b). It 
should, however, be noted that MAS 4.0 and dChip PMMM expression metrics Eire the 
only two under consideration that produce negative numbers, Emd as negative numbers 
cannot be log transformed, these values had to be deal with before log transformation 
Emd subsequent application of the statistical test.
The approach used to deal with this problem was replacement of negative numbers 
with the smallest positive number within the probe set. The results of this analysis 
must therefore be treated with some caution as the analysis is thus undertaken on two 
different subsets of data, one reflecting the true data, and Emother modified set 
containing the lower expressed probe sets.
In MAS 4.0 50% of probe sets had data altered due to the presence of one or more 
negative values, whilst in dChip PMMM data 6% of probe sets had data adjusted. Any 
perceived advantage in the application of transformation or leaving data 
untransformed must therefore be treated with caution. As the margins of improvement 
Eire comparatively small with each expression metric, the prudent approach would be 
the choice of no data transformation.
3.3.2.2 Effect of logarithmic transformation applied to MAS 5.0, RMA and 
gcRMA data
The lack of difference in FDR performance between the transformed and 
untransformed data for MAS 5.0 (Figure 3-5.d) and both RMA (Figure 3.5.e and Figure 
3.5.f) models correlates well with the observations in Chapter Two looking at the effect 
of transformation on the data distributions which showed that no marked improvement 
in the overall correlation to normality was achieved in each of the three datasets with 
the application of a log2 transform.
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The data therefore provides no a priori reason to log transform MAS 5.0 data before 
analysis. Considering RMA, there is no consistent improvement in FDR results using 
either transformed or untransformed datasets and gcRMA performs marginally better 
using the log transformed data. There is thus no reason to diverge from the author’s 
methodologies (Irizarry, et al., 2003; Wu, et al., 2004) which employ a logarithmic 
transform as the last stage in the analysis process.
3.3.3 How does pooling variance influence detection 
outcomes?
Referring to guidance about the application of the t-test to data we are faced with the 
option of two variants of the test, the standard unpaired t-test or the Welch variant of 
the t-test (Welch, 1947). The difference between the two is a question on whether to 
assume equality of variance, which describes the spread of the data.. The standard t- 
test offers additional power compared to the Welch t-test, gained by a better estimate of 
variance because the data can be pooled.
Published data (Baldi and Long, 2001) has indicated that in Affymetrix microarray data 
there is a relationship between variance and mean expression level; as the signal level 
increases for a probe set, so does the variance. In applying a test for differential gene 
expression a researcher will be interested in changes from a low to high (or vice versa) 
situation, and thus the test will be faced with groups with different measured levels of 
variance.
The natural conclusion to this observation is to apply the Welch variant to the t-test to 
overcome this assumption. However as it has already been shown that due to small 
sample sizes, there is a need to maximise all power available from the dataset when 
applying statistical testing, the question of whether pooling variance can improve 
power to detect differentially regulated genes (despite the apparent deviation in 
assumption) is of interest.
Using the already described framework (Figure 3.1) , both the unpaired t-test and 
Welch t-test was applied to the 24 chips with a two-fold change in the Affymetrix Latin 
square dataset and detection of the fifteen spikes assessed using FDR curves over a 
range of sample sizes with multiple samples. MAS and dChip was used in an 
untransformed form, RMA data was analysed as provided after analysis (i.e. in a log2 
form). The resultant summary graphs showing the area under the FDR curve over a 
range of sample sizes is shown in Figure 3.6.
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Figure 3.6 -  Summary AUC plots for each of the six expression metrics, comparing 
the power to detect between the unpaired t-test (which pools variance) and the Welch 
variant of the t-test which calculates group specific variance.
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Looking at the results from the two different t-tests, we can see that there is very little 
difference in performance (Figure 3.6). It could be argued that there is a small 
advantage in using the unpaired t-test on small sample sizes from dChip PMMM data 
and a similar advantage in large sample sizes on RMA data; however, the magnitude of 
improvement is small. The experimental data would appear to support the theoretical 
observations regarding variance and support the application of the Welch t-test to 
Affymetrix datasets.
So far data regarding how sample size affects detection outcome has been overlooked. 
Having settled on the application of the Welch t-test on the data resulting from each of 
the expression metrics (untransformed from MAS and dChip, loga transformed from 
both RMA models) as best practice, observations about the power to detect across the 
range of sample sizes can be reviewed.
Marked improvements are seen across all expression metrics over sample sizes per 
group of three to seven; above this point comparatively small increases in sensitivity 
are obtained for each addition chip run. In the RMA models this critical size is reduced 
with a near consistent plateau of detection once at least six samples per group are 
analysed.
3.3.4 How applicable are non-parametric methods to microarray 
datasets?
By using the relative ranks of the data, non-parametric tests for differential expression 
are less sensitive to data distributions and outliers. However, the trade off for this 
improvement in resilience is a loss in power compared to the parametric test for the 
same size sample, including the observation that with less than seven samples it is 
impossible to obtain a p-value less than 0.05 (the typically applied significance level) 
with the Mann-Whitney test (Motulsky, 1999) .
There are, however, situations where even with good experimental design the extra 
protection against outliers and other biological artefacts in the resultant data may lead 
a researcher to consider the application of a non-parametric test (e.g. the 
heterogeneous sample types found in many cancer datasets). Information about the 
comparative power of non-parametric versus parametric testing, along with data 
indicating at which sample sizes the power of the two groups of test converge, is thus 
important. The Mann-Whitney test was applied to the Latin Square dataset across each 
of the six expression metrics under consideration as a distribution free alternative to 
the t-test and the data analysed using the FDR method. For comparison, summary 
graphs of the Mann-Whitney data plotted against the Welch t-test data are shown in 
Figure 3.7.
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Figure 3.7 -  Summary AUC plots for each of the six expression metrics, comparing the 
power to detect between the Welch variant of the t-test and its equivalent non- 
parametric alternative, the Mann-Whitney test.
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Reviewing the summary FDR plots (Figure 3.7), it can be seen that the Mann-Whitney 
test performs particularly poor at smaller sample sizes, as would be expected. This 
effect is a combination of the lower power of the non-parametric test combined with 
the test being unable to stratify its results, with many probe sets being assigned an 
identical p-value.
Whilst at low sample size the test is practically useless, once six samples per group are 
run the test is closing the gap on the t-test with only a small loss in detection sensitivity 
and by the time the sample size is eight or more the results are nearly identical. 
Practically a researcher may wish to consider the non-parametric test what is believed 
to be a highly variable experimental design once six samples per group are being run.
For larger datasets the power on this very heterogeneous dataset are comparable to that 
from the parametric t-test. The additional resistance of the Mann-Whitney test to 
deviations from normality along with resilience to outliers beckon the suggestion that 
this be the standard test applied to datasets with more than 10 samples per group.
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3.4 Discussion
3.4.1 Reviewing fold change
In all the expression metrics under comparison, fold-change was out-performed by 
statistical testing by a large margin across all sample sizes. In models incorporating 
mismatch probe information there was no power to detect the spiked-in probe sets in 
the dataset being examined, with only a small amount of power in those which utilise 
only the perfect match probes. This improvement in scoring from the PM-Only models 
is likely to be associated with an increase variability of low-expressed probe sets 
introduced by incorporation of MM-probe data in the expression metric algorithms.
Examination of the formulae behind fold-change and the t-test reveal that thought of in 
a simplistic manner, the t-test is an evolved implementation of fold change taking into 
account variance which produces the t-statistic. Integration of this variance 
information improves the power to detect changes in a dataset.
There is however, one situation where a research maybe forced to consider the use of 
fold-change - where insufficient chips have been run to apply statistical testing. 
Irizarry et al. (Irizany, et al., 2003) have shown that the Affymetrix Signal Log ratio, 
which is computed using a Tukey-Biweight method on the probe pair intensities, is an 
efficient method of detecting changes when only two chips are to be compared -  this 
method however is not expandable to experiments with more than two chips. Mariani 
et al. (Mariani, et al., 2003) suggest the application of a variable fold change threshold 
resulting from application of a lowess curve to the standard deviation information. 
These approaches whilst not examined for power to detect, do provide potential 
analysis methods for datasets with sample sizes too small for application of parametric 
testing.
3.4.2 Issues of sample size
Sample size is a major issue for a researcher designing a microarray experiment, since 
from a statistical point of view, the more replicates run the more confidence can be 
determined in the results. However, this comes at the trade off of cost; and these costs 
are currently not insignificant. The biologist designing an experiment is interested in 
the trade off between accuracy of results versus the cost to get those results.
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The other factor to consider in this trade off is what the results actually mean. Whilst a 
statistician is interested in the exact meaning of a 95% confidence level and designing 
an analysis to reflect the exact nature of truth in a dataset, the biologist is typically 
using a microarray experiment as a hypothesis generation exercise, which will 
subsequently be followed by validatory techniques. A biologist must therefore be 
convinced that each additional replicate is worth running in terms of reinforcing 
confidence in the results.
Reviewing the data presented in this Chapter it is clear that the more samples run, the 
more power each test has. However summarising, it can be seen that over sample sizes 
of 3-6 per group large increases in power are seen for each additional chip run, between 
7-10 samples per group there is continued improvement in sensitivity, and over 10 
chips each additional chip adds little to the overall detection of spikes within the 
dataset.
Guidelines on sample size are difficult to deduce because of the underlying variability in 
biological data and experimental design which will affect the power of a test to detect 
differences. It should also be pointed out that samples do fail, and there are QC issues 
which may require the dropping of certain chips. These should be viewed as minimum 
estimates because of the clean and perfect nature of this dataset, and the likely 
influence of additional biological variation would require additional GeneChips in an 
experimental design.
3.4.3 Applying statistical testing to microarrays
In reviewing the data explored in this Chapter, there is the requirement to reduce 
answers to help answer the simple question “Which test should I  use?”
As with all things surrounding the analysis of microarray data there is no simple 
answer. However, it is clear that the choice of test is dependent on the nature of the 
experiment and more critically the number of samples in each group. To review this 
three real-world experimental situations are presented, along with observations about 
the suitability of different tests.
Scenario 1: A small-scale experiment involving three to six replicates per group. In 
this experimental configuration, the t-test is the clear winner with much more power 
than fold change and non-parametric methods. However the test assumes data 
normality and is sensitive to outlying data points. Care would therefore be needed to 
ensure that noisy data (such as a comparison of tumour to normal tissue) are avoided.
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Scenario 2: A middle-sized experiment comprising seven to ten arrays in each group. 
With this sample size the t-test continues to gain power for each additional GeneChip 
run per group. However, the non-parametric test is also beginning to perform well with 
only a marginal decrease in power over its parametric counterpart. Choice of test at 
this sample size must therefore be influenced by the type of sample being run. For 
homogeneous experimental designs (e.g. drug treatment of culture cells) the Welch 
variant of the t-test would be the choice of test. However, in a heterogeneous design 
(e.g. clinical samples) the additional confidence the non-parametric test provides would 
suggest adoption of the Mann-Whitney test.
Scenario 3: A large experiment with more than ten samples in each group. On the 
homogeneous dataset under consideration here, little additional power was achieved by 
addition of replicates. However, once this size of experiment has been reached, it must 
be concluded that the data is likely to be heterogeneous with an increased likelihood of 
deviations from normality and the presence of outlying data points. Here the Mann- 
Whitney test come into its own, with power is almost as good as parametric tests but 
with its resilience against deviations in data distribution and outliers.
3.4.4 Requirements and benefits of logarithmic transformation
In Chapter Two it was shown that from a distributional point of view there was little or 
no benefit to the logarithmic transformation of data from any of the expression metrics. 
It was noted that whilst the loga transform included in RMA and gcRMA did not 
particularly benefit the correlation with normality, there was little to dispute the 
author’s inclusion of this measure in their methods (Irizarry, et al., 2003; Wu, et al., 
2004).
The data presented in this Chapter reveals no difference in the ability to correctly 
identify spikes in the dataset between logarithmically transformed and untransformed 
data with the exception of MAS 4.0 and dChip PMMM models. It was however noted 
that the negative numbers present in these datasets causes problems to the 
transformation and thus the results must be treated with caution.
These data provide no a priori reason for transforming data prior to statistical analysis. 
Detection in data from RMA and gcRMA are not altered by removal of the log 
transformation, so no reason is found to alter from the published methodology.
95
3.4.5 Comparative review of expression metrics
By grouping the data from each test together by expression metric the previously 
generated data can be reviewed in another way to provide information about the 
relative performance of different expression metrics. Figures 3.8, 3.9 and 3.10 show 
data for each expression metric grouped by fold change, the Welch t-test and the Mann- 
Whitney test.
From these observations we can conclude that MAS 5.0, RMA and gcRMA would 
appear to be the best options for the conversion of image data into a workable 
expression summary. Both dChip models make attempts at improving the accuracy of 
the expression summary by using a model to assess standard errors for the expression 
metrics by pooling information across arrays. However, even in this highly 
homogeneous dataset, the technique does not perform as well as the other expression 
metrics and has a reduced ability to detect spiked transcripts using standard statistical 
methods.
It should be noted that the dataset used in these investigations formed part of the 
Affymetrix development process for the algorithms comprising MAS 5.0, and it could 
be the case that the default tuneable parameters in the methodology were influenced by 
the nature of this dataset. In addition the same dataset was key in the development of 
RMA and gcRMA.
However, in the absence of further datasets large enough and with sufficient replication 
to assess this, we must therefore conclude that there is no obvious reason to avoid these 
expression metrics for data analysis.
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Chapter Four 
Approaches to data normalisation
In this Chapter the issue of data normalisation is explored. Section 4.1 introduces the 
concepts of normalisation and the application of normalisation within Affymetrix 
GeneChip data analysis. Section 4.2 reviews the methods used to investigate the effects 
of normalisation on experimental output. Section 4.3 explores the effects of QQ, VSN 
and a rank based normalisation method on the ability to detect the spikes in the U95A 
Latin Square dataset. Section 4.4 discusses the results and observations regarding the 
application of normalisation within an analysis.
4.1 Introduction
4.1.1 What is normalisation?
The Oxford dictionary defines normalise as “verb: bring to a normal or standard  
state”. Applied to microarray data, normalisation is an attempt to remove the impact 
of non-biological influences on biological data by correction of systematic biases. For 
example, this is conceptually similar to the adjustment of expression levels relative to a 
reference gene in Northern blot analysis. This variance in the data can occur for a 
variety of reasons including biological differences between samples, unequal quantities 
of starting RNA, differences in labelling and systematic biases in the measured 
expression levels (Quackenbush, 2002).
The common assumption of most normalisation methods is that the overall 
distribution of signal levels is similar between samples, and that the expression of the 
majority of genes changes little between the conditions under examination (Reimers,
2003). Whilst this would appear reasonable for the majority of laboratory treatments, 
clinical tumours are one example of a sample type that might present with very 
differing expression patterns between samples (Golub, et al., 1999).
4.1.2 Why is there a requirement to normalise data?
Variation in results arises naturally when dealing with results from multiple 
experiments. Many researchers have categorised this variation as being one of two 
types, interesting variation and obscuring variation (Bolstad, et al., 2003; Landis, et al.,
2004). The biological difference that are being looked for in the course of microarray 
experiments are termed an interesting variation, whereas obscuring variation is used to 
describe the variation introduced as part of the experimental process, for example 
differences in sample preparation and labelling, differences resulting from array
1 0 0
production, and those introduced as part of the scanning process. Normalisation aims 
to overcome this obscuring variance and leave the researcher with a dataset 
representing a truer picture of the underlying differences between arrays.
As previously commented, most normalisation methods require the number of genes 
changing in expression between conditions to be small, or assume an equal number of 
increasing and decreasing genes. Zien et al. (Zien, et al., 2001) comment that when 
neither of these conditions are true then intra group normalisation should be applied 
instead of a global normalisation. However, in many cases poor experimental design 
and processing results in groups with distinct non-biological variation, and for this 
reason many researchers prefer to normalise all data together as a single group.
Applied to Affymetrix data, normalisation is applied in two distinct places, prior to the 
combination of probe signals into a probe set expression level, and/or after this 
incorporation.
4.1.3 Normalisation methodologies within expression metrics
The primary reason for the application of normalisation as part of expression meric 
analysis is to address variation in overall array performance due to issues of 
inconsistencies in array fabrication, subtle differences in experimental processing and 
differences occurring at the staining and scanning stage. As these sources of variation 
can contribute significantly to the data output from an array experiment, normalization 
is a critical first step in any analysis of gene expression data.
Normalisation can be applied to a single chip in order to shape the resultant data into 
an expected form, be applied to shift the data from many chips into that from a chosen 
baseline experiment, or use the data from all arrays in the experiment to determine a 
baseline to normalise to.
Historically, many normalisation procedures for microarrays arrays are global 
approaches, based on normalization of the overall mean or median array intensity to a 
common standard (Afiymetrix, 2002b) and are linear in their transformation approach. 
Approaches using non-linear curves have been suggested (Li and Hung Wong, 2001a; 
Li and Wong, 2001b; Schadt, et al., 2001), however these approaches require the choice 
of a baseline value or array for normalisation to.
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However this approach has its limitation when dealing with data with non-linear 
relationships, Bolstad et al. (Bolstad, et al., 2003) comment that it is common to see 
non-linear relations between arrays and the standard normalization provided by 
Affymetrix does not perform well in these situations.
In contrast a normalisation is an integral part of the three-step RMA and gcRMA 
methodologies, using a non-linear normalisation at the probe level. Typically the 
method employs a QQ normalisation method, although options are provided for the 
incorporation of different normalisation algorithms (Bolstad, et al., 2003).
Hartman et al. (Hartmann, et al., 2003) compared MAS 5.0 to RMA methods using 
VSN and QQ normalisation applied at the probe level, in their ability to detect a two­
fold change of the spikes present in the Latin square dataset using two sample groups 
of four GeneChips. They conclude that RMA data with either QQ or VSN normalisation 
produce data where “we are able to detect more o f the spike in genes while getting less 
false positives”. Wang et al. (2004) found the RMA normalization preferable to that 
within MAS 5.0 in analysis of inter-species conserved (ISC) probe sets
4.1.4 Post metric analysis normalisation of Affymetrix data
Post metric analysis normalisation can be applied in an additional attempt to overcome 
variation between arrays which are expected to produce near identical expression 
patterns. Whilst the RMA and gcRMA methods incorporate a cross-array 
normalisation as part of their methodology, the MAS algorithm treats each array as a 
separate entity during analysis. This has both advantages and disadvantages, since on 
one hand inter-array normalisation produces data which is less likely to need further 
manipulation before analysis; however it does produce data which is dependant on the 
other data in the experiment.
The approach taken by Affymetrix to normalisation within Microarray Suite is the 
scaling of data so that each array has the same average value (either a pre-defined value 
termed target intensity or a value determined from a baseline array). A shifting and 
scaling approach is applied after the statistical stages used to convert the image 
information to a numerical signal values for each probe set. As this is the final step in 
the analysis process and data can thus be re-scaled if required. All the data presented 
in this work analysed using MAS 5.0 have used a target scaling intensity of 100.
Post metric normalisation can vary from simple techniques which undertake additional 
shifting and scaling of the data to make it comparable to more complex ones which act 
in a non-linear fashion and attempt to address more complex measurement of data 
similarity such as the distributions of signal values.
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An alternative approach to the global normalisation approaches which use all the 
available data to determine the normalisation baseline, normalisation can also be 
applied to shift and scale the data according to the values of a set of know spiked-in 
transcripts, added as part of the experimental process. Affymetrix have made provision 
for this form of normalisation with the addition probe sets which correspond to Bacillus 
genes that have been modified by the addition of poly(A)+ tails, then cloned into 
pBluescript. These probe sets can thus be used as controls for cDNA synthesis and 
subsequent sample preparation steps.
With the new generation of the U133 series of chips Affymetrix introduced support for a 
different type of normalisation, using a set of housekeeping genes, similar to that used 
in Northern blots. By using a set of 100 genes, the chips are re-scaled so that the 
averages of these housekeeping genes are identical across all chips.
In an investigation of median-interquartile range normalisation and quantile 
normalisation methods, Parrish and Spencer (Parrish and Spencer, 2004) found a 
substantial inflation of the number of genes identified by paired-t significance tests 
when compared to the non-normalised data. This observation was attributed to the 
power of the normalisation technique to overcome experimental variance. In their 
prostate cancer dataset the normalisation had a greater effect on RMA data that that 
from MAS 5.0.
4.1.5 Questions of normalisation
Although each of the expression metrics incorporates some form of normalisation as 
part of their methodology, it is of interest to examine the effect of common post­
analysis normalisation steps on the data in an attempt to further overcome obscuring 
variance in the dataset and the effect of these steps on the identification of spiked-in 
probe sets in a dataset with known truth.
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4.2 Technical Methodology
Data from MAS 5.0, RMA and dChip was examined for normality using the Shapiro- 
Wilks test and Q-Q correlation plots (as described in Chapter Two) following the 
application of QQ normalisation (Bolstad, et al., 2003), VSN normalisation (Huber, et 
al., 2002) and a rank based technique (Breitling, et al., 2004) using the full Affymetrix 
U95A Latin Square dataset with the spiked in samples and control probe sets removed 
(see Section 9.3.2)
The previously described integrated framework (Section 3.2), which took a subset of 
the Affymetrix U95A Latin Square dataset and produced a series of 20 replicates at a 
range of 3 to 12 chips in each of two groups using the MAS 5.0, RMA and gcRMA 
expression metrics, was modified to incorporate post-metric analysis normalisation 
(Figure 4.1).
Figure 4.1
Data processing 
and filtering
Analysis
FDR Analysis
Select samples per group (n)
Store AUC value
Apply statistical test
Filter control probe sets
Apply normalisation technique
Apply expression metric to dataset
Randomly sample n chips from each group
Order test results by significance (descending)
Note position of spiked in probe sets
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Repeat for 3-12 
chips (n) per group 
with 20 samplings 
at each sample size
Figure 4.1 -  Analysis flowchart
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The resultant data from each expression metric was subject to normalisation using QQ 
normalisation, VSN and a rank based technique before the application of statistical 
tests for differential genes expression. The script undertook twenty samplings over a 
range of sample sizes of three to twelve arrays per group and subjected the normalised 
data to analysis using the Welch t-test. In the case of the rank adjusted data the data 
was analysed using the non-parametric Mann-Whitney test in addition to the Welch t- 
test.
The output for each test was fed into an FDR function which extracted the location of 
the spikes from the ordered p-values and calculated the area under the FDR curve as 
previously described. The output for each test was exported into a summary matrix 
containing each of the 200 AUC values calculated, grouped by sample size. Summaiy 
plots were produced charting the average area under the curve (with standard error, 
error bars), across the range of sample size under consideration.
Full details of the technical methodology are given in Section 9.4.1.
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4.3 Exploration and Results
4.3.1 Application of Quantile-Quantile (QQ) normalisation
In Chapter Three the Quantile-Quantile (Q-Q) plot was introduced as a method of 
assessing correlation to normality. QQ normalisation extends this idea with the goal of 
making the frequencies and distribution of probe intensities for each array in a set of 
arrays the same. In the Q-Q plot, the distribution of two data vectors is the same if the 
plot is a straight diagonal line. In QQ normalisation, this concept is extended to n 
dimensions so that if all n data vectors have the same distribution, then plotting the 
quantiles in n dimensions gives a straight line along the line given by the unit vector 
(Bolstad, et al., 2003).
The method works by giving each array the same distribution, which is achieved by 
taking the mean of each quantile and substituting it as the value for each array value 
comprising the quantile data.
Practically, the data from each chip is sorted, independently from one another, with an 
index stored to keep their original order. From this new sorted matrix, the median 
value of each probe is calculated and used to replace the original value in each chip on 
that row. The matrix is then ‘unsorted’ using the original index, giving the normalised 
data.
The caveat for the use of a single standard for all chips is the assumption that there is 
no major change in distributions between chips. Whilst this appears a strong 
assumption about gene distributions, Reimers (Reimers, 2003) comments that in 
practice, the expression levels of genes move up and down roughly equally and it would 
need several hundred genes to be changed greatly and in one direction, to drive 
quantile normalization in error by more than 20%.
In the RMA and gcRMA expression metrics, QQ normalisation is applied at the probe 
level before summarisation of the probe values into a single signal level. However, it is 
also possible to apply QQ normalisation to the resultant expression metric data and 
assess the effect of the normalisation on the outcomes from statistical testing looking 
for the spiked in samples in the U95A Latin Square dataset.
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As the purpose of the QQ normalisation is to synchronise the data distributions 
between chips there is the possibility that the method alters the data distributions 
across a single probe set. As has previously been discussed (Section 2.1.4) the data 
distribution of a single probe set is important if parametric testing is to be applied. It is 
therefore important to first analyse the effect of probe set distributions following QQ 
normalisation.
4.3.1.1 Normality of QQ normalised data
Using the strategies introduced in Section 3.3.1, the normality of data following the 
application of a QQ normalisation was first assessed using the Shapiro-Wilks test for 
normality. The number of non-normal genes (scoring a p-value less than 0.05) for each 
of the three datasets is shown in Table 4.1.
Table 4,1
Analysis Method Number of probe sets deviating from normality (pco.os from SW test)
Untransformed QQ Normalised
MAS 5.0 5799 (46%) 5977 (48%)
RMA 3075 (25%) 3502 (28%)
gcRMA 6371 (51%) 9509 (76%)
Table 4.1 -  Results from  Shapiro-Wilks tests fo r  normality.
The Shapiro-Wilks test data show that there is a slight increase in the non-normality of 
the data from each expression metric after the application of QQ normalisation. This 
observation highlighted the need for further exploration of the nature of this deviation 
from normality using plots showing mean signal plotted against the correlation to 
normality for a Q-Q plot (Section 2.3.2). The resultant plots are shown in Figure 4.2.
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Figure 4.2 -  Plots showing correlation to normality (R2) versus mean expression 
signal for each probe set following the application of a QQ normalisation to each 
expression dataset.
Comparison of the plots to the equivalent plot in non-transformed data (Figure 3.2.d,
3.2.e and 3.2.f) shows little difference in the distributions. MAS 5.0 (Figure 4.2.a) and 
gcRMA (Figure 4.2.C) still show a large number of low expressed probe sets showing 
deviation from normality, with the MAS 5.0 plot showing the majority of the poorly 
scoring probe sets have a relative expression level of less than 100 forming a 
pronounced tail to the plot.
The pronounced return to normality in the lowest expressed gcRMA data is lost, 
forming a tail of non-normal probe sets at low expression levels. Little difference is 
seen in the RMA plot (Figure 4.2.b) except a possible widening of the cluster of genes 
correlating highly with normality. These data show that within this dataset QQ 
normalisation does not have a large effect on data distributions.
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4.3.1.2 FDR performance of QQ normalised data
Performance of QQ normalised data was assessed using the already described 
framework (Section 4.2) using the Welch t-test to detect the fifteen spikes present in 
the 24 chips with a two-fold change in the Affymetrix Latin square dataset, assessed 
using FDR curves over a range of sample sizes with multiple samples. MAS 5.0 data 
was used in an untransformed form, RMA and gcRMA data was analysed as provided 
(i.e. incorporating a final log2 transformation). The resultant summary graphs showing 
the area under the FDR curve over a range of sample sizes are shown in Figure 4.3 
plotted with the non-normalised data for comparison.
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Figure 4.3 -  Summary FDR plots showing the results of analysis using the Welch t- 
test on non-normalised data and QQ normalised data from MAS 5.0 (a), RMA (b) and 
gcRMA (c).
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Review of the MAS 5.0 data (Figure 5.2.a) shows a marginal improvement in detection 
power of mid-ranged sample sizes (6-9 arrays per group), with convergence at small 
and large sample sizes. As MAS 5.0 does not incorporate any inter chip normalisation 
as part of the analysis the application of the QQ normalisation has the potential to draw 
any chips with a minor outlier into line with the other chips and improve detection.
Very little difference in detection power is seen with the RMA data (Figure 5.2.b) with a 
significant improvement in detection seen only for a few sample sizes using non­
normalised data. Data from gcRMA shows a significant loss of power to detect across 
all sample sizes, suggesting that the application of a second round of normalisation to 
the data is detrimental to analysis of gcRMA data.
4.3.2 Application of Variance Stabilisation Normalisation (VSN)
In Chapter Four the Welch t-test was shown to outperform simple fold change by 
incorporation of information on the variance of the probe set expression values 
comprising a group of data. Various publications (Baldi and Long, 2001; Durbin, et al., 
2002; Naef, et al., 2002) have indicated that in Affymetrix microarray data there is a 
relationship between variance and mean expression level, as the signal level increases 
for a probe set, so does the variance. VSN (Variance Stabilisation Normalisation) 
exploits this observation and provides a data transformation based on the mean- 
versus-variance dependency within the natural space data (Huber, et al., 2002).
A model is built of the variance-versus-mean dependence within the dataset before data 
transformation using a combination of data offset, gain and estimate of the true 
abundance for a probe set signal intensity, values that are derived from the modelling 
process. The data then undergoes an inverse hyperbolic sine transformation (asinh). 
The asinh transform is equivalent to the log transformation and gives near identical 
values for numbers greater than five; however the asinh transform does not produce 
negative numbers which cause problems for researchers wishing to implement a fold 
change comparison (Section 3.3.1).
VSN has been proposed as an alternative normalisation method within the RMA 
package as an alternative to QQ normalisation (Hartmann, et al., 2003) on the probe 
level data and was found to perform favourably when compared to MAS 5.0 and an 
RMA model incorporating QQ normalisation. It is therefore of interest to explore how 
the application of VSN to the resultant expression metric data can better inform an 
analysis, tested using spike detection of a dataset with known truth. To make results 
comparable to that from previous analysis, a sinh transform was used to reverse the 
effect of the asinh transform implemented as part of the VSN methodology.
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4.3.2.1 Normality of VSN transformed data
Using the strategies introduced in Section 3.3.1, the normality of data following the 
application of a VSN transformation was first assessed using the Shapiro-Wilks test for 
normality, the number of non-normal genes (scoring a p-value less than 0.05) for each 
of the four datasets is shown in Table 4.2. Data from each expression metric was 
analysed in a natural form, requiring the removal of the final log2 transformation from 
RMA and gcRMA data.
Table 4.2
Analysis Method Number of probe sets deviating from normality (p<o.os from SW test)
Untransformed VSN Transformed
MAS 5.0 5799 (46%) 5808 (46%)
RMA 3075 (25%) 3666 (29%)
gcRMA 6371 (51%) 9760 (78%)
Table 4.2 -  Results from  Shapiro-Wilks tests fo r  normality.
The Shapiro-Wilks tests show that the normality of data from MAS 5.0 is unchanged 
following VSN transformation. However, for RMA and gcRMA there is a marked 
increase in the number of probe sets presenting with a correlation differing from 
normality. This observation highlighted the need for further exploration of the nature 
of this deviation from normality using plots showing mean signal plotted against 
correlation to normality for a Q-Q plot (Section 2.3.2). The resultant plots are shown in 
Figure 4.4.
Comparison of the plots to the equivalent plot on non-transformed data (Figure 3.2.d,
3.2.e and 3.2.f) shows differences in the distributions. MAS 5.0 (Figure 4-4.a) has the 
closest match to the untransformed raw data, still presenting with a large tail of non­
normal probe sets which have a lower expression value. Similarly to the results 
obtained from a QQ normalisation, the RMA plot (Figure 4-4.b) shows a widening of 
the cluster of genes correlating highly with normality (R2 greater than 0.95).
Data from gcRMA (Figure 4 .4 .C) still shows a large number of low expressed probe sets 
showing deviation from normality. However there is a loss of the large cluster of data 
correlating highly with normality, and a general increase in the size of the tail along 
with an increase of density. As found in the results of the Shapiro-Wilks test, the 
majority of data after VSN transformation of gcRMA data is non-normal.
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Figure 4.4 - Plots showing correlation to normality (R2) versus mean expression 
signal for each probe set following the application of a VSN normalisation to each 
expression dataset.
It can be seen that VSN transformation does not appear to have a large negative effect 
on the normality on data from MAS 5.0 and RMA, however the large changes in 
correlation to normality in data from gcRMA suggest the need for caution in the 
application of this method with parametric testing. It is therefore of interest to 
scrutinise the effect of this transformation in the detection of spiked in probe sets in the 
manner previously described.
4.3.2.2 FDR performance of VSN normalised data
Performance of VSN normalised data was assessed using the previously described 
framework (Section 4.2) using the Welch t-test to detect the fifteen spikes present in 
the 24 chips with a two-fold change in the Affymetrix Latin square dataset assessed 
using FDR curves over a range of sample sizes with multiple samples. Data from each 
expression metric was analysed in a natural form, requiring the removal of the final log2 
transformation from RMA and gcRMA data. The resultant summary graphs showing 
the area under the FDR curve over a range of sample sizes are shown in Figure 4.5 
plotted with FDR curves from the non-normalised data for comparison.
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Figure 4.5 -  Summary FDR plots showing the results of analysis using the Welch t- 
test on non-normalised natural space raw data and VSN normalised data from MAS 
5.0 (a), RMA (b) and gcRMA (c).
It can be seen that the application of the VSN transform has very little effect on the 
detection outcomes in each of the expression metrics, with a slight loss of power 
observed in data from gcRMA. The heterogeneity of this sample would suggest that 
there is likely to be little variance between samples, and hence the observation of 
minimal changes in power between the VSN normalised and raw datasets.
5.3.3 The use of rank as an alternative signal measurement
The use of rank instead of actual data readings is a common technique in microarray 
analysis. In Chapter Four we introduced the Mann-Whitney test as a non-parametric 
alternative to the t-test, which uses the data’s group ranking instead of the data value; 
Breitling et al. (Breitling, et al., 2004) introduced a technique based on the product of 
ranks following pair-wise comparison of individual arrays which performed favourably 
with fold-change calculation. Martin et al. (Martin, et al., 2004) proposed an analysis 
method based on Rank Difference Analysis of Microarrays (RDAM) where each signal 
value is replaced a ranking value between zero and one hundred, followed by pair-wise 
comparison of rank differences using the empirical null distribution. The authors 
comment that “this simple transformation is a powerful normalizing procedure” .
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Taking a similar approach to Martin, explorations were undertaken replacing data 
values with a rank value for each array independently (between 1 and 12545) and then 
use these values in the same manner as the signal values in the determination of 
differential gene expression. As this replacement takes the data from an interval data 
type to an ordinal form, examination of the effects of this step on the normality and 
distribution of the data is likely to be more important than that after QQ normalisation 
or VSN transformation.
4.3.3.1 Normality of rank replacement data
Using the strategies introduced in Section 2.3.1, the normality of data following the 
application of rank replacement was first assessed using the Shapiro-Wilks test for 
normality; the number of non-normal genes (scoring a p-value less than 0.05) for each 
of the four datasets is shown in Table 4.3.
The Shapiro-Wilks tests show that the normality of data from RMA is slightly increased 
following rank replacement. However, for MAS 5.0 and gcRMA there is a marked 
increase in the number of probe sets presenting with deviation from normality. This 
observation highlighted the need for further exploration of the nature of this deviation 
from normality using plots showing mean signal plotted against correlation to 
normality for a Q-Q plot (Section 2.3.2). The resultant plots are shown in figure 4.6.
Table 4.3
Analysis Method Number of probe sets deviating from normality (p<0.05 from SW test)
Untransformed Rank Transformed
MAS 5.0 5799 (46%) 8799
RMA 3075 (25%) 3810
gcRMA 6371 (51%) 9177
Table 4.3 -  Results from  Shapiro-Wilks tests fo r  normality.
Data from MAS 5.0 (Figure 4-6.a) shows a large number of non-normal probe sets with 
tails forming in data with high and low mean ranks. Whilst many probe sets are non­
normal many of these form a broad cluster in the higher scoring R2 values, so whilst 
they present as fa iling” normality testing, the robustness of statistical tests may 
overcome the issues this rank replacement generates.
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Figure 4.6 - Plots showing correlation to normality (R2) versus mean expression 
signal for each probe set following the application of a rank based data substitution to 
each expression dataset.
Review of the data from RMA (Figure 4.6.b) shows a large amount of data correlating 
well with normality (R2 greater than 0.95). A small tail is formed on the plot from 
expression values presenting with a low mean rank, and a few top scoring probe sets 
becoming non-normal.
gcRMA data (Figure 4.6.C) presents with the majority of probe sets being non-normal, 
with only a few high and low ranking probe sets correlating with normality. This 
observation once again suggests the need for caution in the application of gcRMA in 
combination with statistical based testing. It is therefore of interest to scrutinise the 
effect of this transformation in the detection of spiked in probe sets in the manner 
previously described.
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5.3.2.3 FDR performance of rank transformed data
Performance of the rank transformed data was assessed using the previously described 
framework (Section 4.2) to detect the fifteen spikes present in the 24 chips with a two­
fold change in the Affymetrix Latin square dataset assessed using FDR curves over a 
range of sample sizes with multiple samples. MAS 5.0 data was used in an 
untransformed form, RMA and gcRMA data was analysed as provided (incorporating a 
final log2 transformation).
Since transformation technically takes the data from an interval type to an ordinal 
form, reference back to the statistical flow chart in Chapter Three (Figure 2.1) shows 
that the correct choice of test is the Mann-Whitney test. Although not ideal, due to the 
lack of power at lower sample sizes, the rank data was subjected to the Mann-Whitney 
test within the FDR framework. The resultant summary graphs showing the area under 
the FDR curve over a range of sample sizes are shown in Figure 4.7 plotted with the 
Mann-Whitney data for the untransformed raw data for comparison.
Interestingly at the smallest sample size of three replicates per group, both MAS 5.0 
(Figure 4-7.a) and RMA (Figure 4-7.b) have an increased power to detect using the rank 
transformed data. Data analysed using MAS 5.0 has a similar power to detect using 
either method, with tight convergence at the higher sample numbers. With the 
exception of a few of the smaller sample sizes, the rank transformed had a lower power 
to detect when applied to both RMA and gcRMA data (Figure 4-7.b and 4.7.C), although 
there is indication of potential convergence as sample size increased.
Because of the power loss associated with using the Mann-Whitney test compared to a 
parametric test on an equivalent sample size it is of interest to examine the FDR 
performance of rank transformed data when subjected to the Welch t-test. Whilst 
technically incorrect because of the data type, it could be argued that data with a raage 
of zero to twelve thousand is a pseudo-interval data type. This is an approach that has 
been utilised (Breitling, et al., 2004) and whilst the data does present as mainly non­
normal, examination of Figure 4.6 shows that for MAS 5.0 and RMA the majority of 
data does present with a correlation tending towards normality.
Rank data was subjected to the Welch t-test within the FDR framework. The resultant 
summary graphs showing the area under the FDR curve over a range of sample sizes 
are shown in Figure 4.8 plotted with the Welch t-test data for the untransformed raw 
data for comparison.
121
122
Area Under FDR Curve
0 500 1000 1500 2000 2500 3000
a>
09
o
73 & 
£  3
o oQ) 0)
S S
fO
RM
A
R
eplicates
.Cr
Area Under FDR Curve 
0 500 1000 1500 2000 2500 3000
l-o-lu
Ol
O)
W
m00
<o
o
73 ^ 
*  3< XTD O so jos sN)
Figure 
4,7
F i g u r e  4 , 7  -  c o n t i n u e d
c)
gcRMA
T h e a r e b c  a l  M a x i m u m
 &
C M
®230 
a. a
LL
1C
to
COc
<
Rank Data 
Raw Data
123 4 5 6 7 8 9 10 11
Replicates
Figure 4.7 -  Summary FDR plots showing the results of analysis using the Mann- 
Whitney test on the original and rank substituted data from MAS 5.0 (a), RMA (b) 
and gcRMA (c).
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Figure 4.8 -  Summary FDR plots showing the results of analysis using the Welch t- 
test on the original and rank substituted data from MAS 5.0 (a), RMA (b) and 
gcRMA (c).
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Review of the data from MAS 5.0 (Figure 4.8.a) and RMA (Figure 4.8.b) shows very 
little difference in power to detect the spiked in probe sets using the Welch t-test 
between the rank transformed and untransformed data. Data from gcRMA (Figure 
4.8.C) shows a small loss in power of detection when rank transformed, although this is 
a relatively small amount. Overall whilst application of this rank transformation does 
impact on the normality of the data it would appear to have very little impact on the 
outcome of spike detection in this Latin square dataset.
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4.4 Discussion
In this Chapter the idea of normalisation was introduced along with experimental 
review of the effectiveness of the normalisation in improving power to detect spiked in 
probe sets within the Affymetrix Latin square dataset. Whilst the application of a 
normalisation step is logical in order to overcome obscuring variance in data, care must 
be taken in their application due to the risk of negative effects on the data. 
Wolkenhauer et al. (Wolkenhauer, et al., 2002) comment that whilst correcting for this 
non-biological variation normalisation can reduce the information content of the data.
4.4.1 Application of QQ normalisation
Following the application of a QQ normalisation the normality of datasets from all 
three expression metrics was slightly reduced, but the data broadly followed the same 
distributions as the untransformed data (compare Figure 5.1 to Figure 3.2 d, e and f). 
Power to detect the spikes in the truth dataset was marginally improved with QQ 
normalised MAS 5.0 data, had no effect on the outcome from RMA data, and slightly 
reduced power in the gcRMA dataset.
These results suggest little evidence against the application of a QQ normalisation, and 
suggest a positive benefit in the application of an inter chip normalisation method to 
MAS 5.0 data.
4.4.2 Application of VSN transformation
The application of a VSN transformation to data from MAS 5.0 had little effect on the 
number of probe sets presenting as being normally distributed, however increased the 
number of non-normal probes in data from RMA and gcRMA. However, VSN 
transformed data had a very similar power of detection when compared to the 
untransformed data.
Whilst there is little evidence to suggest support for the application of a VSN 
transformation as part of a default analysis, VSN may be of use in analyses which use 
analysis of covariance to detect differential gene expression by removing the 
relationship between mean expression signal and variance.
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4.4.3 Application of rank transformation
Substitution of signal values with the data rank within an array resulted in large 
deviations from normality as would be expected as a result of a complete replacement 
of the data distributions. However, the transformation would appear to have very little 
impact on the outcome of spike detection in this Latin Square dataset with similar 
power seen with both the Mann-Whitney and the Welch t-test. A rank based data 
replacement therefore presents as an alternative normalisation method.
4.4.4 Overall Conclusions
Generally each of the normalisation techniques produced very little effect on analysis 
outcomes when applied to the Latin Square dataset. However, it should be noted that 
this is a very clean and homogenous dataset and more typical experimental data may 
benefit more from the application of these techniques.
Finkelstein et al. (Finkelstein, et al., 2002) comment that no single normalization or 
correction method currently available is able to address all the issues normalisation 
aims to overcome, but careful sequence selection, array design, experimental design 
and experimental annotation can substantially improve the quality and biological of 
microarray data. Another approach to deal with the variance is the application of more 
robust statistical testing; it is this that will be addressed in the following Chapters.
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Chapter Five 
Application of robust statistical testing
In this Chapter the application of statistical testing to Affymetrix microarray data is 
revisited looking at more robust testing methodologies designed to address the 
presence of outlier data within a dataset. Section 5.1 introduces the concepts of robust 
methods and examines the requirement to address outlying data within Affymetrix 
datasets. Section 5.2 reviews the methods used to investigate the practicalities and 
power of these tests before Section 5.3 explores the ability of a five robust methods to 
detect the spikes in the U95A Latin Square dataset. Section 5.4 discusses the results 
and observations regarding the application of statistically robust techniques within an 
analysis.
5.1 Introduction
In previous Chapters, the issue of applying statistical testing to microarray data 
highlighted problems of small sample size and the need to apply parametric testing to 
achieve maximal power from a dataset. The effect of systematic changes in the data 
distribution (such as the positive skew seen in some MAS 5.0 probe sets -  Section 
3-3*3) were identified as having the potential to have an effect on the test outcome, 
however, in practice, the non-normality seems did not appear to be extreme enough to 
have a marked effect on the classic t-test.
In an experimental environment there is often a source of data variation which is more 
difficult to control than shifts in data distribution. Problems with the biological 
processing of a sample, such as poor RNA quality or differences in reagents used for 
different chips within a study, can lead to one or more chips presenting with data very 
different to others representing identical data. A researcher may be reluctant to 
exclude such data from an analysis, due both the loss of power from discarding a 
sample and the cost of repetition.
In statistical terms these erroneous data points are termed outliers. Many statistical 
tests are sensitive to the presence of outliers. For example, a single grossly inaccurate 
data point may distort simple calculations of the mean and standard deviation (Iglewicz 
and Hoaglin, 1993). Statistical tests that are designed to overcome the challenges 
introduced by these potentially invalid data points are termed robust tests.
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The Oxford English Dictionary describes robust as “sturdy or able to withstand  
difficult conditions”. Applied to statistics, a test can be considered robust if it is not 
markedly affected by poorly structured data or outlying data points. In this Chapter a 
variety of methods are introduced to overcome outliers, including one method which 
aims overcome distributional issues without reverting to non-parametric 
methodologies.
5.1.1 Factors contributing to the presence of outliers in 
microarray data
A typical analysis looking for differential gene expression is concerned with taking a 
sample of a population, and comparing it to another set of data to draw conclusions 
about the differences. Pivotal to this approach is the belief that that data within a 
group is relativity consistent and is representative of its population.
Outliers in microarray datasets can originate from a number of causes including 
systematic technical outliers, sporadic technical outliers, biological outliers and chance 
outliers (occurring due to the finite sample sizes and sampling used). To detect and 
accommodate these outlying data points sufficient replication of data is required 
(Loguinov, et al., 2004).
Generalising, systematic outliers can be assigned two distinct causes; those occurring 
due to the biological information inputted into the microarray process, and technical 
outliers occurring as a result of the experimental process.
Whilst there is always the possibility that biological variation can be introduced to the 
experimental process, with good experimental design, and standardised sampling 
handling and extraction processes the chance of outliers occurring within an 
experiment can be reduced. There are many reasons for the presence of biological 
variation which ultimately presents as an outlier within an analysis, including 
differences in sample handling and treatment, differing degradation of RNA between 
samples, differences occurring as a result of temperature effects acting on a sample, 
differences in sampling or the issue that cells may be at differing stages of cyclic 
processes or development (e.g. the cell cycle) (Kadota, et al., 2003).
These chances of this type of biological outliers occurring can be reduced with good 
experimental procedure; however there is another source of biological outliers that is 
more difficult to control.
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In some cases, heterogeneity of tissue types can result in outliers, for example biopsies 
may contain more them one distinct cell type however good the pathological extraction 
of the sample. This type of outlier can be more difficult to control and may require the 
ultimate elimination of a sample from analysis.
Because of the large number of steps involved in the experimental process from 
hybridization to image analysis, there are many stages at which systematic technical 
outliers can be introduced to an experiment. Example of reasons for these outliers 
include: dust, scratches on the array surface, imperfections in hybridisation, staining or 
scanning, errors in array production, or sample contamination or miss-labelling 
(Kadota, et al., 2003).
Another important stage at which outliers can also occur is in the initial analysis of the 
image file for conversion into numerical values for further analysis. Such an outlier can 
occur when the estimated difference between the background and the foreground 
intensities from the image analysis is small, or if am integral normalisation step is 
ineffective at producing the homogenous data required for further analysis (Gottardo, 
et al., 2003).
Reviewing the above exploring the origins of outliers, it can be summarised that an 
outliers can occur at any stage where insufficient care has been applied to reduce 
differences between samples, ultimately contributing to an inaccurate sampling and 
increased variation in the dataset.
5.1.1 Detecting outliers in a dataset
There is a considerable literature on the detection and accommodation of outliers 
(Barnett and Lewis, 1994; Iglewicz and Hoaglin, 1993). Iglewicz and Hoaglin comment 
that prior to considering the possible elimination of these points from the data; one 
should try to understand why they appeared and whether it is likely that similar values 
will continue to appear. They do, however, note that outliers are often just bad data 
points.
The ideal approach to examine outliers in a dataset is the examination of all outlying 
data points. This can be achieved by the application of manual or graphical techniques 
to explore the hypothesis that not all outliers are errors and that some outliers are 
genuine; indeed these genuine outliers may be the most important observations of the 
sample. However when applied to the thousands of probe sets within a typical 
microarray dataset this repetitive examination becomes an onerous task.
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We must therefore look towards the less informative statistical techniques to assess the 
degree of outlying data in microarray datasets in order to examine how extreme an 
outlier is acceptable for the test chosen. Review of the statistical literature suggests a 
variety of tests including z-scores, Grubb’s test, Dixon’s test and Rosner’s test to 
identify outliers. However, Hampel warns of the limitation of these techniques stating 
that many commonly applied tests cannot reject one distant outlier within a set of ten 
observations (Hampel, 1985).
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5.2 Technical Methodology
Using the previously described methodology (Section 3.2), an integrated analysis script 
was written in R which took a subset of the Affymetrix U95A Latin Square dataset and 
produced a series of 20 replicates at a range of 3 to 12 chips in each of two groups using 
the MAS 5.0, RMA and gcRMA expression metrics. Next the script took each of these 
indexed matrices, extracted the relevant data and then ran a series of robust statistical 
tests with twenty replicates over a range of ten sample sizes. The statistical tests chosen 
for these robust investigations were three variants of the robust t-test, the trimmed t- 
test, the Winsorised t-test, Yuen’s test, and a randomisation method.
F igures.1
Data processing 
and filtering
Analysis
FDR Analysis
Select samples per group (n)
Store AUC value
Note position of spiked in probe sets
Order test results by significance (descending)
Apply statistical test
Filter control probe sets
Apply expression metric to dataset
Randomly sample n chips from each group
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Repeat for 3-12 
chips (n) per group 
with 20 samplings 
at each sample size
Figure 5.1 -  Flow diagram o f technical methodology fo r  examination o f  power to 
detect performance o f  each robust statistical test.
The output for each test was fed into an FDR function which extracted the location of 
the spikes from the ordered p-values and calculated the area under the FDR curve as 
previously described. The output for each test was exported into a summary matrix 
containing each of the 200 AUC values calculated, grouped by sample size. Summary 
plots were produced charting the average area under the curve (with standard error, 
error bars), across the range of sample size under consideration.
Full details of the technical methodology are given in Section 9.5.1.
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5.3 Exploration and Results
5.3.1 Improving the robustness of the Welch t-test
In previous Chapters it has been shown that the Welch t-test is and appropriate form of
power to detect differential gene expression in the model Latin square dataset. 
However, in light of the observations regarding the number of outliers present in the 
dataset review of the test and explorations into improvement in robustness are of 
interest.
5.3.1.1 Fundamental estimators of the t-test
Review of the formulae behind the t-test yield two fundamental measures used in the 
calculation of the t-statistic (t): the sample mean and the sample variance. Review of 
the complex equation used to determine the degrees of freedom (df) of the Welch t-test 
show that standard deviation is the fundamental measure. The mean is an estimator of 
the location of the data and variance describes the spread.
Where: x , y : Means of groups. S',2, S’2: Standard deviations of groups, 
m, n : Number of observations in each group.
5.3.1.2 Robust estimators for the t-test
deviation can be substituted for more robust estimators of location and spread. The
robust statistical test. The median absolute deviation (MAD) is a measure of the scale
the t-test for analysis of Affymetrix microarray data because of its lack of assumption 
about equality of variance. In addition the test has been shown to perform well in its
x - y
m - l  n - 1
Expanding the ideas of Iglewicz and Hoaglin (1993) the values of mean and standard
alternative estimators of median and median absolute deviation (MAD) are compatible 
with other variables within the t-test formulae and should in theory provide a more
or dispersion of a distribution about the median, calculated as the median of the 
absolute-value distances of the points about the median.
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Combinations of the estimators for location and spread into the t-test formula results in 
four different tests statistics.
Standard Deviation Median Absolute
(SD) Deviation (MAD)
Mean Welch t-test Mean /  MAD test
Median Median /  SD test Median /  MAD test
5.3.1.3 FDR performance of robust variants of the t-test
Performance of each robust variant of the Welch t-test was assessed using the 
previously described framework (Section 5.2). The ability of each test to detect the 
fifteen spikes present in the 24 chips with a two-fold change in the Affymetrix Latin 
square dataset was assessed using FDR curves over a range of sample sizes with 
multiple samples. MAS 5.0 data was used in an untransformed form, RMA and gcRMA 
data was analysed as provided incorporating the final logs transformation. The 
resultant summary graphs showing the area under the FDR curve over a range of 
sample sizes are shown in Figure 5.1.
Review of the FDR plots (Figure 5.1) indicates that the technique with the most power 
to detect was the combination of mean and standard deviation (a standard Welch t- 
test). Substitution of the median for the mean still yielded good results; however, 
results indicated slight loss of power in comparison. Substitution of the standard 
deviation with the more robust median absolution deviation from the median 
significantly reduced the power of the test to determine the fifteen spikes in the dataset, 
and substitution of the median for the mean reduced this further.
Figure 5.1
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Figure 5.1 -  Summary FDR plots showing the results of analysis using robust 
variants o f the Welch t-test on data from MAS 5.0 (a), RMA (b) and gcRMA (c).
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5.3.2 The trimmed t-test
The robust variants of the t-test introduced in Section 5.3.1 are based on the 
accommodation of outlying data points by use of more robust estimators within the 
analysis method. Another approach for dealing with outlying data points is the 
elimination of suspect data. Trimming is the simplest of methods available for dealing 
with the elimination of outliers from a dataset, whereby the largest and smallest 
observations are deleted from the sample.
This non-discriminatoiy approach to removing outliers results in a robust estimator of 
the mean that is relatively insensitive to the outlying values and an unbiased estimate 
of the population mean. However the trimmed data does not have a normal 
distribution even if the data are from a normal population and the trimming acts to 
reduce the sample variance (Dixon and Tukey, 1968; Tukey and McLaughlin, 1963).
The amount of trimming applied to a dataset is described as degrees of trimming. 
Removal of one data point from each end of a dataset is termed 1 degree of trimming, 
two points from each end, 2 degrees of trimming and so on.
5.3.2.1 FDR performance of the trimmed t-test
Performance of the trimmed t-test was assessed using the previously described 
framework (Section 5.2) applying one and two degrees of trimming. The ability of each 
test to detect the fifteen spikes present in the 24 chips with a two-fold change in the 
Affymetrix Latin square dataset was assessed using FDR curves over a range of sample 
sizes with multiple samples. MAS 5.0 data was used in an untransformed form, RMA 
and gcRMA data was analysed as provided incorporating the final log2 transformation. 
The resultant summary graphs showing the area under the FDR curve over a range of 
sample sizes are shown in Figure 5.2.
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Figure 5.2 -  Summary FDR plots showing the results of analysis using first and 
second degree trimmed t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c).
It can be seen that across each of the three expression metrics the power to detect is 
severely reduced at each additional degree of trimming with some convergence of 
results towards the higher sample sizes. Comparison to the Welch t-test suggests that 
the power to detect may be similar to that obtained from a dataset equivalent in size to 
the resultant dataset after trimming. To explore this effect, the FDR graphs were re­
drawn with the data from the trimmed samples shifted along the x-axis to their 
equivalent sizes after trimming. The resultant plots are shown in Figure 5.3.
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Figure 5.3 -  Summary FDR plots showing the results o f analysis using first and 
second degree trimmed t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c). 
Data from the trimmed tests has been shifted to be equivalent to the Welch t-test data.
5.3.3 The W insorised t-test
In the previous section the trimmed t-test was introduced in which both tails of the 
dataset are simply omitted. This had the effect of reducing the size of the dataset being 
analysed and hence the associated power to detect the spiked in samples of the Latin 
square dataset. Based on Winsor’s principle that "All observed distributions are 
Gaussian in the middle", the Winsorised t-test works by eliminating the outliers and 
replacing them with data from the edge of the remaining distribution. In one degree 
Winsorisation, the smallest and largest values are given the values of their nearest 
neighbours. Thus:
Resultant Dataset
Original 1 2 3 4 5 67 8 9
1 degree Winsorised 2 2 3 4 5 6 7 8 8
2 degree Winsorised 3 3 3 4 5 6 7 7 7
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Similarly to the trimmed t-test, for a symmetric distribution, the symmetrically 
trimmed or Winsorised mean is an unbiased estimate of the population mean. 
However, the trimmed or Winsorised mean does not have a normal distribution even if 
the data are from a normal population (Iglewicz and Hoaglin, 1993).
The formula for calculating the t-statistic with Winsorised data is identical to that used 
for the Welch t-test. However the resultant t-statistic is revised to account for the 
changes in data, reflecting the amount of original data (h) left in the sample, sized (N).
To obtain the p-value associated with a t-statistic from Winsorised data, standard 
significance table can be employed, with h -i degrees of freedom (instead of N-i) (Tukey 
and McLaughlin, 1963).
5.3.3.3 FDR performance of the Winsorised t-test
Performance of the Winsorised t-test was assessed using the previously described 
framework (Section 5.2). Wilcox (2001) asserted that the trimmed-mean approach is 
desirable if 20 percent of the data are trimmed under non-normal distributions, 
therefore one and two degrees of Winsorisation was applied to the data from each 
probeset.
The ability of each test to detect the fifteen spikes present in the 24 chips with a two­
fold change in the Affymetrix Latin square dataset was assessed using FDR curves over 
a range of sample sizes with multiple samples. MAS 5.0 data was used in an 
untransformed form, RMA and gcRMA data was analysed as provided incorporating 
the final log2 transformation. The resultant summary graphs showing the area under 
the FDR curve over a range of sample sizes are shown in Figure 5.4.
As seen with the trimmed t-test, it can be seen that across each of the three expression 
metrics the power to detect is severely reduced at each addition degree of Winsorisation 
with some convergence of results towards the higher sample sizes. Comparison to the 
Welch t-test suggests that the power to detect may be similar to that obtained from a 
dataset equivalent in size to the resultant dataset after Winsorisation. To explore this 
effect, the FDR graphs were re-drawn with the data from the Winsorised samples 
shifted along the x-axis to their equivalent sizes reflecting the amount of original data 
rem aining in the sample. The resultant plots are shown in Figure 5.5.
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Figure 5.4 -  Summary FDR plots showing the results of analysis using first and 
second degree Winsorised t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c).
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Figure 5 . 5  -  Summary FDR plots showing the results of analysis using first and 
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Data from the Winsorised tests has been shifted to represent the amount of original 
data remaining.
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5.3.4 Yuen’s t-test
Yuen and Dixon (Yuen and Dixon, 1973) suggested an improved robust test could be 
achieved by combining the trim m ed means and W insorised variances of a dataset to be 
used in conjunction with W elch's t-test. The m ethod was further developed by Yuen 
(Yuen 1974).
5.3.3.3 FDR performance of Yuen’s  t-test
Performance of the Yuen’s t-test was assessed using the previously described 
framework (Section 5.2) applying one and two degrees of trim m ing/W insorisation. 
The ability of each test to detect the fifteen spikes present in the 24 chips with a two­
fold change in the Affymetrix Latin square dataset was \assessed using FDR curves over 
a range of sample sizes with m ultiple samples. MAS 5.0 data was used in an 
untransform ed form, RMA and gcRMA data was analysed as provided incorporating 
the final log2 transform ation. The resultant summary graphs showing the area under 
the FDR curve over a range of sample sizes are shown in Figure 5.5.
As seen with the trim m ed and W insorised t-tests, it can be seen th at across each of the 
three expression m etrics the power to  detect is severely reduced a t each addition degree 
of trim m ing/W insorisation with some convergence of results towards the higher 
sample sizes. Comparison to  the Welch t-test suggests that the power to detect may be 
sim ilar to  th at obtained from  a dataset equivalent in size to  the resultant dataset after 
application of the Yuen techniques. To explore this effect, the FDR graphs were re­
drawn with the data from the Yuen’s t-test shifted along the x-axis to  their equivalent 
sizes after trim m ing. The resultant plots are shown in Figure 5.7.
146
,Cr
Area Under FDR Cun/e 
0 500 1000 1500 2000 2500 3000
d
U1
00
<0
o
-<
rs>
Is)
R
M
A
R
eplicates
Area Under FDR Curve
0 500 1000 1500 2000 2500 3000
0»
cn
o>
K»l M00
<0
o
n »IS) -»
Figure 
5.6
F i g u r e  5 . 6 -  c o n t i n u e d
c)
gcRMA
©
0 
a: p
LL
13
<
C M
Yuen 1 deg 
Yuen 2 deg
Welch t-testo
5 6 7 8 9 10 11 123 4
Replicates
Figure 5.6 -  Summary FDR plots showing the results of analysis using first and 
second degree Yuen's t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c).
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Figure 5.7 -  Summary FDR plots showing the results of analysis using first and 
second degree Yuen’s t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c). Data 
from the Yuen tests has been shifted to be equivalent to the Welch t-test data.
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5.3.5 Re-sampling based testing
W ith the exception of the M ann-W hitney test each of the tests examined so far has been 
a variant of the t-test which makes the assum ption the data being drawn from a normal 
distribution. It was highlighted in Section 2.3 that problems exist with differences in 
data distributions between probe sets which cause technical problems with these 
conventional statistical testing m ethods (Motulsky, 1999).
The calculation of a p-value for each of these variant methods relies on comparison to 
results obtained from  “perfect” datasets which conform to the t-distribution and m atch 
the assum ptions of a test. Back as far as the i93o’s Fisher and Pittm an had suggested 
the development of tests that are not affected by the shape of the data distribution and 
yield an accurate confidence value. These tests were term ed exact tests (Fisher, 1935; 
Pitm an, 1937; Pitman, 1938).
However, it was not until the advent of computers however that these tests were 
developed and as computing power became more advanced and accessible they became 
popular research tools (Edginton, 1997). Re-sampling methods depart from theoretical 
distributions and instead derive inference based on repeated sampling with the same 
dataset.
Using these m ethods the tests derive an exact p-value for data instead of looking up 
from  tables derived from asymptotic data. As a result the methods are robust against 
the effects of outliers within the data.
W ithin re-sam pling there are two differing methodologies of random isation and 
perm utation. Perm utation techniques exhaust all possible outcomes for data sampling 
re-arrangem ent and calculate a perfect exact p-value for the data, whilst random isation 
tests sim ulate a large num ber of possible outcomes to derive a p-value for the dataset. 
(Edginton, 1997; Good, 2000).
Randomisation testing has been applied to m icroarray data (Dudoit, et al., 2000), 
however its use is not common and is generally available as an add-on module for 
complex statistical environments (e.g. SAS (Mehta and Patel, 1999)).
S.3.5.2 Pilot experiments using randomisation testing
Randomisation testing works to calculate a p-value based on the distribution of the 
data rather than that obtained from an asymptotic method. In previous Chapter it has 
been shown th at the Welch t-test is the param etric test of choice for determ ination of 
differential gene expression, therefore, in developing a random isation based test, it was 
the Welch t-test methodology that was chosen.
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The methodology behind the m ethod is a simple repetitive process. Initially the t- 
Welch t-statistic is calculated between the two groups of data (to ). The data is then 
regrouped and then re-sam pled into two groups of identical size to the initial dataset. 
The t-statistic is then calculated for the new groups and compared to the initial t- 
statistic (to ). If the new value is greater than the original value then this is noted. This 
process is repeated a set num ber of tim es before a p-value is calculated by dividing the 
num ber of samplings whose t-statistic was greater them to by the num ber of samplings 
applied. A flow chart of this process is show in Figure 5.8.
An im plem entation of this m ethod was w ritten in as a R function and was applied to 
the 24 chip subset of the Latin Square dataset containing sixteen spiked in probe sets 
using 1,000,000 random  re-sampling steps. Graphs of the p-value obtained from this 
analysis plotted against the p-value obtained from conventional Welch’s t-test are 
shown in Figure 5.9. Review of this data indicates a good correlation between the two 
techniques. The p-values for each of the spiked-in transcripts are shown in Table 5.1.
Figure 5.8
Compute t statistic for 
original data (to)
Repeat n times
Calculate p-value
(times t. >= to divided by n)
Sample Data
Compute t statistic for 
sampled data (tn)
Figure 5.8 -  Flow chart o f the random isation t-test methodology.
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Figure 5.9 -  Plots showing p-values obtained from randomised re-sampling based t- 
test plotted against those from the Welch t-test. Figure 5.9.b shows a expanded 
section of Figure 5.9.0 with p-values from o -  0.05. Red circles around data points 
indicate data from the 16 spiked-in transcripts within the dataset. Figures 5.9.C and 
5.9A show the data from 5.9.0 split according to MAS 5.0 detection calls.
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Further review of the data identifies a group of genes with smaller p-values that score 
more significantly using the randomisation test (Figure 5.9.b). To investigate this effect 
further, the data according to the detection calls given as part of the MAS 5.0 analysis, 
with one group representing the probe sets where the value across all arrays are called 
as absent, and another containing probe sets where one or more arrays are called as 
marginal or present (an identical split to that used in Section 2.3.2 looking at data 
distributions).
Review of the relationship between these two groups of data and the Welch t-test data 
indicates that the probe sets with some probe sets called present, correlate very tightly 
with the results from the Welch t-test. Data with arrays called absent also shows good 
correlation, however it is this dataset which contains probe sets with large differences 
in p-values between the two methods.
Table 5.1
Spike R andom ised p-value W elch t-test p-value
407_at 0.000001 1.99E-08
546_at p < r 6 1.15E-07
i7o8_at 0.000558 7.66E-04
I024_at p < r 6 5.20E-10
I09i_at 0.000001 9.37E-07
1597—at 0.003308 2.68E-03
338i8_at p < r 6 9.64E-08
36o85_at 0.000001 1.22E-09
36202_at p < i*6 3.26E-14
363H—at p < 1-6 1.15E-05
36889_at 0.000006 1.40E-06
37777—at 0.00005 1.78E-05
3^734—at 0.000009 3.99E-06
39058_at 0.000018 1.30E-05
40322_at p < 1-6 6.86E-09
684_at 0.000001 5.25E-11
Figure 5.1 -  Comparison o f p-values fo r  spiked-in transcripts between randomised t- 
test (1,000,000 step random isation) and the Welch t-te s t
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5.3.5.3 How many re-sampling steps are required?
In the initial testing of the method, an arbitrary figure of 1,000,000 was chosen for the 
number of random re-sampling steps applied to the data. As the technique is very 
computationally intensive it is essential to choose a figure for samplings that will 
produce statistically sensible and relevant results, but within a practical period of time. 
With the number of datasets that a microarray experiment produces, it is not feasible to 
run all the possible data permutations within a reasonable time (the 24 chip dataset has 
5.2 x 1023 distinct permutations of the data)
To address this, a modified version of the program was coded which outputted the p- 
value after each random re-sampling step. Review of the data on a probe set by probe 
set basis indicated that there was convergence on a approximate p-value after a certain 
number of re-samplings, the number of steps before this convergence is seen being 
dependant on the final p-value. It is observed that probe sets resulting in a larger p- 
value converge on a single value much faster than those that have a smaller value. The 
smaller the resulting p-value the greater the number of permutations required to 
converge on this point. Example plots are shown in Figure 5.10.
It can be reasoned that for a gene to have a large p-value the observed statistic must 
exceed the actual statistic on many occasions. In contrast, probe sets that yield a 
smaller p-value will only exceed this threshold a fraction of the number of times, so as 
the p-value decreases the number of re-samplings between observing a significant 
result increases. This suggests that the run time for a full microarray dataset can be 
reduced by calculating the number of permutations required dependant on expected p- 
value.
5.3.5.4 Application of a binomial error model to reduce re-sampling steps
Research into potential methods for estimating the number of re-samplings required 
lead towards exploration of error modelling using standard binomial theory (Mehta, 
1999). Binomial theory enables a confidence measurement to be made using the 
number of samplings (n) and the resultant p-value (p):
Error
Rearrangement of this formula gives a method for estimating the number of re­
sampling steps required (n) if the researcher is willing to pre-define the confidence (s) 
they wish to have in the resulting p-value (p).
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Figure 5.10 -  Convergence o f p-values fro m  probe sets resulting in a large (5.10.0) ,  
m id (5.io.b) and sm all (5.10.C and 5.10A ) p-values over a range o f sam plings during 
the application o f a 100,000 step random isation t-test.
An example of the relationship formed between samplings and p-value is shown in 
figure 5.11 with error rates set at 0.1 and 0.05. Integrating this new model into the 
randomised re-sampling methodology gives a revised analysis which is represented in 
the flowchart in Figure 5.12.
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Figure 5.11 -  The relationship between p-value and samplings required following the 
application of the binomial error model at go% and 95% confidence in the resultant p- 
values
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Figure 5.12 -  Revised flowchart incorporating error model.
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5.3.5.5 Testing the revised model
The efficiency of the error model was tested by implemented the revised functions into 
the code modified in Section 5.3.5 3 which outputted the p-value at each stage of the 
process. Figure 5.13 shows the results indicating that the error model yields near 
identical p-values (identical would no be expected due to the randomness of sampling) 
and terminated the run of the program at a point where it would appear the p-value has 
stabilised around a certain value.
5.3.S.6 Computationally defining the model
It has previously been commented that re-sampling based techniques are 
computationally intensive; indeed this is why after their conception is was many years 
before their usefulness and uptake into research was possible (Edgington, 1997; Good, 
1999)- In the case of the pilot testing undertaken in Section 5.3S.2 the running of 
1,000,000 permutations on 12545 probe sets took several days when run on a P4 
3.0GHz machine within the R environment. To make re-sampling a useful research 
tool, avenues to reduce this time warrant exploration.
It is clear that the error model has the potential to reduce this time, by eliminating the 
need to run many samplings for probe sets which are likely to result in a high p-value. 
In addition explorations were made into the most computationally effective methods of 
implementing the methodology.
Investigations were undertaken in implementing the code in a variety of programming 
languages (Visual Basic, Perl and R), but these higher level interpreted languages were 
markedly superseded in speed by the lower-level compiled languages. The 
methodology was therefore re-coded into compiled C, taking at tab-delimited text files 
as it input. This solution was found to be the fastest implementation of the method.
In addition to the faster implementation of the basic algorithm, it was found that the 
revised algorithm incorporating the error model imposed an additional overhead to the 
execution of the method due to the requirement to calculate a p-value and the error 
model following each sampling. This issue was overcome by the application of a 
stepped model to the error model. Following each run with a set number of samplings, 
the data which could be removed according to the error model was removed and the p- 
value stored before re-analysis with a higher number of samplings. This was applied 
using a stepped approach up to a maximal number of samplings.
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Figure 5.13 -  Convergence of p-values from probe sets resulting in large (5.13.0), mid 
(5.i3.b) and small 1(5.13.0 and 5.13-d) p-vcdues over a range of samplings. The red 
lines show an example of data run without the error model for 100,000 
randomisations (Figure 5.10) and the black lines show the same dataset run with the 
error model, terminating when confidence in the p-value was achieved.
5.3.5.7 FDR performance of the randomised re-sampling based t-test
Performance of the randomised t-test was assessed using the previously described 
framework (Section 9.3) using the stepped approach introduced in Section 5.3.5.6 
starting at 10,000 samplings and increasing to 1,000,000 in steps of 10,000. The error 
level was set at 5%. Due to the computational requirements of this analysis only a 
single sample at each sample size was run for this test in contrast to the twenty run for 
the other tests.
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The ability of each test to detect the fifteen spikes present in the 24 chips with a two­
fold change in the Affymetrix Latin square dataset was assessed using FDR curves over 
a range of sample sizes with multiple samples. MAS 5.0 data was used in an 
untransformed form, RMA and gcRMA data was analysed as provided incorporating 
the final log2 transformation.
Initial review of the data suggested a similar FDR response to that obtained from the 
distribution independent Mann-Whitney test. Summary graphs showing the area 
under the FDR curve over a range of sample sizes are shown in Figure 5.14 
incorporating the information from the Welch t-test and Mann-Whitney test for 
comparison.
In general the performance of the randomisation re-sampling based test was very 
similar in response to that from the Mann-Whitney test. At lower sample size (3-5 per 
group) there was very little power to detect, power which increased over the middling 
sample sizes until at those over 9 per group, a similar response was seen for all three 
tests.
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Figure 5.14 -  Summary FDR plots showing the results of analysis using randomised 
re-sampling based t-tests on data from MAS 5.0 (a), RMA (b) and gcRMA (c). 
Additional lines from the Welch t-test and Mann-Whitney test are show for 
comparison.
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Diaconis and Efron (Diaconis and Efron, 1983), recommend that when the sample size 
is small and does not conform to the param etric assumptions, re-sampling is 
recommended as a remedy. In contrast, the data presented here suggest that when 
applied to  m icroarray data there is no power advantage to  the random isation test, with 
the M ann-W hitney test taking a fraction of the tim e to  compute.
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5.4 Discussion
In the introduction to this Chapter, the idea of outlying data points within Affymetrix 
microarray datasets was introduced.
5.4.1 Robust variants of the t-test
Building on the ideas suggested by Iglewicz and Hoaglin (Iglewicz and Hoaglin, 1993) 
for robust estim ators, the t-test was reviewed and more robust measures of location 
and spread implemented within the t-test methodology. The resultant options for 
location (mean and median) and spread (standard deviation, median absolute 
deviation about the median) resulted in three variants of the Welch t-test, three of 
which can be considered more robust.
The technique with the m ost power to detect was the combination of mean and 
standard deviation (a standard Welch t-test). Substitution of the median for the mean 
still yielded good results; however, results indicated slight loss of power in comparison. 
Substitution of the standard deviation with the more robust median absolution 
deviation from the median significantly reduced the power of the test to determ ine the 
fifteen spikes in the dataset, and further substitution of the median for the mean 
reduced this further.
The m easurem ent of the variance (spread) of the data would appear to be having a 
significant effect on the power of the te s t This correlates with statem ents by Baldi and 
Long (Baldi and Long, 2001) who comment that estim ating variance is the major 
lim itation of the t-test at smaller sample sizes.
5.4.2 Trimmed, Winsorised and Yuen’s t-tests
The robust variants of the t-test work by attem pting to accommodated outliers into the 
statistical analysis. A differing approach is the elim ination of these outlying data points 
from the dataset Wilcox (Wilcox, 2001) and Lix & Keselman (Lix and Keselman, 1998) 
comment that when multiple factors such as non-norm ality and heterogeneity of 
variance occur, this has the effect of inflating the Type I error rate (false positives 
reported). They suggest the application of robust methods such as the trim m ed means 
and W insorised variances are applied.
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The trim m ed, W insorised and Yuen’s t-test all remove a predeterm ined am ount of data 
from  the tails of the data set working under the assum ption that only one or two 
erroneous data points exist in the data. The W insorised m ethod replaces the lost values 
with others drawn from  the new tails of the dataset, and Yuen’s test combines trim m ing 
with W insorisation.
Each of the above m ethods perform ed poorly in the detection of the spikes w ithin the 
Latin square dataset. W hen the data was considered to  represent the sample size of the 
data following the application of the trim m ed techniques (equivalent to shift along the 
x-axis of the FDR graphs), power was slightly improved in comparison to the Welch t- 
test, however to achieve this much data has been discarded.
Removal of outliers would appear to have some success in the improvement of power to 
detect if data is pre-filtered and then compared to  equivalent sample sizes. However 
the application of these techniques can be view as akin to throwing data away, with a 
large cost burden for each m icroarray experiment. The choice of a test which can 
overcome outliers in a dataset is a more preferable approach, combined with better 
experim ental design to  enable the inclusion of all data collected as part of an analysis. 
This observation supports research by Keselman and Zumo (Keselman and Zumbo, 
1997) who found that the nonparam etric approach has more power than the trim m ed- 
mean approach.
5.4.4 Randomised Re-sampling based t-test
Randomised re-sam pling presents an interesting compromise between the distribution 
issues encountered with the standard Welch t-test, w ithout the need to choose a non­
param etric approach and replace data with rank inform ation. By re-sampling an 
pseudo exact p-value can be generated representing the distribution of the probe set 
under te s t
Initial pilot testing of the technique showed high correlation between the results of the 
random ised m ethod and the Welch t-test (Figure 5.9). This correlation can be used to 
support the application of the Welch t-test to m icroarray data; if the random ised test 
calculates a p-value according to the actual data distribution and the Welch t-test yields 
sim ilar values then this suggests that the data follows a near normal distribution, which 
is a required assum ption of the Welch test.
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Application of the random ised m ethod for the detection of spikes in the Latin square 
dataset yielded sim ilar results as those obtained from the M ann-W hitney test. In 
comparison to the Welch t-test, the random ised test showed lim ited power at low 
sample sizes, slightly less power at middle sizes, and equivalent power at sample sizes 
over 9 per group.
W hilst this technique gives reasonable results, the com putational and time overheads 
required for its application question the practicality of application in a research setting. 
If near identical results can be obtained using a test that is more robust against outliers 
and distribution issues in lesser tim e, then the Mann-W hitney test is the test of choice.
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Chapter Six 
Application of a Bayesian Framework
In this Chapter the problem of analysis on datasets with a small sample size is revisited 
with the application of a Bayesian framework applied to exploit trends in the data. 
Section 6.1 introduces the Bayesian methodologies and key work applying these 
techniques to m icroarray data. Section 6.2 details the modifications made to the 
previously described analysis framework (Section 3.2) to incorporate Bayesian methods 
for the identification of the spiked-in data in the Affymetrix Latin square d ataset 
Section 6.3 reviews the methods used to optimise the tests using spike detection in the 
Latin square data and compares the results to other statistical techniques. Section 6.4 
discusses the results and observations about the application of Bayesian methods to 
Affymetrix m icroarray data.
6.1 Introduction
In  previous Chapters the issue of small sample size has been a recurring issue 
influencing the options available for the application of statistical testing, specifically 
issues of estim ating variance in the classic t-test for differences between the means. 
This lack of sample size results in poor estim ates of w ithin-treatm ent variance and 
hence, a corresponding poor perform ance of the t-test (Baldi and Long, 2001). 
Historically these tests have been developed for a single analysis between two groups of 
data, however in microarrays many thousands of these tests are run in parallel. 
Although there is no complete substitute for experim ental replication to allow the 
sample results to represent those of the population, Bayesian methods aim to improve 
the confidence that can be achieved from an analysis by incorporating inform ation 
regarding sim ilarities between parallel observations and thus reduce the need for 
excessive replication.
6.1.1 Introduction to Bayesian methods
Named after Thomas Bayes (an English clergyman and m athem atician), Bayesian data 
analysis combines Bayesian probability theory with statistical data analysis techniques 
to  make predictions about future events based on our current inform ation (Eddy, 
2004). A single m icroarray comprises many parallel pseudo-replicated experiments, 
w ith some genes being represented by more than one observation, and sim ilarities in 
the resultant data between other probe sets reporting distinctly different transcription 
profiles.
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It has previously been noted th a t there is a relationship between the mean expression 
level and variance calculated for a dataset (Naef, et al., 2002). It is this observation 
th at has been suggested as the basis for a Bayesian m ethod using inform ation provided 
by probe sets of sim ilar expression levels to attain  pseudo-replication of the 
experim ent.
6.1.2 The Baldi and Long Bayesian Framework
In Section 4.1.2 the factors th a t affect the power of a statistical test to  detect differences 
were highlighted and include variability of the population (Hatfield, et al., 2003), the 
desired detectable differences and an acceptable error rate (Wei, et al., 2004). In  their 
2003 paper, Baldi and Long introduced a framework for differential gene expression 
based on Bayesian estim ates of a gene’s variance incorporated into the Welch t-test to 
improve detection power.
The model is based on the observation th at mean expression level and variance are 
related w ithin m any m icroarray datasets (Figure 6.8). Variance is calculated by 
combining the given variance for a probe set with a prior estim ate of the expected 
variance for th at gene - calculated from  the average of the variance of other genes of 
sim ilar expression level. These two figures for variance (the probe set variance and the 
local variance) are then  combined according to a weighting factor. The weighting factor 
is controlled by the researcher and is a tuneable param eter dependent on how 
confident the experim enter is th a t the background variance of a closely related set of 
genes approxim ates the variance of the gene under consideration.
The analysis steps for the fram ework can be described in the following workflow 
description:
i) For each probe set calculate the mean, standard deviation (SD) for
each group of data
ii) Separately for each group of data:
a. order the data by mean expression value
b. for each probe set, calculate a Bayesian SD m easurem ent from  a 
sliding window either side of the current probe set.
iii) Blend this Bayesian SD value with the probe set SD value
iv) Calculate the t  statistic (assum ing inequality of variance) using the
probe set m eans and the Bayesian SD m easures.
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v) Calculate the Bayesian degrees of freedom
vi) Calculate a p-value using the Bayesian-t and degrees of freedom.
6.1.4 Application of the Bayesian framework to Affymetrix Data
Baldi and Long dem onstrate the effectiveness of their algorithm s using an E. coli 
dataset w ith four replicates per group from m icroarray data obtained from  nylon 
m em branes containing 4,290 probes (Arfin, et al., 2000; Long, et al., 2001). Review of 
the workflow in Section 6.1.3 indicates two m ain user tuneable param eters, the size of 
the window use for local variance estim ation, and the confidence param eter used in the 
blending stage of the algorithm . In  the initial publication (Baldi and Long, 2001), no 
guidelines for the tuneable param eters of the methodology are given, and in the parallel 
publication (Long, et al., 2001) little guidance is given as to  the requirem ents for 
param eter selection.
In  com parison to  the dataset used to  develop the framework, Affymetrix GeneChip data 
com prises a different biological technology and undertakes many m ore pseudo-parallel 
experim ents (up to  47,000 probe sets in the current generations of GeneChips). W hilst 
the Bayesian fram ework has proven a popular tool w ithin the cDNA m icroarray 
community, few publications exist regarding the application of this framework to 
Affymetrix data, and those th a t exist, do not details of the param eters selected 
(Hatfield, et al., 2003; Li, et al., 2005; Saidi, et al., 2004; Tong, et al., 2001).
It is therefore of in terest to validate the application of the Bayesian framework to 
Affymetrix gene chip data and explore the optim al param eters for the local variance 
window size, differing options in the application of the blending param eter and 
alternative m ethods for the estim ation of the localised variance.
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6.2 Technical Methodology
Using the previously described methodology (Section 9.3.5), an integrated analysis 
script was w ritten in  R which took a subset of the Affymetrix U95A I.atin Square 
dataset and produced a series of 20 replicates a t a range of 3 to  12 chips in each of two 
groups using the MAS 5.0, RMA and gcRMA expression m etrics. Next the script took 
each of these indexed m atrixes, extracted the relevant data and then runs a variety of 
variants of the Bayesian fram ework (allowing tuning of the user alterable param eters) 
w ith twenty replicates over a range of ten  sample sizes.
Figure 6.1
Data processing 
and filtering
Analysis
FDR Analysis
Select samples per group (n)
Store AUC value
Order test results by significance (descending)
Apply statistical
Note position of spiked in probe sets
Filter control probe
Randomly sample n chips from each group
Apply expression metric to dataset
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Repeat for 3-12 
chips (n) per group 
with 20 samplings 
at each sample size
Figure 6.1 -  Flow diagram  o f technical methodology fo r  exam ination o f pow er to 
detect perform ance o f each variant o f the Bayesian fram ew ork.
The output for each test was fed into an FDR function which extracted the location of 
the spikes from  the ordered p-values and calculated the area under the FDR curve as 
previously described. The output for each test was exported into a sum m ary m atrix 
containing each of the 200 AUC values calculated, grouped by sam ple size. Summary 
plots were produced charting the average area under the curve (with error bars 
reporting the standard error), across the range of sample size under consideration.
Full details of the technical methodology are given in Section 9.6.
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6.3 Results
In  previous Chapters, the response to  a test applied against a variety of different 
expression m etrics has been considered. However, tuning the m any param eters of the 
Bayesian fram ework w ith a variety o f values against three expression m etrics would 
yield m ore data than  could sensibility be interpreted. Thus, in an attem pt to  minimise 
the variables under consideration, optim isation was undertaken using MAS 5.0 data. 
Following the identification of optim al values for each tuning param eter w ith this 
dataset, com parisons can m ade the RMA and gcRMA models using identical analysis 
settings.
6.3.1 Defining an optimal Bayesian window size
I t has already been com m ented th a t the dataset used for the development of the 
Bayesian fram ework and used to  illustrate its effectiveness a t improved power of 
detection in  differential gene expression between two groups was an £ . coil dataset on 
nylon m em branes containing 4,290 probes (Arfin, et al., 2000; Long, e t al., 2001). Key 
to  the analytical m ethodology is the application of a sliding window over probe sets 
sorted by m ean expression level to  determ ine an average local variance for probe sets of 
a sim ilar expression level. As Affymetrix data contains m any m ore probe sets than  the 
developm ent dataset it is thus o f in terest to determ ine the ideal window size for 
maximal power of detection.
Guidelines from  the authors relate to  the E. coli dataset (Baldi and Long, 2001), and 
suggest a window size o f 101. In  the follow-up paper (Long, e t al., 2001) the issue of 
window size is further explored a t values of 41,101, and 161, w ith a value of 101 chosen 
for subsequent analysis. However, they also state “ W indow sizes o f larger than 100 
genes often perform  w e ll” In  the supporting package Cyber-t 
(h ttp://visitor.ics.uci.edu /genex/cybert/)  the authors com m ent “A  sliding w indow  o f  
101 genes has been show n to be quite accurate when analyzing 2000 or more genes, 
w ith  only 1000 genes a  w indow  o f 51 genes m ay w ork better”.
As Affymetrix data contains m any m ore probe sets than the nylon m em brane arrays 
used to  develop the m ethod it was hypothesised th a t a larger window may be m ore 
appropriate for estim ation of the local variance. However is should also be noted th at 
accurate determ ination of th is window size is key to  accurate results from  the Bayesian 
m ethod. If too small a size is chosen, insufficient inform ation will be incorporated to 
determ ine an accurate variance estim ate, however if too large a window is chosen the 
resultant local value will contain inform ation from  probe sets w ith have an expression 
level (and hence variance) vastly different from  the probe set under consideration.
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6 .3.1.1 Using FDR performance to tune the window size
To assess the optimal window size, the output from the previously described FDR 
framework (Section 2.x) was used to compare results. The ability of the Bayesian test 
with different window sizes to detect the fifteen spikes present in the 24 chips with a 
two-fold change in the MAS 5.0 Affymetrix Latin square dataset was assessed using 
FDR curves over a range of sample sizes with multiple samples. Window sizes of 50, 
100, 200, 300, 500, 750 and 1000 were chosen for consideration. The resultant 
summary graphs showing the area under the FDR curve over a range of sample sizes 
are shown in Figure 6.2. In addition data from the Welch t-test applied to MAS 5.0 
data is shown for comparison to the standard test.
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Figure 6.2 - Summary FDR plots showing the results of analysis using the Baldi and 
Long Bayesian framework on MAS 5.0 data with a variety of sliding window sizes.
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Review of the data in Figure 6.2 shows that overall the power of the Bayesian m ethod is 
greater than that of the standard Welch t-test, especially at the smaller sample sizes, 
where the conventional test has a m arked loss of power. For comparison the power 
achieved from the Bayesian m ethod with ju st three samples per group is equivalent to 
that obtained from the Welch test with five samples.
Analysis of the optim al window size indicates that an increase in power is observed as 
the window sizes rises from 50 to 500 (Figure 6.2.a and 6.2.b), beyond 500 the power 
begins to reduce again (Figure 6.2.c) indicating that a window size of 500 would appear 
the optim al size for application to  this Affymetrix dataset. This value is approximately 
5% of the probe sets to  which the window is applied, which corresponds to guidelines 
for lowess smoothing, which also suggests a default window size at 5% of the size of the 
dataset (MathW orks, 2004).
6.3.2 Defining an optimal blending weighting
As previously described in Section (6.1.2) the Bayesian framework uses a combination 
of the actual probe set variance blended with the locally calculated variance from probe 
sets with a sim ilar mean expression level. W ithin the methodology, the blending 
weighting is a num ber between zero and infinity which indicates the weight given to the 
Bayesian prior estim ate of local variance; the larger the weighting the larger the 
confidence given to the local variance. The variances are then blended using the 
Dirichlet distribution according to  the blending param eter (Baldi and Brunak, 2001). 
The Dirichlet distribution is the m ultivariate generalisation of the beta distribution and 
is assum ed as the prior distribution of a multinomial distribution in Bayesian statistics 
(W ikipedia, 2005). The authors suggest the param eter is set to three tim es to num ber 
of experim ental observations when the sample size is small, and that the value is 
reduced to a figure equal to  the num ber of observations as the num ber of observations 
increases.
In choosing values for the weighting param eter, two separate application models were 
chosen. The first model altered the blending param eter as the sample size altered; 
thereby applying the desirable property of the Bayesian approach converging to the t- 
test as the experim enter carries out additional replications and thus becomes more 
confident in the observed estim ate of w ithin treatm ent variance. A second model was 
also applied in which the blending param eter was fixed and not dependant on the 
sample size.
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6.3.2.1 Using FDR performance to tune the blending parameter
To assess the optimal blending parameter, the output from the previously described 
FDR framework (Section 9.6) was used to compare results. The ability of the Bayesian 
test with a window size of 500 to detect the fifteen spikes present in the 24 chips with a 
two-fold change in the MAS 5.0 Affymetrix Latin square dataset was assessed using 
FDR curves over a range of sample sizes with multiple samples. Blending parameters 
fixed at 5,10,15 and 20 were compared along with a variable blending parameter based 
on 1, 2, 3, 4 and 5 times the sample sizes in each group was applied. The resultant 
summary graphs showing the area under the FDR curve over a range of sample sizes 
are shown in Figures 6.3 and 6.4. In addition data from the Welch t-test applied to 
MAS 5.0 data is shown for comparison to the standard test.
F igure 6.4
Figure 6.4 -  Summary FDR plots showing the results of analysis using the Bayesian 
framework on MAS 5.0 data using different fixed blending weightings.
Review7 of the data for fixed blending shows very little difference between the different 
parameter values, however there is a general trend that the smaller the fixed blending 
parameter, the more powerful the resultant Bayesian test. However as this is not a 
mode the authors recommend the test is run in, it is the results from the variable 
blending that are of more interest.
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Figure 6.5 - Summary FDR plots showing the results o f analysis using the Bayesian 
framework on MAS 5.0 data using different variable blending weightings calculated 
as a multiple o f the sample size per group.
Review of the data assessing the power achieved from the Bayesian version of the t-test 
across of a range of variable blending values dependant on the sample size indicates 
similar results to those achieved from the fixed blending, namely that little difference is 
seen between the different values. In addition it should be noted that every variant of 
the Bayesian test performed better than the Welch t-test, especially at the smaller 
sample sizes.
As a final comparison, the FDR output from an analysis implementing a fully Bayesian 
estimate of the variance was compared to the results from fixed blending with a value of 
5 and variable blending based on three times the sample size (Figure 6.6). A reasonably 
powerful test is observed, however it does lack power across all sample sizes when 
compared to the blended varieties of the test.
It can therefore be concluded that the blending stage of the Bayesian framework is key 
to the additional power obtained when compared to the standard methods, however the 
exact value of blending weighting seems less critical than the application of this stage 
itself. Thus there is no reason to deviate from the authors recommendation that the 
blending weighting be applied at a value three times the sample size in each group.
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Figure 6.6 -Summary FDR plots showing the results o f analysis using the Bayesian 
framework on MAS 5.0 data comparing the effect o f variable and fixed blending 
weightings versus a fully Bayesian estimate of a probe set’s variance.
6.3.2 Application of a robust local variance estimate
It had already been commented that accurate determination of the local variance is key 
to accurate application of the Bayesian model. In Section 6.3.1 the window size was 
tuned to achieve maximal power to detect. To achieve this power it can be assumed 
that at this optimal window size, an accurate measure of the localised variance has been 
obtained. As an alternative to this window size, another approach a more robust 
method for determining the variance value representing this window. In the 
framework as presented by the authors, the reported local variance is calculated as the 
mean of the variances for all probe sets within the current window. It is proposed that 
use of the median of variances, as an alternative to the mean, may yield improvements 
in the local variance estimation.
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6 .3.2.1 Using FDR performance to tune the blending parameter
Models using both the mean and median of the local variance were applied to 
untransformed data from MAS 5.0, and log2 transformed data from RMA and gcRMA 
with the results being assessed using the previously described FDR methodology 
(Section 9.6). The resultant summary graphs showing the area under the FDR curve 
over a range of sample sizes are shown in Figure 6.6. In addition data from the Welch 
t-test applied to MAS 5.0 data is shown for comparison to the standard test.
Review of the data comparing the use of mean versus median for estimation of the 
localised variance within the Bayesian framework yields markedly differing results 
dependant on the expression metric the methodology was applied to. When applied to 
MAS 5.0 data the mean estimate of the local variance has substantially more power 
than that obtained from the median.
F igure 6 .7
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Figure 6 .7  S u m m a ry  FDR p lo ts  show ing  the results o f  ana lysis using  the B ayesian
fr a m e w o r k  using  the runn ing  m ean  a n d  m edian  o f  the locally calculated  variance
app lied  to a ) M A S  5 .0  da ta , b) R M A  da ta  a n d  c) gcR M A  data.
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With data obtained from RMA and gcRMA little difference was seen between the two 
variants of the model. There is therefore, little support for taking the median of the 
local variance window as an alternative to the mean. A possible reason for this 
observation was revealed when the relationship between mean and variance was 
examined for each of the three expression metrics (Figure 6.8.a, 6.8.d and 6.8.f). 
Whilst the reported relationship between mean and variance was observed with data 
from MAS 5.0, no clear relationship was observed with data from RMA or gcRMA, and 
data with variance being independent of the expression signal. Reversing the log2 
transform introduced as the last stage of the RMA and gcRMA expression metrics re­
established a relationship between the mean and variance (Figure 6.8.c and 6.8.e).
Whilst the Bayesian framework does not utilise the relationship between mean and 
variance, the blending stage with a typically constant variance across all expression 
levels would appear to act to control highly variable data and therefore improve the 
power of detection over the standard Welch t-test. This effect is similar to the 
procedures developed by Tusher et al. (Tusher, et al., 2001) who introduced a constant 
to the variance components of the t-test methodology to stabilise the denominator in 
the equation.
FDR analysis of the Bayesian framework was undertaken to explore the effect of the 
logarithmic transform of the data on the detection of the fifteen known spikes with data 
from MAS 5.0 and RMA (Figure 6.9). The results indicate that at smaller sample sizes 
there is an increase in power observed when the analysis is undertaken with natural 
space data.
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Figure 6.8  -  Relationship between mean and variance for natural and log space data 
for each expression metric examined using a 12 sample dataset comprising one group 
of the Affymetrix Latin square dataset.
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Figure 6 .9 - S u m m a ry  FDR p lo t show ing  the results o f  ana lysis  using  the B ayesian
fr a m e w o r k  using  the runn ing  m ean  a n d  m edian  o f  the locally calculated  variance
app lied  to d a ta  in logarithm ic a n d  n a tu ra l space fo r  M A S  5 .0  a n d  R M A  data .
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6.4 Discussion
Overall, the application of the Baldi and Long Bayesian fram ework for the detection of 
differential gene expression would appear to  be a powerful technique that overcomes 
the lim itations of some of the m ore standard statistical approaches at smaller sample 
sizes. Incorporation of inform ation on the local variance determ ined from probe sets 
with a sim ilar m ean expression level along with the actual variance for the probe set 
under scrutiny yields power increases in  the ability to  detect differentially regulated 
genes when com pared to  the standard  Welch t-test. An approxim ate comparison shows 
th a t the power achieved from  the Bayesian m ethod w ith ju st three samples per group is 
equivalent to  th a t obtained from  the W elch test w ith five samples.
The guidelines provided w ith the fram ework are somewhat lim ited in  the effect th at 
altering the various user tuneable param eters has on the experim ental outcome, hence 
the requirem ent to  investigate how changes in the local variance window and the 
blending weighting altered the outcom e for the correct identification of spikes in the 
Aflymetrix U95A Latin square d a tase t
Investigations into the optim al sliding window size, used to estim ate the local variance 
indicated suggested th a t w ith MAS 5.0 data, a window size of 500 gave the maximal 
power of detection of the sixteen spikes in the test dataset. This value is approximately 
5% of the num ber o f probe sets represented on the GeneChip under analysis and is 
com parable to  guidelines given for the application of lowess smoothing, which uses a 
sim ilar sliding window over a dataset. The author’s recom m endation of a window size 
of 101 represents a sim ilar proportion of their developmental dataset and it is thus 
suggested th a t researchers apply a window size with a figure of 5% of the probe sets 
present on the array under analysis.
Explorations of the ideal blending param eters com pared the application of fixed 
blending across a range of sam ple sizes versus a m ore dynamic model using a m ultiple 
of the replicates in each group as suggested by the authors of the methodology. 
Comparison of the two m ethods showed little difference in detection power, however 
when com pared to a fully Bayesian m ethod they proved superior. The data supports 
the application of a blending weighting as per the m ethod author’s suggestion, a t a 
value three tim es the sample size per group.
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Incorporating some of the ideas for statistical robustness introduced in Chapter Six, a 
final investigation was undertaken to explore the application of the median variance 
within the sliding window of localised variance. Data from MAS 5.0 yielded more 
power from the mean of the localised variance, RMA and gcRMA data gave similar 
results from either the mean or median. A final investigation of RMA data indicated 
that at small sample sizes, addition power was obtained by removing the logarithmic 
transform introduced as the final stage of the expression metric.
A summary plot comparing the best Bayesian results from MAS 5.0 and RMA 
compared to the Welch t-test show significant increases in power of detection at the 
lower levels (Figure 6.10). In summary, it is therefore suggested that researchers 
should employ the default mean estimate of the localised variance and consideration is 
given to the removal of the transformation when utilising the RMA expression metric. 
Overall the Bayesian framework presents as a very powerful analysis tool, allowing a 
research to extract the maximal amount of information from a cost-limited experiment 
and providing the greatest power of all of the statistical tests considered.
F igure 6.10
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Figure 6 .9  -  S u m m a ry  FDR p lo t show ing  the results o f  ana lysis  using  the B ayesian
fr a m e w o r k  using  the runn ing  m ean  a n d  m ed ian  o f  the locally calculated  variance
app lied  to d a ta  in logarithm ic a n d  n a tu ra l space f o r  M A S  5 .0  a n d  R M A  data .
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Chapter Seven 
Approaches to annotation and exploration of 
Affymetrix microarray data.
In this Chapter the issue of annotation and exploration of the biological meaning of 
data is introduced. Section 7.1 introduces the need for annotation, the types of 
annotation available to assist in the interpretation of microarray data and highlights 
the limitations of many of the currently available tools and methodologies. Section 7.2 
discusses the requirements and technical processes used in the development of a 
solution to data annotation and exploration. Section 7.3 introduces the key concepts 
identified and developed within the resultant software solution. Section 7.4 provides a 
functional overview of the MADRAS (MicroArray Data Review and Annoation System), 
highlighting the annotation and exploration tools available to the microarray 
researcher. Section 7.5 discusses how intuitive and comprehensive software tools are 
key to efficient experimentation using microarrays.
The work in this Chapter was undertaken in a joint collaboration with Daniel 
Kirwilliam, Bioinformatacist for the Wales Gene Park, Cardiff University.
7.1 Introduction
Work in previous Chapters has concentrated on investigating the optimal methods for 
the identification of differentially-regulated probe sets within an Affymetrix microarray 
dataset. However, identifying these probe sets is only the first start of an experimental 
process working towards the goal of determining and understanding the biological 
functions behind these experimental observations.
To draw conclusions about the functions operating within a dataset the key identifier 
linking observations between GeneChips, the probe set identifier (e.g. “i7o8_at”) must 
be annotated and expanded to provide a meaningful description of the biology the data 
is describes.
As part of the output from Affymetrix Microarray Suite (Affymetrix, 2001), the user is 
provided with a short textual description of the gene function the probe set is targeted 
at detecting, or an identifier for less well-characterised probe sets. However, RMA 
(Irizarry, et al., 2003) and gcRMA (Wu, et al., 2004) analysis metrics do not provide 
this information as part of the analysis process and the dChip (Li and Hung Wong, 
2001a) analysis methodologies rely on external annotation sources to label probe sets.
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In  practice, the concise description offered by Affymetrix is often missing or poorly 
com prehensible due to  the m achine encoding and processing of the inform ation, and 
some researchers have chosen to  assem ble their own Affymetrix annotation from  the 
original probe sequences. As Zhong et al. comment, “assem bling comprehensive 
annotation inform ation fo r  all probe sets o f any A ffym etrix m icroarrays rem ains a  
tim e-consum ing, error-prone and  challenging task” (Zhong, et al., 2003).
7.1.1 Making sense of experimental data
The volume of data th a t a m icroarray experim ent produces is not insignificant, and the 
prospect of developing analysis strategies can be a daunting task for the novice user. 
For a researcher interesting in  looking for differentially regulated genes w ithin a 
dataset, th is process can typically be reduced to  a three step process:
i) Selection of genes o f in terest (extraction of genes with the largest fold 
change o r the application of statistical testing).
ii) Collecting inform ation on the probe set identifiers determ ined to  be of 
interest, for example data describing a gene name and its functional 
inform ation.
iii) Exploration and scrutiny of these findings in an attem pt to  identify links 
between significant observations and link these to  meaningful biological 
hypotheses.
The first stage in  the process, the statistical analysis of data and the production of a list 
o f “interesting genes” is potentially the easiest stage in the process, and once decisions 
have been m ade about the type of analysis to be undertaken the results can be 
com puted in  m inim al tim e and returned to  the user. It is the subsequent annotation 
and exploration of these results th a t present as a potential bottleneck in analysis.
By the very nature of a m icroarray experim ent, which provides a genome-wide picture 
of transcription w ithin the cell, the results that are retuned are likely to  take the 
researcher into areas they have no previous expertise in, highlighting new m echanisms 
and processes to  explain the phenotypic differences between the cells of interest. If the 
list is small, th is is easily achieved by reading database inform ation and the available 
literature where appropriate. However, processing a list of hundreds of probe set 
identifiers typically returned from  a statistical analysis is a much m ore onerous task.
Having established accurate annotation for each probe set, the potential then exists to 
assist in the sum m arisation of a list of significant results. W hilst m any results may 
exist as stand-alone observations, m any others may occur as a result of parallelisation
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of results, either through replication of expression m easurem ent on the m icroarray 
chip, or as a result of com plem entary biology acting on a series of linked transcripts.
Establishm ent of the resources and tools required to  undertake such annotation and 
exploration of a dataset is thus key to  the analysis of m icroarray data beyond the 
num erical stages o f analysis. In  addition the usability of these tools and establishm ent 
of effective workflows m ust be considered in  order to  undertake efficient exploration of 
a dataset’s results.
7.1.2 Introduction to gene annotation
A nnotation can be viewed as the com m entary for each probe set and links the codes 
used to  identify expression levels on m icroarrays to  a variety of biological inform ation 
about w hat the m easurem ent represents. A nnotation th a t may be of relevance to  a 
researcher undertaking a m icroarray experim ent can take m any differing forms, from  
sim ple inform ation such as the gene nam e and functional description, through m ore 
descriptive inform ation about function such as gene ontology, through to  inform ation 
on the complex interactions of a gene w ithin a pathway.
In  hum ans, m icroarrays are attem pting to  m easure the mRNA levels representing the 
20,000-25,000 genes currently estim ated to  be present in  the genome (International 
Hum an Genome Sequencing Consortium , 2004). A nnotation of gene function, th a t is 
the linking a sequence with in  the genom e to  a biological process, can be achieved in  a 
num ber of different ways; looking a t the sequence inform ation and identifying 
expressed sequence tags (ESTs), linking biological products (mRNAs o r full length 
cDNAs) back to  the original sequence o r via homology to  genes in  other organism s. 
The prim ary consideration of annotation explored in  th is Chapter relates to  Homo 
sapiens; however the annotation sources and challenges for o ther species are also 
briefly discussed.
7.1.2.1 Primary sequence annotation
A nnotating an Affymetrix m icroarray experim ent is the process of linking back to  the 
sequence th a t the probe set represents, and then linking forw ards to  inform ation about 
the function of the gene. GenBank (Benson, e t al., 2004) is the prim ary public 
repository for hum an sequence inform ation, w ith each accession num ber representing 
a unique subm ission to  the database. GenBank identifiers are an im portant and 
common linker across all m icroarray technologies, bu t a GenBank identifier does not 
necessarily represent a gene, and a probe set may link to  m ultiple accession num bers.
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To overcome the lim itations of the sequence based system  of GenBank, UniGene is an 
experim ental system  for autom atically partitioning GenBank sequences into a non- 
redundant set of gene-oriented clusters (Pontius, e t al., 2003; W heeler, e t al., 2003). 
Each UniGene cluster contains sequences th a t represent a unique gene, as well as 
related inform ation such as the tissue types in  which the gene has been expressed and 
m ap location. Currently UniGene contains 52,888 clusters of which 24,071 contain 
both mRNAs and ESTs. I t is the UniGene database th a t is used as the basis for the 
design of each generation of hum an Affymetrix GeneChips with the latest clustering 
and genomic sequence inform ation available utilised a t the tim e of chip design (this 
inform ation is reflected in  the chip nam e, e.g. U95 series were built on UniGene build 
95).
The default annotation produced by M icroarray Suite for each probe set is a 
concatenated field containing inform ation from  the GenBank record (e.g. the record for 
probe set 4 i237_at is “H om o sapiens / REF=D32i2g /DEF=Cluster In d . :H um an  
m RNA fo r  HLA d a ss-I (HLA-A26) heavy chain, complete cds (done cM IY-i) 
/cds= (5 ,no2) / gb= /gi= 6g9597 /ug= H s.181244 /len-1523 /LEN=1574”). This field 
shows th a t the probe set is designed from  UniGene cluster Hs.181244 representing 
GenBank sequence D32129.
However w ith each new build of the hum an genome, additional inform ation is included 
which can yield new insight about the target of a particular probe set on a chip. The 
UniGene database changes regularly, since sequence data is re-clustered about once a 
m onth. As a result, the presence of new sequence inform ation can change the clusters. 
As the sequences of an Affymetrix probe sets are fixed, these changes can result in  a 
probe detecting the transcription of different genes or transcripts based on the current 
clustering. As such even though the binding of probes to  transcripts in the 
experim ental sam ple is fixed, the interpretation of what the resultant signal 
m easurem ents represent is a much m ore dynamic entity.
7.1.2.2 Affymetrix probe set annotation
The key resource available to  a researcher to  link the probe set identifiers on GeneChip 
to  inform ation regarding biological function, is the NetAffx web portal 
(http://w w w .netaffx.com). Through th is website, Affymetrix make current annotation 
data for each probe set available, including the inform ation allowing the linking of a 
probe set between the various annotation databases available. W hilst some researchers 
have chosen to  undertake their own annotation processing working form  the probe 
sequences and building upwards (Gautier, et al., 2004), to  the m ajority of researchers 
choose to  use the inform ation provided by Affymetrix.
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It should be pointed out, however, th a t there are lim itations to  the annotation 
m ethodologies employed by Affymetrix. The approach has assum ed a “one probe set- 
one target relationship for the in terpretation of the data and therefore the system does 
not deal well w ith situations where a subset of oligonucleotide probes in a probe set 
may be assigned to  another gene (or m ore than one gene) based on the current 
UniGene clustering and genom e annotation. W hilst th is issue will hopefully be 
resolved over tim e as the stability o f UniGene cluster increases and additional m ethods 
can be developed to  incorporate all of the inform ation th at the experim ental design 
provides, the issue o f m ulti-gene fam ilies will still rem ain.
7.1.2.3 Secondary meta databases
W hilst the RefSeq and UniGene databases are concerned with collation and simple 
annotation of the prim ary sequence data, there are a variety of second level, m eta 
databases which undertake to  collate further relevant inform ation and relate them  to  
prim ary databases. Examples include LocusLink (M aglott, et al., 2000; Pruitt, e t al., 
2000; P ru itt and M aglott, 2001), centered on genomic location (e.g. curated sequence 
and descriptive inform ation about genetic loci); PFAM (Bateman, et al., 2004; 
Sonnham m er, e t al., 1997) for protein dom ain structure; OMIM (Online M endelian 
Inheritance in  M an) (Ham osh, e t al., 2005; M achet, 1998) for disease-related gene 
inform ation; and GeneCards (Rebhan, e t al., 1997; Rebhan, et al., 1998; Safran, et al., 
2003) for com prehensive inform ation from  other databases on hum an genes.
T ab le 7.1
LocusLink Curated sequences and 
descriptions of genetic loci
http://www.ncbi.nlm.nih.gov/LocusLink
OMIM Online Mendelian inheritance in 
man: a catalog of human genetic 
and genomic disorders
http://www.ncbi.nlm.nih.gov/Omim
Pfam Protein families: multiple 
sequence alignments and profile 
hidden Markov models of protein 
domains
http://wwwsanger.ac.uk/Software/Ifam
GeneCards Integrated database of human 
genes, maps, proteins and 
diseases
http://bioinfo.weizmann.ac.il/cards
Table 7.1 -  Sum m ary o f selected m etabase inform ation and URLs fro m  Nucleic A cid  
Research M olecular Biology Database Collection 2004 (Galperin, 2004).
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These secondary databases are designed to provide information from the perspective of 
genes, disease or proteins and provide a much more user-friendly gateway to a variety 
of information. However, the information is less complete than in the primary 
sequence databases.
The nature of the information in such databases is generally human curated, and more 
readable than the coded nature of the primary sequence databases and thus represents 
an essential resource in the determination of probe set function and links to other 
results within the biological system of study.
LocusLink is a descriptive database centered on the idea of a single genomic locus 
representing a single gene, with an emphasis on well-characterised loci (Maglott, et al., 
2000; Pruitt, et al., 2000; Pruitt and Maglott, 2001). LocusLink provides a single 
query interface to curated sequence information and descriptive information about 
genetic loci. This includes official nomenclature (symbol, name), aliases, sequence 
accession numbers, phenotypes, MIM numbers, UniGene clusters, homology and map 
locations. At the time of writing LocusLink contains 33325 loci, which all have well 
established links with the UniGene database.
The LocusLink database is in the process of being discontinued and superseded by the 
newer Entrez Gene system (Maglott, et al., 2005). However, at the current time, a large 
proportion of Affymetrix microarray annotation resources use LocusLink identifiers as 
a key linker of information. LocusLink information is likely to remain key to the 
interpretation of microarray data during the transition period between NCBI systems; 
indeed the LocusLink identifiers are identical to those within Entrez Gene. However, 
some of the supplemental information provided for each identifier is different
OMIM is a curated database of human genes and genetic disorders which currently 
contains around 15,000 records describing a single gene and the disorders relating to it 
(Hamosh, et al., 2005; Machet, 1998). OMIM focuses primarily on inherited, or 
heritable, genetic diseases and is considered to be a phenotypic companion to the 
human genome project. The OMIM record typically includes information about which 
diseases appear to be linked to specific genes, along with primary references that 
explain how the gene was sequenced and mapped to specific chromosomal regions. 
The record is hand-curated by various expert contributors and often presents as a 
lengthy textual description of the science surrounding a gene.
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7.1.3 Linking gene functions
Each of the annotation sources th a t have been introduced have been very gene-centric 
and concentrate on the data relating to  the single gene under scrutiny. One of the 
powers of m icroarrays is the parallel observation of many different genes 
sim ultaneously looking for patterns in  expression values. To exploit this potential 
annotation m ust be exam ined betw een probe sets, looking for links in the probe sets 
flagged as significant. Intuitively, if several m ethods deliver the same functional 
annotation then one m ight have a higher confidence in the results.
M anual pattern  searching is one approach th a t can be used, looking for correlation in 
the annotation between probe sets. However, th is is a somewhat “hit and m iss” 
approach dependent on the sources used and extent of annotation available for a gene. 
In  addition, different database curators may use different words for the same function, 
or may m ean different things by the sam e word. The context in which a gene was found 
(e.g. “TGF0- induced gene”) may not be particularly associated with its function.
The key resource needed to  assist in  the linking of probe set observations is a linking 
netw ork betw een different genes w ith linking in  expression or common function. Two 
potential gateways to  th is type of inform ation are the various gene pathways and the 
application of gene ontology to  functionally annotate a gene of interest.
7.1.3.1 Gene Ontology
The Gene Ontology consortium  (http://w w w .geneontology.org)  has undertaken a 
project to  produce a controlled vocabulary th at can be applied to  all organism s and be 
robust against change w hilst the knowledge of gene and protein roles in cells is 
accum ulating and changing (Ashburner, et al., 2000; H arris, et al., 2004). It is a 
collaborative effort to  address the need for consistent descriptions of gene products in 
different databases.
The developed ontologies allow the description of the attributes of a gene product in 
three non-overlapping dom ains of m olecular biology. The M olecular Function dom ain 
contains ontologies describing the tasks perform ed by individual gene products (e.g. 
“carbohydrate binding” or “ATPase activity”), whereas, the Biological Process dom ain 
describes broad biological goals, such as m itosis or purine metabolism, which are 
subsequently linked to  ordered assem blies of m olecular functions. The final dom ain, 
Cellular Component describes the sub-cellular structures, locations, and 
m acrom olecular complexes (e.g. “nucleus” or “telom ere”) which a gene is believed to  be 
functional in.
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In  addition to  the controlled vocabulary com prising the gene ontology project, 
collaborating databases provide linking database objects and gene ontology term s, 
which are hand curated and docum ented along w ith supporting docum entation. These 
ontologies represent a unified, consistent system, term s occur only once, and there is a 
dictionary of allowed words. The term s have free text definitions and stable unique 
identifiers. Furtherm ore, term s are related to  each other: the hierarchy goes from very 
general term s to  very detailed ones.
A variety of m ethods have been developed to  assist in the annotation and analysis of 
m icroarray data using gene ontology to  provide inform ation and links between 
observations. On of the sim plest tools FATIGO, (Al-Shahrour, et al., 2004), undertakes 
sim ple counts of ontology term s for each of the genes in a list against each the term s in 
a single layer o f the gene ontology hierarchy. Tuneable param eters allow for selection 
of the ontology dom ain and hierarchy level. However, each option requires a re-run of 
the program , which is a repetitive error prone task to  fully explore a m icroarray dataset.
EASE, the Expression Analysis System atic Explorer (Hosack, e t al., 2003) makes 
attem pts to  im prove on the lim itations of FATIGO by undertaking a statistical analysis 
on the significance of the num ber of counts in a particular category and presenting 
results as a p-value. To overcome the issue of m ultiple probe sets linking to  the same 
gene (and hence gene ontology annotation) over-representing and raising significance, 
EASE converts all accessions to  LocusLink accession num bers before reporting counts. 
GO M iner (Zeeberg, e t al., 2003) is another tool which undertakes a sim ilar analysis 
approach, bu t integrates diagram m atical representation of the ontology hierarchy to 
supplem ent results. Use of gene ontology would appear to be a powerful m ethod of 
supplem enting basic gene annotation w ith a m ore system  biased annotation helping to  
identify links between significant results (Li, et al., 2004).
7.1.3.2 Pathways
Pathways contain inform ation, m ost commonly presented in diagram m atical form  of 
how genes in te rac t A pathway can represent a series of interacting proteins allowing a 
biological function to  occur, or can chart the links between the genes involved in 
initiating a response. Historically pathways were often determ ined for diagram s in 
textbooks, bu t these have the lim itation of not being in a com puter-readable form at. A 
variety of pathway databases have evolved to collate inform ation in a m achine readable 
form  including the KEGG (Kanehisa, et al., 2004; Ogata, e t al., 1999)* GenMAPP 
(D ahlquist, et al., 2002) and BioCarta (BioCarta, 2005) projects.
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Each of these projects relies on contribution from experts w ithin the global research 
community to  subm it data and thus each project contains only a few thousand well 
annotated pathways (m ore in section 7.4.4). GenMAPP is provided by the authors as a 
software tool for the production of pathw ay diagram s, and has the facility to  overlay the 
results of a m icroarray experim ent in  the form  of shaded gene squares, providing a 
visual representation of gene expression w ithin a pathway.
7.1.4 Limitations of current tools
So far in th is introduction the issue o f exploration and annotation of data has been 
covered from  the technical provision of inform ation, rather than the interaction w ith it 
in  order to  undertake an analysis. In  contrast to  the “black box’* approach in which 
statistics chooses the significant changes in  a dataset and an autom ated system makes 
sense of the results and returns a series of hypothesis about the observations in a 
dataset, biologists often approach their data w ith a set of pre-determ ined ideas about 
w hat they m ight be observing, and m ay wish to  approach their data from  a variety of 
angles.
A nother issue to  the typical researcher with lim ited computing skills is the 
m anagem ent and processing of data between experim ents and form ats required for 
differing software packages. An example would be the com bination of selected data 
from  two stages of an experim ent. As analysis tools are often developed by 
com putationally-expert users, issues of user interaction and complexity are often 
overlooked. Researchers are often frustrated w ith the tools provided for them , and 
dem and sim pler, m ore user friendly program s.
C urrent tools available for the exploration of data follow a gene centric approach, where 
each line of in terest m ust be followed from  the initial probe set identified through a 
series of linked resources to  gain the desired insight regarding th at observation. In 
addition, current approaches to  the annotation and exploration of m icroarray data keep 
the data and annotation separate, w ith researchers often relying of spreadsheet tools 
such as MS Excel to  bring together inform ation.
Experience shows th at exploration for a single probe set can result in the creation of 
m ultiple web windows to  access the required inform ation. W hilst th is m anual process 
may be acceptable for a small list of genes, it becomes an onerous task when typical 
lists of several hundred results are encountered. This problem  can be sum m arised as 
data is available rather than accessible.
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7.2 Development of an analysis tool
The issue of exploring and annotating data is an area that has received surprisingly 
little attention from the academic development com m unity, with most work 
concentrating on development of algorithmic based analysis problems (e.g. RMA, 
dChip, SAM). Effective use of computing and bioinformatics resources applied to the 
problems faced by biologists are however important and can reduce the time required 
to perform routine repetitive tasks.
Many annotation sources are publicly available and there is increasing linking between 
resources, however the requirement to firstly obtain and then review the numerous 
pages of text and screens containing differing segments of information required to 
understand the biological functions represented by the data from a single probe set 
cannot be view as an efficient analysis workflow. A solution was thus envisaged 
allowing a biologist to drive the simultaneous visualisation of data and annotation of 
their data.
7.2.1 Developmental drivers
As a result of interactions with researchers accessing the Cardiff University GeneChip 
service it became apparent that in contrast to the black box approaches to analysis (e.g. 
statistical analysis and clustering) where data is inputted and a list of definitive answers 
is output, biologists typically have ideas about the results of their data and wish to 
explore their data from a variety of angles and test pre-existing hypotheses.
One of the key drivers for the development of a new analysis solution was frustration in 
answering simple questions a novice user may have about their data. Examples include 
“Can I see my data for all cyclin genes?”, “Can I see the data for this list of candidate 
genes?”, “Is there any link in the underlying biology from these significant results?”, 
and “Are there any other probes for this gene in my dataset?”
Whilst the questions appear simple, providing answers requires the combination of a 
variety of differing tools and often repetitive submission of queries to databases in 
order to attempt to construct answers. Efficient tools to process these queries therefore 
present as a major bottleneck in analysis. The biologists who generate the datasets 
must ultimately undertake the analysis and interpretation of the data, rather than rely 
on the non-expert guidance given by a bioinformatician in order to achieve the 
maxim um  amount of interpretation of the biology contained within a dataset.
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7.2.2 Requirements for an analysis environment
Many functionally excellent analysis tools have found lim ited uptake in their use due to 
issues of complexity for the research w ith average com putation skills. This is 
exemplified by R environm ent (R Development Core Team, 2004) in which much 
m icroarray developm ent has been undertaken. However, as the environm ent is alm ost 
entirely com m and line driven th is has lim ited its usage by those undertaking 
m icroarray research, and is often lim ited to  the developm ent community  rather than 
the user base.
In  developing a solution to  the challenges of com bining data and annotation, the 
decision was m ade to  develop a solution for intensive usage by the average biological 
researcher. As such the need for an easy to  use, intuitive interface w ith d ear 
functionality was identified along w ith challenges of the m ultiple operating systems in 
use w ithin an establishm ent. An environm ent accessed through a webpage was viewed 
to  be an ideal solution to  overcome these issues, and provides the added benefit of the 
portability of access to  data from  differing workstations.
The technical requirem ents of a web-delivered system result in the need for a central 
data repository and delivery system  which provides additional scope for sharing data 
between users. The system  was therefore envisaged to  allow the sharing of data w ithin 
a research group, enabling interesting and key results to  be shared between users 
w ithout the need to  leave the analysis environm ent for transfer.
7.2.3 Developmental aims
In  an attem pt to  overcome the lim itations of current system s and to  assist the average 
m icroarray user w ith the issues and challenges highlighted regarding the annotation, a 
solution is desired, built on the fundam ental idea of drawing together user data w ith 
relevant and m eaningful annotation. Such a solution would enable the exploration of 
results and annotation in order to  draw  biologically meaningful conclusions from  
GeneChip data in an rapid exploration environm ent.
Forming an integral part of the typical analysis workflow, the system  should build on 
the idea th a t an analysis is typically concerned with the linked observations between 
about collection of results (not ju st a single gene value), and thus allow a move from  
typical gene-by-gene analysis to  looking and analysing groups of data, looking for links 
in  the underlying biology. Ideally, th is functionality would be supported by relevant 
analysis tools to  assist in the identifications of links between results highlighted as 
significant.
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7.3 MADRAS
Microarray Data Review and Annotation System
7.3.1 Key concepts
Review of the tools available to  the m icroarray researcher revealed th at typically the 
functions of analysis and annotation were kept very separate by the m ajority of 
common packages. Having undertaken a statistical analysis, one tool is required to 
view the experim ental data and a series of others are required to  annotation the 
findings of the statistical analysis. In  addition the m ajority of tools work from  flat text 
files, which m akes the com bination of data a tricky task  for the average com putationally 
shy researcher. Key to  the developm ent of MADRAS was the identification of three 
separate data stream s which when com bined can provide an environm ent suitable for 
the rapid exploration of data.
7.3.1.1 Experiments
W ithin MADRAS, the data from  each GeneChip array is indexed and stored as a 
separate entity w ithin the database. However, the text file output from  each of the 
common expression m etrics consists of a data m atrix containing data from  many 
differing arrays form ing the columns of the m atrix, with the probes and their associated 
signal intensities form ing the rows of the m atrix. The basic upload file for MADRAS is 
based on the MAS 5.0 Pivot Table export (Affymetrix, 2001), where each chip is 
represented w ith up to  three columns of data with column name suffixes identifying the 
data type. M ore inform ation on data form ats is contained in Section 9.3.1.
As part of the upload users are given the chance to  give an appropriate short nam e for 
each GeneChip, and add a description for each chip. At this point the data is then split 
for database storage with entries being added to  a “chips” table containing the 
sum m ary inform ation for each chip, and the raw data values (including A /M /P calls) 
are uploaded into a single “data” table, all uniquely indexed for retrieval later.
The uploaded data can then be combined in the system to  form  “experim ents” which 
form  collections of chips. The key flexibility by adopting this approach is the ability to  
edit and combine collections of chips for analysis “on the f l y ”, w ithout the need to  
combine the original experim ental output files using tools such as M icrosoft Excel. In  
addition data can be grouped w ithin an experim ent as the user desires using functions 
for re-ordering the chips w ithin an experim ent.
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The MIAME guidelines have attem pted to develop a common set in  inform ation that 
should be stored for each array to  describe the Minim um  Inform ation About a 
M icroarray Experim ent (MIAME) (Brazma, e t al., 2001). The attem pt of this initiative 
is to  enable the in terpretation of the results of the experim ent unambiguously and 
potentially to  reproduce the experim ent In  developing the MADRAS database the 
decision was m ade not to  burden the user w ith inputting the substantial am ounts of 
inform ation regarding the experim ental processes, experim ental design and sample 
descriptions required for a MIAME com pliant database. The MADRAS database 
should be seen as a constituent o f an experim ental tool, rather than a repository for the 
storage and retrieval of publishable data, such a function is better served by initatives 
such as the ArrayExpress (Brazma, e t al., 2003; Parkinson, et al., 2005), GEO database 
(B arrett, e t al., 2005; Edgar, e t al., 2002) or Stanford M icroarray Database (Gollub, et 
al., 2003; Sherlock, e t al., 2001).
7.3.1.2 Probelists
The concept behind the probelist is to  provide functionality in allowing the creation of 
subsets of data of in terest to  the user. A probelist is a list of Affymetrix probe set 
identifiers (present on a specific chip type) which are grouped together with a collective 
nam e and description (e.g. cell cycle genes). The source of identifiers that form  a 
probelist can come from  a variety of sources and include the results of statistical 
analyses, collections of prior knowledge relating to  an analysis (e.g. published lists of 
genes involved in  DNA repair), o r another researcher’s published results.
In  addition MADRAS has additional inform ation which can be of interest to  the user 
and is delivered in  the form  of a probelist. Examples of functions returning a probelist 
include; searches of the annotation database across a variety of fields, finding probe 
sets on a chip relating to  a list o f gene names, and pathway data from  BioCarta, 
GenMAPP and KEGG (further details in section 7.4.4)
7.3.1.3 Annotation
There are m any annotation sources available to a researcher, some linking directly 
from  Affymetrix identifiers (e.g. NetAFFX) others relying on linker inform ation (e.g. 
LocusLink, Entrez Gene), and others referenced by gene nam e (e.g. OMIM). The 
problem  when attem pting to  annotate ju st a single probe set using these tools is the 
num ber of windows to  switch between on a desktop, and the am ount of inform ation 
th a t m ust be sifted before the key inform ation about a probe set can be com prehended.
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The approach taken in  MADRAS was to  review all of the common annotation sources 
and to  extract only the fields deem ed to  be of m ost use after consultation with a variety 
of m icroarray users. The outcom e was a com bination of inform ation that could take a 
researcher from  the basic inform ation about a probe set all the way to  a short 
description of function, all contained w ithin the same page. The way the annotation 
database was built also allows for easy searching for other probe sets representing the 
sam e gene on a chip and presence w ithin pathways from  BioCarta, GenMAPP and 
KEGG. In  addition links to  the original sources were made available, along with 
inform ation of homologues of the probe set in other species.
7.3.1.4 Combining the three stream s
Combining these three data stream s is the central feature of MADRAS and form s the 
basis o f the exploration functions (see Figure 7.1 for a graphical overview of the design). 
Selection of a probe set from  w ithin a probelist draws the user data (form atted into an 
experim ent) in the graphical form  of a b ar chart and heatm ap, along with a variety of 
annotation sources into  a single overview for th at probe set. Navigation tools then 
allow easy shifting between probe sets in  a probelist allowing for rapid exploration of 
data.
The heatm ap is a m ethod of visualising the intensity of data using colour intensity, in 
the MADRAS im plem entation data is first log transform ed and then m edian centred. 
Data below the m edian is given a colour value between o and 255 on the green 
spectrum , scaled according to  the data value where the data point furthest from  the 
m edian is given maximal colour saturation, with values near the m edian representing 
w ith a shade of green nearing black. Data above the m edian is sim ilarly coloured using 
the red spectrum . The results are represented w ith a series of coloured cells below each 
bar on the bar chart (Figure 7.2).
7.3.2 Technical details
Having highlighted the desire to  develop a web accessible system to  overcome the 
design challenges of platform  dependence, m ulti-location accessibility, and allowing for 
the potential of data sharing, issues still rem ained on the optim al set of program m ing 
and delivery tools to  be used for the system. In designing the MADRAS, the current 
state of developm ent environm ents suitable for delivery of a database drive web 
program  was reviewed and a num ber of solutions examined.
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Figure 7.1 -  Diagrammatical representation of the data relationships in MADRAS.
The result was the adoption of the open source PHP/mySQL platform. PHP (PHP: 
Hypertext Preprocessor) (http://unvw.php.net) is a CGI scripting language, interfacing 
with an Apache (http://www.apache.org) web server. Linking with PHP and Apache, 
the system interfaces with an open source mySQL (http://www.mysql.com) database 
engine for storage and retrieval of user and annotation data.
Further details of the technical concepts and data structures comprising the MADRAS 
system are contained in Section 9.7.3.
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7.4 Functional Overview of MADRAS
The MADRAS package is available to  users via a web interface and acts as an interface 
for a user between the curated annotation for Affymetrix GeneChips and their own 
experim ental data.
7.4.1 Data exploration
Combining the three data stream s of user data, annotation and probelists lead the user 
to  explore their data. The “Explore” window allows the user to  first select experim ents 
which have been defined as collections of uploaded data before the selection of a 
probelist containing probe sets o f in te re st Once a probe set is selected from w ithin a 
probelist, the program  then interrogates the database and returns a graphical 
representation of the data (if present) for th a t probe set along with a sum m ary page of 
gene annotation. A com bination of interface select boxes and buttons then allow a user 
to  rapidly move through the probe sets in  a probelist w ith data and annotation returned 
as the exploration proceeds. At the tim e of w riting MADRAS is unique in providing this 
com bination of annotation and data from  a probe set in  a unified view.
7.4.1.1 Data visualisation
Data for a probe set is retrieved from  the database of values for each chip contained 
w ithin the current experim ent for graphical display w ithin the explore view of 
MADRAS. Once retrieved from  the database the data is prim arily displayed in  the form  
of a bar chart (Figure 7.2), w ith additional colouring of the bars to represent the 
presence call (absent /  m arginal /  present) from  M icroarray Suite when th is additional 
inform ation is uploaded w ith the expression values.
Additional options are provided to  enhance the display of the data through the 
application of a logarithm ic scale an d /o r the elim ination of the values of expression 
level from  each bar. As an alternative to  the bar chart representation of the user data, a 
heatm ap style diagram  for the data is also shown. The heatm ap is generated by taking 
all of the data available for the probe set under scrutiny with the current experim ent 
and assigning a colour (further technical details in Section 7.3.1.4).
A chip w ith a low expression value com pared to  others in the experim ent will be 
coloured green, w hilst high expressers are coloured red, with those in the middle 
having no/little colour assigned. In  the example visual representation (Figure 7.2), the 
high expressing heart data is clearly seen as red, w hilst the low expressing testis data is 
green, w ith the m iddle expressing lung data having little colour representation.
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Figure 7.2 -  Graphical representation of user data comprising a bar chart and 
heatmap diagram (see Section 7.3.1.4). The background of the chart can be shaded by 
the user to highlight different groups of data contained within the experiment.
In practice this alternative display methods would appear to be a good alternative to the 
bar chart when rapidly exploring data within a probe list as the eye is not required to 
move to reassess the information presented and intuitively shows which chips are low, 
middle and high expressers relative to the probe set’s experimental data.
7.4.1.2 Annotation
In the introduction to this Chapter the various sources available to annotate a probe set 
were discussed along with the pro and cons of each methods and direction. The major 
limitation encountered was the separate nature of the sources, and the multiple 
windows required to fully assimilate information about a probe set. MADRAS attempts 
to overcome these issues by providing a custom assembled series of sources of 
annotation which can be displayed on a single page in combination with the user’s 
experimental data.
To gauge the sources that would provide maximal information and insight for a probe 
set, a series of local biologists and system users were quizzed regarding their views on 
wThat they view as good annotation sources, along with a feel for the relative importance 
and use of the suggestions made. The outcome of these discussions and the following 
design stages is an annotation page leading from simple gene annotation (e.g. name 
and symbol), through more comprehensive fields of information to homologues to 
genes in other species.
The primary sources of annotation information for the MADRAS system are NetAffx 
(Liu, et al., 2003), LocusLink (Maglott, et al., 2000; Pruitt and Maglott, 2001), 
HomoloGene (Wheeler, et al., 2005), OMIM (Hamosh, et al., 2005; Machet, 1998) and
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Biocarta (BioCarta, 2005). Practical exam ination of theses sources and the links 
between them  resulted in  the Locuslink identifier being deemed m ost appropriate for 
linking Aflymetrix probesets to  annotation sources; it links directly to  the Refseq 
(P ruitt and M aglott, 2001) function description and is commonly used to  link to  other 
annotation sources and pathw ay data.
The plethora of inform ation contained w ithin each of the sources identified was 
reduced to  the fields th a t were deem ed m ost descriptive about the function of the gene 
and ordered down the annotation page leading a user into the specifics of the probe set 
/  gene’s function, the concept being th a t rapid exploration required only a few key 
details about the probe set. However, if th is inform ation proved to be of interest, 
further details were also available w ithout the need to link out to another page. W hilst 
the system  was designed to  reduce the need to  link to  other databases, links were 
provided back to  the original annotation inform ation for users who would prefer to 
consult the original data sources. The sources chosen are able to  give a user a quick 
overview of gene function, disease related inform ation, gene ontology and pathway 
inform ation.
Gene nam es and function were obtained from  the RefSeq and Locuslink function 
inform ation, while disease and phenotypic inform ation is provided in the form  of the 
OMIM text entry. W hilst the OMIM record does provide a very comprehensive 
sum m ary of the gene which has been hand curated, the record is often lengthy and has 
the potential to  obscure im portant inform ation. The decision was thus made to  make 
the OMIM inform ation available by revealing inform ation already presented in  the 
page. This can be viewed as the com putational equivalent of opening a flap in a book 
containing extra inform ation, w hilst retaining the original structure of the book.
Inform ation regarding the potential links between the probe set of interest and others 
involved in a system  are provided by provision of the bottom  level gene ontology field, 
along with pathway inform ation obtained from GenMAPP, Biocarta and KEGG. In  
addition the chromosome m apping location inform ation is displayed, obtained from  
the Locuslink record.
Recognising the fact th at there often m ultiple probe sets supposedly representing the 
sam e gene, the nature of the links in  the LocusLink database allows for inform ation to 
be presented regarding the presence of other probe sets for the locus of interest, and 
probe sets present on other generations of gene chips. This inform ation allows for the 
corroboration of findings between datasets even if these have been run a t differing 
stages of the Aflymetrix GeneChip release cycle.
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The inclusion of HomoloGene inform ation allows the expansion of insight and 
provision of linked inform ation betw een species. This inform ation enables sparsely 
annotated genes to  achieve an enhanced description by using inform ation from  other 
species. W hilst th is functionality is of lim ited use for researchers using hum an 
samples, those undertaking studies using other species w ith more lim ited annotation 
(e.g. rats) may find th is inform ation of use to  overcome the limitations of the species 
specific annotation.
An example explore page is shown in Figure 7.3 showing the combination of data and 
annotation, all on a single page.
7.4.2 Annotation searching
The establishm ent of a database linking a variety of annotation sources provides the 
possibility of rapidly answering the difficult questions th at were proposed in the 
developm ental drivers for the MADRAS system. The idea of the probelist is 
fundam ental to  the exploration of data w ithin MADRAS, and the search facility 
provides all its results in  the form  of probe set identifiers which can then be explored in 
com bination w ith the user’s data.
The explore page contains a sim plified universal search box which seeks the search 
term  across a range of annotation fields including gene name, gene symbol, gene 
product and the functional summary. To re-use the example of searching for cyclin 
genes, the power of th is approach was highlighted when seeking for these genes on the 
HG-U133A chip. MADRAS was able to  find additional genes as a result of this sim ple 
search com pared to  those hand curated over a period of several m onths by the user.
To expand the functionality of the generic sim ple search, an advanced search page is 
provided which seeks the term  using a wildcard search against specific annotation 
fields including the official gene nam e, gene symbol, gene product, functional 
summary, Locuslink identifier, alias gene symbols, chromosome location and gene 
ontology. In  addition the advanced search is able to  search the annotation for 
homologues of the genes and relate these back to  the GeneChip type the search was 
undertaken on (Figure 7.4).
7.4.3 Gene pattern finder
The parallel nature of m icroarray experim ents can often yield result for system which 
are seen to  respond in parallel to  the experim ental situation, and a researcher will often 
be interested in  finding genes w ith a sim ilar expression pattern  to a gene already 
highlighted as being of interest.
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D ata Selection
Data exploration requires the se lection  o f  an experim ent 
©  (a selection  o f  uploaded chip  data) and a probelist <2> (a 
list o f  AffvTnetrix probe identifiers.
D ata N avigation
Data can be navigated by direction selection of probes ® 
or by browsing back and forward through the probelist ®. 
The user is presented with an annotation summary and 
graphical representation of the experimental data for the 
selected probe.
Search O ptions
The search box ® on the explore page undertakes a 
generic search of gene names, functional summary' and 
identifier fields and returns results as a new' probelist. 
Options are provided for more specific search options in 
the advanced search page.
Graph F orm atting
A variety of display options are provided for the data along 
with function to re-order data and colour the background 
of the graph ®.
A ltern ative representation
The presence of other probe sets representing the same 
transcript is flagged to the user ©, along with a link to 
create a probelist containing these additional probe sets.
A nnotation  Links
Direct links to the relevant pages from each original 
annotation source are provided along side probe set 
annotation ®.
OMIM Annoation
The large OMIM text field is hidden by default, but the 
page is expanded to show the record as part of the 
annotation with a simple click ®.
H om ologues
A simplified annotation table is provided using 
homologue data where available, this data is initially 
hidden from view, but easily expanded into view <S>.
Figure 7.2 -  Example of the “Explore” page with overview of key functions.
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In contrast to other packages which require the user to select a gene of interest and 
then do a “find similar” search MADRAS provides the functionality to undertake a 
search for a theoretic gene pattern as well as experimentally existing ones. This is 
achieved by use of a unique ‘slider interface’ (similar to a graphic equaliser) (Figure 
7.5), making it possible to design a pattern of gene expression of expected observation 
and then search for all the genes that match that profile (e.g. find  me genes with high 
expression in the heart samples’").
F igure 7.4
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Figure 7.4 -  Screenshot of advance search options
There are mathematically numerous methods to undertake the pattern matching 
(Stum, et al., 2002) each of which has advantages and disadvantages and sensitivity 
issues when presented with data of a particular makeup. To overcome these issues and 
to reduce the burden on the user to make these statistical decisions MADRAS provides 
a single robust pattern matching algorithm in the form of a Pearson’s correlation. Each 
probe set within the experimental dataset is compared to the master expression pattern 
defined by the user and a R2 value calculated. Options are then provided regarding the 
filtering of these results before ultimate return of the information in the form of a probe 
list of similar genes.
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Figure 7.5 -  Screenshot of similarity search options
7.4.4 Integration of pathway information
In Section 7.1.3.2, the concept of pathways was introduced as a way of documenting 
gene interactions and links between function. Pathways are introduced in MADRAS as 
a methods of generating GeneChip specific probelists containing all the probes present 
on a chip present within a pre-determined genetic pathway. At the time of writing, 
MADRAS contains information on the genes involved in 72 GenMAPP, 121 KEGG and 
502 BioCarta pathways. The user is presented with an interface containing the names 
of each pathway, and upon selection the data is returned as a chip-specific probelist of
probe sets present within the pathway of interest, which can then be explored and
interrogated (Figure 7.6).
7.4.5 Probelist analysis
The annotation methods above are very much gene centric and are concerned with the 
information regarding a probe set in isolation. The formation of probelists within 
MADRAS provides an ideal and unique opportunity for further analysis of the data they 
contain looking for potential links and patterns with them. This is achieved using a 
combination of visualisation and data mining techniques.
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7.4.5.1 Probelist clustering techniques
Patterns within a probelist can be visualised using gene clustering techniques 
(Quakenbush, 2001; Sturn 2001). In a similar approach to that used in the similarity 
search, single robust methods are implemented in MADRAS for the visualisation of 
clustered data from the data linked to a probelist. Experiments can be clustered and 
the resultant dendrogram viewed and explored. Probe sets clustering is visualised in 
the form of a log transformed median centred red-green heatmap (Figure 7.7)
F igure  7.6
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Figure 7.6 -  Screenshot of pathways selection screen. Once a pathway is selected the 
probe sets on the currently selected GeneChip present within the pathways are 
returned as a probelist.
The tree view and heatmap graphics are produced using the free R statistical language 
(R Development Core Team, 2004). Following data export from within the MADRAS 
system. The output from R is then read back into the system for display. The graphics 
are also produced in Adobe Acrobat format and the user is provided with links to 
download copies for reference.
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7.4.5.1 Methods to access probelist similarity
A user will often have undertaken a series of analyses on a dataset, or have prior 
knowledge of implicated genes and wish to compare these looking for similarities 
between the results. Unfortunately the methods available to undertake such a 
comparison are limited, and based on simple counts of matches between lists. 
MADRAS contains two tools for the examination of similarity between lists; a Venn 
diagram tool, and a probelist similarity tool for multiple lists.
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Figure 7.7- Example o f probe set clustering visualised as a heatmap.
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The Venn diagram tool is able to simultaneously assess the similarities between three 
separate probelists, and undertakes counts for similarity between each of the groups. 
The output shows these counts overlaid on a Venn diagram (Figure 7.8) indicating 
similarity between the contents of each probelist. By selecting a group, the user is 
presented with a probelist of the common probe sets which can easily be saved as a 
probelist for further analysis and exploration.
To address situations where a user may wish to examine similarities between more 
than three probelists simultaneously, a probelist similarity tool is provided with an 
output similar to the distance calculator commonly found in a road atlas. The method 
returns a table showing the number of probes common between each pairing of the 
probelists selected (Figure 7.9)
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Figure 7.8 -  Venn diagram showing similarities in content between probelists
7.4.5.2 Over-representation analysis
Perhaps the most time consuming aspect to microarray analysis is converting gene lists 
into meaningful biological answers. To achieve this, the user must access the probe sets 
within their probelist of interest looking for links biological links and patterns between 
the observations. Links between probe sets can be formed by common wording in their 
title, presence in a pathway, or shared gene ontology.
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Figure 7.9 -  Similarity counts between probelists
Building on the ideas presented in the EASE package (Hosack D.A., et al., 2003) 
MADRAS applies the idea of over-representation of terms across a wide range of 
annotation fields and returns a statistical significance value for the observations made.
Over-representation analysis is concerned with counting features within a sample and 
then comparing it to observations within the population and judging for significant 
over-representation of an observation in the sample. This can be conceptualised by 
using a bag of wrhite and black balls. If the bag contains 50 white and 50 black balls and 
a user selects 10 balls and 7 of these are white and 3 are black, is the number of white 
balls selected significant over-represented? The start point for applying this method to 
microarray data is undertaking counts of the terms of interest for each probe set in a 
probelist and then the application of statistical techniques to examine significance.
If a user is interest in the over-representation of the term “cardiac” in their probe list of 
interest, the first stage is to undertake counts of this term in the population. This is 
achieved by retrieving all the available annotation for the GeneChip of interest and 
searching for matches. However as there are multiple probe sets for the same gene 
there is the potential for over representation due to chip design, and not necessarily 
biological significance. To overcome this, the population annotation must be reduced
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to  those representing loci only, achieved by the reduction of the population probe set 
list to  unique Locus Link identifiers. The num ber of hits for “cardiac” is noted along 
with the num ber of unique loci represented on the GeneChip under scrutiny. A sim ilar 
process is then undertaken on the probelist with the reduction of the data to unique loci 
and counts of m atches to  the search term .
As in m ost situations, there are many statistical techniques which can be applied to the 
resultant table of four values to  access the significance between the sample and 
population. EASE (Hosack, et al., 2003) uses a modified version of the Fisher’s exact 
test for this com parison, with a contingency sample set up to compare the reference set 
(GeneChip population), to  the sample set (probelist inform ation). However, it has been 
shown th at Fisher's exact test is not necessarily the optim al test for this type of 
com parison and should be used only when very few genes are involved (Man, et al., 
2000). As an alternative, MADRAS implements the statistical assessm ent of 
significance by using the hypergeom etric distribution, a m ethod prim arily concerned 
with sampling w ithout replacem ent from  a binom ial population (Doniger, et al., 2003).
MADRAS uses its large m ulti-source annotation to  facilitate this over-representation 
analysis. In addition to  com parison for presence within well defined pathway 
(BioCarta, GenMAPP and KEGG) fields and bottom  level gene ontology inform ation, 
MADRAS also undertakes text analysis on the gene name and functional summ ary 
fields. These text fields are broken down into individual words and counts undertaken 
on each word w ithin the description. In addition word-pairs are accessed to  overcome 
language issues which may results in under-representation of significant term s (i.e. 
“cell” will be well represented in the population; however “cell cycle” may be a 
significant word pairing in a probe list).
The question of correction for m ultiple testing on this data is one not fully resolved. 
Due to the num ber of different assessm ents made on the data for the same probelist 
this form of correction should be applied. However argum ents persist regarding the 
independence of categories (especially for the hierarchical gene ontology inform ation), 
so it is not d ear how to correct for m ultiple testing (Hosack, et al., 2003; Zeeberg, et al.,
2003). MADRAS incorporates a Bonferonni correction as part of the over- 
representation analysis, bu t leaves the choice of application to the user.
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7.5 Discussion
The issue of com bining data in  an intuitive, accessible form at has becoming a m ajor 
challenge for the bioinform atics com m unity (Orphanoudakis, et al., 2005). Work on 
MADRAS has dem onstrates the benefits of combining experim ental data, theoretical 
data and annotation, along w ith analytical tools aimed at assisting the interpretation of 
a dataset, in a single rapid exploration environment. Such an environm ent forms the 
final part of a m icroarray analysis workflow, taking in the results from the experim ent, 
along w ith those from  other analyses and statistical tests and aims to  accelerate the 
tim e spent deducing conclusions for further experim entation or publication from the 
data.
Although bioinform atics software is best w ritten by trained bioinform aticists, many 
have argued th a t to  best capitalise on th is investm ent it is ultim ately the researcher who 
created those datasets (and are thus the custodians of it) who m ust be empowered to  
undertake the data analyses (Tilstone, 2003). Although early-stage data analysis 
focuses on statistical and m athem atical tools, often in collaboration with experts in 
these disciplines, there soon becomes a point where the biomedical researcher 
them selves m ust take the lead in  data analysis and understanding. This point is 
typically when biological and clinical data m ust be integrated with the expression data, 
and when the results m ust be interpreted in  the wider context of other prior knowledge 
(typically from  a range of public databases).
MADRAS has proven to  be a highly usable platform  for m icroarray research. Its 
brow ser interface has proven popular and it allows easy cross-platform  compatibility, 
along w ith easy access from  m ultiple locations. Linking together the required resources 
for analysis into  a single “snapshot” enables rapid data exploration stemming from 
m eaningful biological questioning combined with analytic tools to add confidence in 
any patterns emerging.
W hilst issues of usability and accessibility are not a t the forefront of many developers 
working in the field, the extra work required to achieve these assets can only be view as 
a positive step, enabling the tool be applied to  the drivers of the biomedical research, 
the biological researcher.
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Chapter Eight 
Summary and Discussion
8.1 Microarray data analysis
There has been an explosion in the development and provision of m icroarray 
technology in the last decade, w ith the num ber of probe sets represented on each 
generation of Affymetrix GeneChips following Moore’s Law and doubling every two 
years (Affymetrix, 2000).
There has been great investm ent by the research com m unity into establishing 
m icroarray services w ithin many institutions, and provide the expertise to assist 
researchers undertake experim ents on a chosen platform . The protocols to  undertake 
the biological process in the experim ent have been well characterised and much 
expertise exists as to “best practice”.
However, there has been a perceived lack of investm ent and exploration into the effects 
of the varying analysis approaches on the quality of results obtained, and guidance on 
“best practice” for data analysis. A lack of firm  guidance, along with a lack evidence to  
dem onstrate the comparative effectiveness of one methodology versus another has 
created a knowledge and guidance gap.
Many m icroarray services do not have the expertise to  analyze the data nor the long 
term  interest to learn it and as a result many researchers are left in a position where 
they can generate vast am ounts of data, to  which they have litde idea how to analyse 
and understand the results it contains. Consequently, the researcher may be left feeling 
let down by the technology and those who deploy it.
Following a back to  basics approach the work undertaken in this thesis has attem pted 
to  introduce the reader to  the m any steps involved in the analysis of a m icroarray 
experim ent centred on the detection of differential gene expression once it has left the 
experim ental system, and interrogate the effect of each stage on the ultim ate 
experim ental outcomes.
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8.1.2 Analysis stages to determine differential gene expression
There are m any num erical analysis stages involved in the process of converting the data 
obtained from  the scanned array image into the desired results from an experiment. 
The analysis required for a typical analysis to  identify differentially regulated genes 
between two groups of data can be broken down into a five step process:
1. Application of an expression m etric to convert the inform ation contained w ithin 
the scanned array image into a summary expression signal level for each probe 
s e t
2. M athem atical transform ation of the resultant dataset to overcome distributional 
issues.
3. The utility  of a norm alisation stage to  reduce comparative variability between 
experim entally sim ilar data and address differences in data distributions 
between arrays.
4. The application of techniques to  identify differentially regulated genes, which are 
typically returned as a list of *interesting genes9
5. Exploration and annotation of these “interesting genes* in  an attem pt to  a draw 
m eaningful biological conclusion to  the observations and substantiate the 
hypothesis of the experim ent
In  th is thesis a variety of com binatory techniques were applied to stages one to  four in 
order to  determ ine the effects of different options on the detection of genes with known 
differential expression, w ith the goal of providing guidance on the issues involved with 
an analysis, and suggestions on techniques to consider dependant on experim ental 
design (Chapters One to  Six).
Completing the experim ental process w ith the annotation and exploration of the results 
from  previous stages requires the incorporation of inform ation from  a wide range of 
other sources in tim e efficient m anner, along with tools to assist in the interpretation of 
sizable am ounts of inform ation (Chapter Seven).
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8.3 Exploring best practice using the Affymetrix 
Latin square dataset
Datasets suitable for the exploration of the many analysis options presenting to the 
researcher, along w ith inform ation regarding the expected results are few. In this work, 
a single dataset (the Affymetrix HG-U95A Latin square dataset) was identified and 
exploited to  explore the effect of m any different analysis issues and combinations. At 
each stage the results were reviewed and analysis undertaken to  assist in the 
determ ination of the optim al methodologies that could be applied for the analysis of an 
experim ent designed to  determ ine the differential expression of genes between groups 
of data.
8.2.1 Factors influencing the choices of expression metric
Initial investigations into data distributions were applied to data from six expression 
metrics; MAS 4.0, MAS 5.0, dChip PMMM and PM-Only models, RMA and gcRMA 
used to analyse the complex background component of the 59-chip Latin square 
dataset. These results indicated that results from MAS 4.0, both dChip models and 
RMA on the whole correlated well with the assumption of normality; however data 
from MAS 5.0 and gcRMA presented with a proportion of the data with marked non­
normality.
Investigations into the application of commonly applied statistical tests (fold-change, t- 
test and Mann-Whitney test) to determine the power to detect fifteen known two-fold 
changes with a 24-chip subsection of the data indicated that analysis using MAS 5.0, 
RMA and gcRMA consistently outperformed the earlier empirical MAS 4.0 and model 
based expression metrics of dChip. It should be noted that the dChip PM-Only model 
did perform markedly better than the PMMM model, suggesting that inclusion of the 
MM probes reduces the clarity of detection within the dataset Use of MM match 
probes would appear to add to the technical variation observed, and explains the 
improved power of detection with expression metric utilising only the perfect match 
probe information.
A potential caveat in the identification of MAS 5.0, RMA and gcRMA being most 
successful in the detection of the spiked-in data in the dataset, is the fact that the 
dataset used in these investigations formed a key part of the development process for 
each algorithm, and the values of tuneable parameters were influenced according to the 
features of this dataset.
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However, the findings correlate well w ith work by Chloe et al. () who explored many 
different com binations of the m any stages involved in expression m etric analysis using 
a fully synthetic spiked-in experim ent (200 spiked in RNA with known fold-change, 
and a background of 2551 transcripts w ith known concentration). They concluded that 
the optim al set of algorithm s for maximal spike detection included the background 
correction and perfect m atch probe adjustm ent from  MAS 5.0, followed by the 
application of the m edian polish steps from RMA (although the MAS 5.0 expression 
summ ary was also a top perform er).
Although gcRMA consistently outperform ed the power of the other m etrics to detect 
the spikes in  th is dataset, it is a relatively new methodology, which has presented with 
data distributions which may cause issues with the application of subsequent analysis 
stages, and it is suggested th a t further exploratoiy analysis using real-world datasets is 
required before full confidence can be achieved in th is m etric. In  contrast, MAS 5.0 
and RMA are established expression m etrics which present w ith good power of 
detection and validation using other datasets. The ultim ate choice in which expression 
m etric to  be applied m ust be determ ined having considered w hether the researcher 
wishes to accept the small loss in detection power incurred by the inclusion of the data 
obtained from  the m iss-m atch probes.
8.2.2 Application of post-metric analysis normalisation
Applied to  the homogenous Latin square dataset, the observation th at application of 
post-m etric analysis norm alisation using QQ-normalisation, VSN and a rank based 
m ethod produced very little effect on analysis outcomes and power of detection is 
unsurprising.
However, the application of a post-m etric norm alisation step in a typical biological 
experim ent may form  an im portant analysis stage which will enable data to be 
com parable and be a powerful ally to  facilitate the extraction of meaningful and 
accurate analysis results reflecting the likely biological changes with the systems under 
exploration.
Norm alisation can be applied in  a variety of ways, dependant on the type of nature of 
the variability th a t requires control and reduction. N orm alisation can be applied to the 
full dataset which can be useful if there is the presence of a few chips with differing 
distributions to other chips in the experim ent, or to  the arrays w ithin a single group of 
data where the nature of the biological samples w ith that group suggests th at high 
variability may occur w ith a subsection of supposedly identical observations.
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The choice as to  w hether to  apply norm alisation stages as part of a data analysis should 
be influenced by issues of data variability, and a series of exploratory tests to examine 
the nature of the resultant data is suggested (e.g. MVA plots, distribution plots) to 
determ ine the sources of variability w ithin a dataset undertaken. The results of these 
observations will influence the choice of norm alisation method. The methodology 
behind QQ norm alisation suggest its application to  data with skewed or differing 
distributions, VSN is designed to  overcome issues of differing variability between 
samples. Chloe et al. (Choe, et al., 2005) reported that the loess norm alisation was 
their preferred m ethod for post-m etric analysis norm alisation.
8.2.2 Data transformation
Data transform ation has been a popular analysis stage, applied to m icroarray data in an 
to  control distributional differences and to  allow shift data distributions towards a 
m ore norm al form , allowing for the application of param etric statistical tests. In 
Chapter Two it was shown th a t from  a distributional point of view there was little or no 
benefit to  the logarithm ic transform ation of data from  any of the expression metrics. It 
was noted th a t w hilst the log2 transform  included in RMA and gcRMA did not 
particularly benefit the correlation w ith normality, there was little to  dispute the 
author’s inclusion of this m easure in  their m ethods (Irizarry, et al., 2003; Wu, et al., 
2004).
Data presented in  Chapter Three, looking at the effect of transform ation on the 
detection of spikes w ithin the Latin square dataset reveals no difference in the ability to 
correctly identify spikes in  the dataset between logarithm ically transform ed and 
untransform ed data. It was thus concluded that there is no a priori reason for 
transform ing data prior to  statistical analysis. Detection power in data from RMA and 
gcRMA were not altered by removal of the log transform ation, so no reason was found 
to alter from  the published methodology.
The effect of the logarithm ic step w ithin the RMA m etric was re-visited in Chapter Six 
investigating the application of a Bayesian framework exploiting the relationship 
between m ean and variance to  better inform the param eters w ithin the t-test and 
therefore improve power of detection. I t was found th at logarithm ic step of the m etric 
elim inated the m ean/variance relationship and thus slightly dim inished the power to 
detect the spiked-in transcripts of the dataset.
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Overall little support was found for the application of a transformation step as part of 
each analysis. Whilst the removal of the transformation step from RMA data would 
appear to slightly improve detection power for data from this metric, the researcher 
may wish to retain the transformation step and apply the metric in the form the authors 
believe best represents the biological meaning within a dataset.
8.2.3 The utility of statistical tests to identify differential gene 
expression
A variety of statistical tests were applied to the 24-chip subsection of the Affymetrix 
Latin square dataset to compare the ability of each test to significantly identify the two­
fold change in expression for each of 15 spiked-in transcripts. The relative power of 
each test compared to others was unaffected by which expression metric was used for 
the first stage analysis of the CEL files. Compared to fold-change alone, statistical tests 
incorporating the spread of the data (in addition to just the location used in fold- 
change) significantly increase the power to detect the spiked-in transcripts.
8.3.3.1 Comparison of classical parametric tests versus the comparable 
non-pa rametric alternative
Issues of sample size have made the parametric t-test a popular choice for the analysis 
of microarray data. Having validated the use of the test by examination of the data 
distributions (with caveats for the MAS 5.0 data, and marked non-normality with 
gcRMA data), two variants of the t-test (dependent on the assumption of equality of 
variance between groups) were compared to the non-parametric equivalent Mann- 
Whitney test across a range of sample sizes.
At small sample sizes (3-6 per group), the non-parametric test had significantly 
reduced power to detect the spikes, with the gap closing over the mid-ranged sample 
sizes (7-10 arrays per group). At the comparatively large sample sizes (11-12 samples 
per group), the power of detection was similar between the parametric and non- 
parametric techniques.
There was no difference in detection power between the versions of the t-test which do 
and do not assume heterogeneity of variance and as a link has been established 
between variance and signal magnitude it is suggested that researcher accept the 
potential for a very small loss in power, and utilise the Welch variant of the t-test which 
does not assume equality of variance between groups.
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8.3.3.2 The utility of more robust variants of the t-test
A variety of variants of the t-test designed to accommodate for outliers in the sample 
dataset were com pared using the same framework for assessing detection of spikes in 
the Latin square dataset. The results indicated th at the utility of such tests is akin to 
throwing data away and shows com parative power to  standard tests with a reduced 
sample size.
The results suggest th a t prim ary analysis of the array results and pre-filtering to 
remove or norm alise outlying arrays is preferable over an approach that attem pts to 
accommodate the erroneous data and produce meaningful results. The m agnitude of 
sam ple size in a typical exploratory m icroarray experim ent is not sufficient to allow for 
the application of these m ore robust statistical tests.
8.3.3.3 Implementation of a robust randomisation based testing method
Application of the random ised m ethod, which uses random isation to define the actual 
data distribution for the sam ple rather than com parison to  a known distribution, to 
detect the spiked-in data of the Latin square dataset yielded sim ilar results as those 
obtained from  the M ann-W hitney test. W hen compared to the Welch t-test, the 
random ised test showed lim ited power at low sample sizes, slightly less power at 
m iddle sizes, and equivalent power a t sample sizes over 9 per group.
W hilst the technique gives reasonable results, the overheads in tim e and com putational 
power required for its application question the practicality of application w ithin an 
typical research environm ent. The observation, th at near identical results can be 
obtained using M ann-W hitney test which is m ore robust against outliers and 
distribution issues in  lesser tim e further reduce the m erit of random isation based 
testing.
8.3.3.4 The utility of a Bayesian framework method
The Balid and Long (Baldi and Long, 2001) Bayesian framework utilised the 
relationship between the signal m ean and variance w ithin a group of data to  better 
information the variance param eters of the t-test and improve power of detection. 
Comparing results from  the Bayesian analysis on ju st three samples per group, to  those 
from  the standard Welch t-test indicate that sim ilar power is seen to five arrays per 
group in the Welch te s t
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The difference in power between the tests reduces as sample size increase, bu t the 
Bayesian test continually outperform s the standard t-test methodology. Overall, the 
Bayesian fram ework presents as a very powerful analysis tool, allowing a research to 
extract the maximal am ount of inform ation from  a cost-lim ited experim ent and 
providing the greatest power of all of the statistical tests considered.
8.3 Drawing conclusions on “best practice”
Review of the work undertaken in  this thesis (Section 8.2) identified a series of 
conclusions regarding the relative perform ance of differing combinations of analysis 
methodologies to  detect tru th  in  a dataset, and which can assist in the definition of 
“best practice” in  the analysis of Affymetrix m icroarray data. W hilst the investigations 
provide an im portant corpus of inform ation and background to the analysis of 
GeneChip data, there are lim itations to  the explorations undertaken and more general 
issues of experim ental design which significantly contribute to  the accuracy of any 
analysis.
8.3.1 Reviewing the inference obtained from the Latin square 
dataset
The I .atin square data represents a very hard analysis situation, with the focus of 
investigations being on m ethods to  detect a known num ber of un-related changes 
represented w ith ju st a two-fold change in  expression signal between the two groups. 
More typically and experim ent will contain many m ore probe sets with transcriptional 
differences between groups presenting w ith a variety in the m agnitude of difference 
between the groups.
In addition, the nature of unchanged background data across all chips is 
uncharacteristically homogenous. In  contrast to the single mRNA sample which was 
hybridised as a “complex background” for the Latin square experim ent, the background 
in a typical experim ent will accompany the differentially regulated data, and whilst 
much data will be com parable differences between cells and patient samples will 
produce a much m ore variable background overlaid with the “real changes”, which 
m ust be identified.
Biological variation is one of m any compounding factors on the num ber of replicates, 
and is likely to  be substantially m ore in many experim ents than th at from  technical 
variance.
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As a result, conclusion which can be drawn about the relative power of different 
techniques to  detect the spikes, and to  relative power dependant on sample size can 
only guide as to  the best m ethods to  overcome the technical variation within the 
system. Accordingly, when undertaking an experim ent it is prudent to use the best 
tools to extract inform ation from  the data, but however sharp the tool, it will be unable 
to extract m eaningful results if the variability between arrays is the overwhelming 
factor of the experim ental observation.
8.3.2 Experimental design and sample size
Guidelines from  the Affymetrix Best Practices Expression Analysis work group reported 
th a t to  obtain high quality data which can be readily compared between studies, site 
and over tim e are dependant on three critical aspects of good experim ental design, each 
designed to  reduce the variability between samples, and therefore facilitate more 
accurate analysis. The three recom m endations were the standardisation of tissue 
sampling, storage and processing procedures, experim ental design which makes 
com parisons between equivalent tissue types and undertaking sufficient biological 
replicates. Each one of these stages is concerned with the reduction of variability 
between resultant array data.
Sample size is probably the single m ost im portant factor in m icroarray experim ental 
design for a variety of reasons. The num ber of replicates in each sample group is key to  
achieving confidence in  the obtained results and influences the choices of test which 
can be applied to  a dataset. W hilst m ore replicates does result in a “better experim ent* 
th is im provem ent has a significant cost im plication with each addition replicate 
addition over £500 to  the experim ental budget. There is therefore a requirem ent to 
identify sensible compromises to  these two divergent requirem ents to the num ber of 
replicates, the researcher will often wish to  undertake the minimum num ber possible, 
w hilst the statistician would argue, the more data the better.
Although statistical m ethods exist for power-calculation the key piece of inform ation 
these require is the variance expected within the system, as it requires experim ental 
results to determ ine the factors, the researcher is left in  a circle of cyclic logic. As an 
example, the p o w er. t . t e s t  function in R requires four pieces of inform ation; the 
num ber of observations per group, the Standard deviation for the dataset, the required 
significance level and the true difference in means. The relationship between variance 
and expression observed further obscures the m atter, a single variance level cannot be 
determ ined for an experim ent; as the inform ation on the m agnitude of change expected 
and prediction of signal levels would be required to fully derive a power calculation.
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Guidelines on sam ple size are difficult to deduce because of the underlying variability in 
biological data and experim ental design which will affect the power of a test to  detect 
differences. It should also be pointed out that samples do fail, and there are QC issues 
which may require the dropping of certain chips.
Drawing conclusions regarding the num ber of replicates needed to achieve confidence 
in  results is a complex m atter, and it can only be advised that more replicates are 
needed than  the attem pts to  define “best practice” indicate. The findings should thus 
be viewed as m inimum estim ates because of the clean and perfect nature of this 
dataset; the likely influence of additional biological variation would require additional 
GeneChips in an experim ental design.
8.3.4 The requirements to better define “best practice”
Ultimately it is the quality of input to  the m icroarray experim entation process that will 
have the greatest effect on the output. A well designed experim ent built on a good 
understanding of the biology m ost likely to  affect the results will yield the best results. 
However, the application of the “best” analysis techniques a well designed experim ent 
will maximise the num ber of true results returned, and can assist in overcoming some 
of the inherent issues of undertaking many thousand experim ents in parallel.
Key to  the definition of “best practice” are reference datasets to with known tru th  to 
which differing analysis methodologies can be applied and the power of detection 
quantitavely described. The work in  this thesis used the Affymetrix HG-U95A Latin 
square dataset as its tru th  dataset, which a t the tim e of writing was the only publicly 
available dataset w ith known tru th  which can be sectioned to  provide biologically 
meaningful sam ple sizes. However, when compared to other reference datasets (e.g. 
the GeneLogic spiked-in set) it is lim ited in the num ber of spiked-in samples.
Ultimately, the analysis community requires a variety of datasets to  benchm ark 
different analysis com binations against from a range of sample types, over a range of 
sample sizes, w ith a significant num ber of known changes. Such datasets should 
represent a variety of sample types, over a full range of relevant sample sizes, with 
differing fold-changes of spiked-in samples, over m ultiple groups of data to enable full 
exploration of the range of statistical techniques available.
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Such an approach should yield datasets which can be used to  both train  and validate 
new models for expression analysis. The provision of a num ber of diverse datasets 
should also elim inate the current risk of over-training and optim isation of methodology 
based on the tru th  in  a single dataset. It is ultim ately possible th at the optim al analysis 
methodology may vary according to  experim ental design, variability and the desired 
outputs from  an experim ent.
8.3.4 Future horizons in expression analysis
The work undertaken in th is thesis has followed the traditional analysis approach of 
converting the image data into an expression value for each probe set, before the 
transform ation, norm alisation and analysis of the data to identify the differentially 
regulated genes. The processes involved in the conversion of the image data into signal 
values is a complex one, which as it has been shown can yield a variety of differing 
results which should be directly comparable.
The gcRMA m etric is one example of how integration of inform ation regarding the 
array design can improve results by incorporation of other well defined thermodynamic 
binding inform ation. One key area for developm ent is the integration of the 
inform ation th a t each GeneChip array contained, and the techniques to  produce the 
m ost biologically m eaningful data.
Barrera et al. (Barrera, et al., 2004) have shown th a t the application of two-way 
ANOVA techniques to  the probe level data can increase the power of detection by 
incorporating m ore data into the analysis and providing additional links between 
related experim ental observations com prising the data subm itted for analysis.
Reduction of the num ber of analysis stages required for an analysis can only assist in 
the reduction of variability of experim ental outcome, and the probe level approaches 
which elim inate  further stages of data reduction are likely to improve experim ental 
efficiency.
However, control of variability would appear to be the biggest hurdle to  each stage of 
analysis and experim entation, w ith variability occurring from  samples, through 
processing, through arraying and through analysis. A badly designed and executed 
experim ental cannot be accurately analysed, no m atter how good the analysis approach 
is.
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8.4 Making biological sense of analysis results
Initial stages of data analysis are concerned in the m anipulation and processing of the 
num erical inform ation th at an experim ent produces, and is involved in a substantial 
data reduction exercise, typically producing a list of *interestingn results in the form  of 
a list of probe set identifiers. At th is point the expertise in  analysis shifts from  that of 
the com putational biologist back to  the biomedical researcher who m ust take the lead 
in making sense of the data analysis and either form  or confirm hypotheses from  the 
results.
W hilst previous stages have been concerned with data reduction, the process of 
exploring the results will typically require the integration of additional data from  a 
variety of sources to  assist understanding. The nature of the task, taking a researcher 
into areas of biology th at they may not be fam iliar, coupled with the lim itations of 
available tools and exploration environm ents make th is a significant task in term s of 
both tim e and difficulty.
8.4.1 Integration of resources to improve exploration efficiency
W ork on the MADRAS (M icroarray Data Review and Annotation System) environm ent 
centred on the developm ent of a rapid exploration environm ent which would enable 
researchers to  question their data, review their results along with selected relevant 
annotation fields, and provide analysis tools to  assist in the complex task of drawing 
conclusions regarding the biological processes contributing to  the observed results.
Such an environm ent form s the final part of a m icroarray analysis workflow, taking in 
the results from  the experim ent, along with those from other analyses and statistical 
tests and aim s to  accelerate the tim e spent deducing conclusions for further 
experim entation or publication from  the data. Feedback from  the local user 
community suggests th at the concept and im plem entation bridges a gap in current 
workflow system s and has proven a very useful research tool.
The annotation in MADRAS was chosen after consultation with a variety of users as to 
the inform ation they would find m ost useful to rapidly understand the transcript being 
represented by an Affymetrix probe set. It is im portant that this process is ongoing as 
advancem ents in  genome annotation may alter the im portance of databases and the 
fields they contain.
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As an example the NCBI Locus Link database is in the process of transition to 
EntrezGene which aims to form and provides a unified query environment for genes 
defined by sequence, however as a result certain data made available in the Locuslink 
database have been removed and must therefore be sourced from alternative locations.
The formation of a comprehensive annotation may prove a useful resource which can 
be applied and utilised to a wide range of emerging high-throughput technologies as 
many of the issues of interpreting and exploring data are likely to be shared issues with 
common solutions.
8.4.2 Improving overrepresentation analysis
Whilst the annotation and exploration of experimental data is key to completing 
analysis of a dataset, there is also a need to place such data in the context of the wider 
annotation and metadata resources available to the researcher. Although it is possible 
to undertake manual literature review using the information contained within the 
MADRAS annotation summary, this is a labour-intensive process which is subject to 
user bias. To assist in overcoming these barriers, MADRAS incorporates over­
representation analysis applied to an extended range of data fields, gene annotation 
and pathway data.
It should be pointed out however, that there are limitations to the techniques used to 
assess any significant in the data within a probelist. The basis of analysis within 
MADRAS is the presence of linked significant results with defined linked between the 
annotation genes, either via association into a pathway, or via the textual description. 
As a result, a set of well annotated yet less signiciant genes are likely to be identified 
over a single probe set as significant, due to issues of data overload and systematic bias 
in analysis approaches.
A potential future avenue for this type of analysis is the scoring of annotation quality, 
so that well explored parts of the genome do not over-shadow less represented, but 
potentially more important parts, with the possibility down weighting probe set with a 
quality and prevalence of annotation.
Whilst, automated analysis does prove a useful and convenient tool in many analysis 
scenarios, it does underpin the requirement for the researcher to fully understand their 
experiment and the analysis applied, and to fully explore the results from a variety of 
angles in contrast to a “black box”, data in answers out system which may report 
significant, yet ultimately uninteresting results.
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8.4.3 Building and extending the MADRAS system
MADRAS allows the facile exploration of expression data from  one specific m icroarray 
platform  in a gene-centric fashion in  com bination with key m etadata from  several 
public databases (LocusLink and OMIM in particular). W ork on MADRAS has 
dem onstrated the benefits of combining experim ental data, theoretical data and 
annotation, along w ith analytical tools aim ed at assisting the interpretation of a dataset, 
in a single rapid exploration environm ent A logical progression of this work would be 
the application of the obtained knowledge and experience to expand the system to 
accept data from  other m icroarray platform s and technologies.
Overcoming the lim itations of the over-representation analyses could potentially be 
achieved by the incorporation of additional inform ation to supplem ent the u n ra ted  
data contained in  the annotation fields. One potentially interesting development idea 
would be the extension of m ass-parallel annotation m ining tools to larger corpuses of 
text (e.g. the PubM ed abstracts text corpus) (Chaussabel and Sher, 2002). Such an 
approach would require a com bination of data mining, statistical and natural language 
processing (NLP) techniques w ith the aim  to identify the more subtle and detailed links 
between genes which are lost in  reduced data that is contained w ithin many annotation 
summ aries (Jenssen, et al., 2001).
High throughput technologies in biomedical science are yielding huge volumes of 
experim ental and clinical data including gene, protein, chromosome and tissue 
inform ation. As they investigate the same underlying biology each of these techniques 
are ultim ately com plim entary, thus improving the insight that can be achieved. The 
evolving challenge of biomedical inform atics is to  begin to  integrate different sorts of 
experim ental data w ith public annotation data, along with analysis tools to  make the 
best possible conclusions from  the assembled inform ation.
By drawing inform ation together and then analysing it in  a m ass-parallel approach, 
patterns in the observations can be assem bled and then explored for sim ilarity yielding 
new insight into the underlying m echanisms for disease. M icroarray data, and the 
MADRAS system, form only one part of the overall biological picture th at can be 
obtained using current experim ental techniques. It is therefore hoped that the 
successes of MADRAS and its fundam ental ideas can be developed to  incorporate data 
from  other technologies allowing parallel exploration of results from  m ultiple systems.
An example would be the incorporation of m ass-parallel proteom ics data in a situation, 
where a researcher may have mRNA and protein level data from  the same sample and 
wishes, for example, to  ask how the genes th a t are changed at the mRNA level behave at 
the protein level, and vice versa.
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Fundamentally, the issue of providing tools to the biomedical researcher which can 
accelerate the experim ental process is one worthy of much attention by the 
bioinform atics com m unity in parallel to  the large am ount of algorithm ic and statistical 
research being applied to  the high-throughput technologies. Ultimately it is the 
interpretation of the biological data th a t should be providing the key research driver.
8.5 Conclusions
M icroarray based expression profiling provides a useful research tool to gain new 
insights into biological systems. During the period that the work presented here was 
undertaken, data analysis m ethods have greatly advanced, with more on developing the 
accuracy of analysis, and the techniques which can best extract meaningful inform ation 
from  the data. However, w ith m any m ore analysis experts entering the field and 
wishing to  make a m ark, there is a risk th at answers to  basic questions are over 
shadowed by work on m ore complex com putational and statistical m ethods and many 
simple yet powerful m ethods are overlooked.
Understanding the fundam ental concepts is essential in the application of statistical 
tests and to  underpin future work aim ing to  link m icroarray data to  its biological 
annotation. Although it can be argued th at bioinform atics software is best w ritten by 
trained bioinform aticists, com puter scientists and statisticians, it is ultim ately the 
researcher who created the experim ent and commissioned dataset who m ust be 
empowered to  undertake the data analyses as they are the ones who wish to  best 
capitalise on their investm ent.
To the researcher, there is the requirem ent of a large investm ent of tim e and energy 
required to  understand m icroarray analysis and its im plem entation. To this end, many 
groups have m ade decisions to  “out source” their analysis and rely on external 
expertise. The risk of such an approach is th at a lack of understanding of the 
lim itations and factors affecting analysis will lead to  sub-optim al experim ental design 
and im plem entation, which will results in frustration from the user when their data is 
returned w ithout significant m eaningful results. A sim ilar outcome is likely from  black 
box analysis approaches.
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Consequently, a m iddle ground m ust be found where the required user knowledge is 
m odular, so they can understand the system at whatever level they require for 
comfortable acceptance of any additional leaps of faith. To back up this approach the 
analysis com m unity needs to  be able to  provide firm  answers to  simple questions raised 
by the non-expert user and practical substantiated guidance as to best practice.
Adoption of the elem ents of good experim ental design, good experim ental processing, 
best practice analysis and tools to  fully exploit the inform ation returned from  an 
experim ent should enable the full potential of m icroarray technology to be realised, 
allowing the researcher to  move from  a system able to  detect the obvious 
transcriptional changes in a system, to  one which can detect even the sm allest of 
nuances between sam ple groups and assist in the further annotation and 
understanding of genome functions.
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Chapter Nine 
Materials and Methods 
9.1 Introduction
The following sections provide supplemental information to support the exploration 
and results in previous chapters. These sections aim to inform the reader of the 
technical methodology behind each stage of analysis and identify the key functions and 
ideas utilised. In addition, further information is provided on the datasets and 
expression metrics chosen for analysis and comparison.
9.2 Data distributions and their effect on analysis 
options
The following information supports the work undertaken in Chapter Two which is 
concerned with the assessment of data distributions on Affymetrix GeneChips data.
9.2.1 Introduction to the Affymetrix Latin Square dataset
The Latin Square data was release by Affymetrix and formed part of the development 
cycle and validation for the MAS 5.0 software suite (Affymetrix, 2001b; Affymetrix, 
2002a; Affymetrix, 2002b). The dataset consist of a series of transcripts spiked-in at 
known concentrations and arrayed in a Latin Square format along with a complex 
background of human pancreatic mRNA.
The supporting documents from Affymetrix state that the Latin Square design for the 
human data set consists of 14 spiked-in gene groups in 14 experimental groups. The 
concentration of the 14 gene groups in the first experiment is o, 0.25, 0.5,1, 2 ,4 , 8,16, 
32, 64,128, 256, 512, and i024pM. Each subsequent experiment rotates the spike-in 
concentrations by one group; i.e. experiment 2 begins with o.25pM and ends at opM, 
on up to experiment 14, which begins with i024pM and ends with 5i2pM. Each 
experiment contains at least 3 replicates, with two concentrations being represented 
with twelve replicates.
The 59-chip data set was downloaded from the Affymetrix website 
(http://www.affymetrix.com/support/technical/sample_data/datasets.cffic) as a 
series of pre-processed cell intensity (CEL) files, each containing a list of intensity 
values for each oligonucleotide probe on a GeneChip.
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9.2.2 Overview of Expression Metrics
Six different algorithm s were applied to extract a single expression values for each 
transcript represented by a series of probes on the image data. In addition to a 
quantitative expression value, four of the analysis m ethods also provide a qualitative 
m easurem ent indicating if the transcrip t is detected (Present), not detected (Absent), 
or marginally detected (M arginal). The expression values and calls for relative gene 
expression (Absent, Present or M arginal) were exported from each package into 
delim ited text files. Further details of the algorithm s and methodology for each 
expression m etric follow in Sections 9.2.1.1 -  9.2.I.6.
9.2.2.1 Microarray Suite 4.0
M icroarray Suite (MAS) 4.0 (Affymetrix, Santa Clara CA) calculates expression values 
using an em pirical m ethod summing the PM-MM value and correcting for background 
noise. The expression level outputted by MAS 4.0 is term ed Average Difference.
The Average Difference for each probe set is an average of the differences between each 
PM probe cell and its control MM probe. Thus, in those probe sets where the mismatch 
probe has a higher intensity value than  the perfect m atch the Average Difference will be 
negative. In  general, MM is greater than  PM for about 1/3 of the probes on any given 
array (Irizarry et al., 2003a)
MAS 4.0 also generates an Absolute Call which indicates a confidence for the Average 
Difference being sufficiently different from  background for the probe set to be 
considered expressed. A decision m atrix is employed to  determ ine the presence or 
absence of each transcript on each chip.
In this study, data was analysed using global norm alisation and target intensity (TGT) 
of 100 and exported to tab delim ited text file w ithin M icroarray Suite 4.0. TGT is an 
arbitrary target intensity value which each chip is scaled to in order to  facilitate 
com parison between chips.
9.2.2.2 dChip PMMM Model
Li and Wong (Li and Hung Wong, 2001a; Li and Wong, 2001b) were the first to 
propose m odel-based expression m easures. They observed th at PM values are often 
less than MM values and identified the need for non-linear norm alization, and 
proposed the use of m ulti-array sum m aries for the detection and removal of outliers.
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dChip attem pts to make im provem ents over the MAS 4.0 algorithm s by application of 
an invariant set norm alization m ethod and model-based expression values (MBEI). The 
MBEI value is the weighted average of PM/MM differences. dChip also applies an 
outlier detection algorithm  to elim inate values from  potentially cross-hybridizing 
probes and subtracts away the cross-hybridization signals equally from  a probes PM 
and MM value, th a t results in sensitivity to  expression changes at the low concentration 
level. However, in  many cases the resultant expression values are sim ilar to  those 
obtained from  MAS 4.0 as Average Difference values.
CEL file data was analysed in  dChip version 1.3, using the PMMM model with default 
settings, incorporating default m edian chip norm alisation and application of the MBEI 
model.
9.2.2.3 dChip PM-Only Model
The dChip package contains algorithm s which can calculate an expression value using 
either both the PM and MM probes, o r the PM probe values only, dependent on 
analysis settings. The PM-Only algorithm  uses only PM probes and results in the 
production of all-positive expression values, which is im portant for researchers wishing 
to  apply fold-change analysis. However, the model has a slight caveat, w ith the 
absorption of some background signal into the expression values due to  the MBEI 
calculating the weighted average of background-adjusted PM values. This effect 
reduces sensitivity a t lower concentration levels (Li and Wong, 2001b; Naef, et al.,
2002).
CEL file data was analysed in dChip version 1.3, using the PM-Only model w ith default 
settings, incorporating default m edian chip norm alisation and application of the MBEI 
model.
9.2.2.4 Microarray Suite 5.0
In response to  consum er dem and to  elim inate negative values and produce a m ore 
robust expression m etric, Affymetrix integrated new statistical algorithm s into MAS 
5.0. MAS 5.0 utilises a series of statistical techniques in the conversion of image 
intensity data across a series of probes into an expression value, and steps are taken to 
avoid the production of negative num bers. Average Difference was replaced w ith a new 
expression level term ed Signal (Affymetrix, 2001b; Affymetrix, 2002a; Affymetrix, 
2002b).
The analysis process first undertakes a zoned based background correction using the 
lowest 2% of probe intensity values. These values are then sm oothed to ensure an even
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transition across the chip. For each probe, an ideal m ism atch value is calculated (to 
elim inate the possibility of negative values) and subtracted to  adjust the PM intensity 
for non-specific hybridisation. The adjusted PM intensities are log-transform ed to 
stabilize the variance before application of a One-Step Tukey’s biweight estim ator, to 
yield a robust m ean of the values. Signal is outputted as the trim m ed mean of the 
antilog of the biweight value.
The Absolute Call from  MAS 4.0 is replaced with a detection call and associated 
detection p-value. Detection p-value is calculated using a Wilcoxon rank test of the 
probe values, looking for a statistical difference between the MM values and the PM 
values. The detection call is determ ined by cut-offs applied to the p-value and are user 
tuneable.
In this study, data was analysed using default param eters w ithin M icroarray Suite 5.0, 
w ith the application of a TGT of 100.
9.2.2.5 Robust Multi-chip Average (RMA)
The Robust M ulti-chip Average (RMA) m ethod (Irizarry, et al., 2003) consists of three 
steps: a background adjustm ent, quantile norm alization and finally summarization. 
RMA can be broken down into a three step process, firstly probe-specific background 
correction to  com pensate for non-specific binding using the PM probe distribution (it 
should be noted th a t the background adjustm ent step in RMA ignores the MM values 
present on each array).
Secondly, the application of a probe-level m ulti-chip quantile-quantile (Q-Q) 
norm alization to  unify PM distributions across all chips and finally the generation of a 
robust probe-set sum m ary by reducing inform ation for individual probes to  a single 
value for the probe set using the log-normalized probe-level data by m edian polishing 
and a robust m ulti-chip linear model fit on the log scale.
RMA analysis was im plem ented using the “a ffy” m odule (Gautier, et al., 2004) of the 
BioConductor project (Gentleman, e t al., 2004) im plem ented w ithin the R environm ent 
(Ihaka and Gentleman, 1996). W hilst many different analysis models have been 
developed by the BioConductor community, default settings were employed for 
background correction, norm alisation (Q-Q) and polishing.
231
9.2.2.6 gcRMA
gcRMA is a development of the RMA model which aim s to improve the background 
correction by incorporating information about predicted hybridisation (Wu, et al.,
2004). The method builds on the work of Naef and Magnasco (Naef and Magnasco,
2003) who propose a solution useful for predicting specific hybridization effects using 
the base composition of the probes. Probe affinity is modelled as a sum of position- 
dependent base effects
The model takes advantage of sequence information to appropriately describe non­
specific binding variation. The authors claim that this practical adjustment results in 
improvement in overall sensitivity and specificity when compared to other methods 
(MAS 5 0, RMA).
In this study, data was computing using the gcRMA module of BioConductor 
(Gentleman, et al., 2004) implemented in R (Ihaka and Gentleman, 1996) using 
default settings, and options for prior computation of the binding affinities from the 
sequence information provided by Affymetrix.
9.2.3 Data filtering and preparation
Data from the 14 spiked-in genes (37777_at, 684_at, I597_at, 38734_at, 39058_at, 
363ii_at, 36889_at, I024_at, 36202_at, 36085 at, 40322_at, 407_at, i09i_at, 
i7o8_at) and 67 control probe sets (with AFFX prefix) were removed from the 
resultant files from each of the six expression metrics, leaving 12545 probe sets for 
further analysis.
9.2.4 Technical Methodologies
9.2.4.1 Formal testing of normality
Formal testing of normality was undertaken by application of the Shapiro-Wilks test to 
the 59 values for each probe set using the sh a p iro . t e s t  function in the R base 
system (Ihaka and Gentleman, 1996). This analysis was repeated for data from each of 
the six expression metrics under review.
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9.2.4.2 Assessing correlation to normality
Correlation to normality was calculated as the Pearson’s R2 value from a Quantile- 
Quantile (QQ) plot of the 59 data values for each probe set against 59 values generated 
to be representative of a normal distribution. Analysis was undertaken using the R 
function r n o r m  to generate a normally distributed dataset, which was correlated each 
probe sets data using the c o r  function.
9.2.4.3 Calculation of skew
The skew for the data from each probe set was calculated using the s  k e w n e s s  function 
from the ei07i library (Dimitriadou, et al., 2004).
9.2.4.4 Application of the Box-Cox transformation and assessment to 
normality
The Box-Cox function was applied to data from each probe set using values of lamba 
from -2 to 2 in steps of 0.1 (Section 2.3.6). Code to undertake this process was written 
using the R language and the results of the transformation assessed for correlation to 
normality using QQ plots (Section 9.2.4.2). The value of maximal correlation to 
normality was returned as the result of the Box-Cox function.
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9.3 Statistical approaches to the detection of 
differentially regulated genes in Affymetrix 
datasets
The following information supports the work undertaken in Chapter Three which is 
concerned with the determining the power to detect “truth” in a dataset with known 
spiked-in values. The initial image data was subject to analysis using a variety of 
expression metrics and testing to determine differential gene expression across a range 
of sample sizes.
9.3.1 Defining the exploratory dataset
Reviewing the associated documentation of the Latin Square experimental design 
(http://um nv.cffjm etrix.com /support/technical/sam ple_data/datasets.q ffx)  
identified replicate chips where most spikes vary by only 2-fold. Further review of the 
information indicated that each of these, four replicates in the I.a tin square design were 
replicated over three separate chip wafers, resulting in 12 replicates in each group for 
the 14 spiked in transcripts with a 2-fold change in concentration.
Table 9.1
Spiked transcript concentration (pM)
Probeset Chips M, N, 0 , P Chips Q, R, S, T
I597_at 0 0.25
38734_at 0.25 0.5
39058_at 0.5 1
363ii_at 1 2
36889_at 2 4
I024_at 4 8
36202_at 8 16
36o85_at 16 32
40322_at 32 64
407_at 512 1024
i09i_at 128 256
i7o8_at 256 512
37777_at 512 1024
684_at 1024 0
Table 9.1 -  Spiked transcript concentration for the spiked in data o f the Affymetrix
Latin Square dataset.
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9.3.2 Review of the spiked-in transcripts
In Section 9.2.1 considering data distributions it was stated that data for fourteen 
probes spiked in by Affymetrix was excluded prior to investigations. However, review 
of the literature (Cope, et al., 2004; Wolfinger and Chu, 2002) suggests inconsistencies 
in the information provided by Affymetrix.
The data suggests that 407_at and 37777_at follow the same spike-in pattern, and 
probe set 338i8_at fills the missing gap in the Latin Square grid. Probe set 546_at is 
designed against the same target as 36202_at (Unigene ID Hs. 75209) and the data 
support this observation. The Latin Square dataset can thus be considered to contain 
sixteen probe sets which contain known truth in terms of the spiked-in transcript 
according to the Latin Square design (407_at, 546_at, I708_at, I024_at, i09i_at, 
1597—at, 338i8_at, 36o8s_at, 36202_at, 363ii_at, 36889_at, 37777_at, 38734_at, 
39058_at, 40322_at, 684_at).
Extracting the information for the 24 chips containing replicates across two groups of 
12 chips shows that the majority of probe sets present with a two-fold change in the 
spiked-in transcripts, with the exception of probe set 684_at, which is represented with 
spikes of o and 1024 pM in the two groups. This probe set was therefore removed from 
further analysis, leaving fifteen probe sets for detection.
9.3.3 Overview of analysis
The aim of the analysis undertaken in this section of work was the real world 
exploration and validation of the ability of combinations of expression metrics and 
statistical testing to identify known changes in a dataset. Such an analysis also allows 
for investigations into the issue of data transformation.
In addition the number of replicates present in the Latin Square dataset allow for the 
consideration of the relative performance of differing analysis approaches using 
experimentally plausible sample sizes (ranging from 3 to 12 replicates in each group 
representing a single state).
Key to the approach is the identification of methods to identify the detection of “truth” 
from the analysis results, and make meaningful comparison between expression 
metrics and approaches to detection differential gene expression.
235
9.3.4 Performance assessment using FDR curves
In order to determine the relative performance of differing methods to correctly 
identify the known truth in the form of our 2-fold change in expression of the 16 spiked 
in probes FDR curves were generated visualising the performance in differing tests 
from each resultant dataset and at a range of sample sizes.
FDR curves are based on the idea of ROC (Receiver Operator Characteristics) curves 
plotting specificity against sensitivity. ROC curves are generated using the whole 
dataset and were found to produce small differences because of the small amount of 
known truth in the dataset. Instead die FDR curve focuses on a smaller amount of the 
dataset, in our case the first 200 hundred genes ranked on the basis of statistical 
significance from a test statistic - behaviour after that is not recorded. A graph is then 
plotted scoring one mark vertically for detection of known truth and one mark 
horizontally for a false positive.
This provides a more intuitive visualisation of the performance of each method and is 
in the order of magnitude that are likely to be considered for follow up study using 
complementary methodologies, i.e. it is quite acceptable to review a list of 200 genes 
for further annotation and follow up. Using this method we can get an idea of the false 
positive rate in such a strategy. In order to quantify the results of the many graphs we 
can use the area under the curve to quantify performance. A perfect result gives the 
largest area where the 16 spikes are the first probe sets identified in the ordered list, 
less perfect tests yield smaller areas (Figure 9.2)
9.3.5 Development of an analysis framework
The analysis framework can be broken down into three main processing stages, 
generation of random samplings from the data set, application of expression metric 
analysis and application of tests for differential gene expression and the assessment of 
power using FDR curve analysis. The results of each stage for the inputs to the next, 
with various variations applied before submission to the next stage.
9.3.5.1 Random sampling of data at a variety of sample sizes
To obtain an idea of confidence that can be inferred from the results of downstream 
testing, the 24 chip dataset was randomly sampled to produce 20 replicate datasets 
over a sample size range of 3-12 (Figure 9.1). The result of this sampling was an index 
of filenam es at each of the 200 samplings.
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F i g u r e  9 .1
24 CEL files from  
Affymetrix Latin Square Dataset
Generate 200 random samplings of data 
representing 20 replicate datasets at each of 
10 sample sizes (3-12 per group)
Index of CEL filesnames for each of 200 
random samplings of the dataset
Figure 9.1 -  Overview of sampling from Latin Square dataset.
9.3.5.2 Application of expression metric analysis to each dataset
The index produced in 9.3.5.1 was combined with the CEL file data to apply differing 
expression metrics to the data. The result in each case was a 200 element array 
containing matrices of expression values for each of the random samples previously 
generated. Analysis using MAS 4.0, MAS 5.0, and the dChip models was undertaken in 
the respective software package (as opposed to Bioconductor implementation) as a 
single analysis run of all 24 chips. The resultant text files were then imported into R 
along with the index data and matrices produced by extracting the relevant columns 
from the uploaded file (Figure 9.2). For each expression metric a master array was 
formed containing the expression data for each sampling.
F igure 9.2
Index of CEL filesnames for each of 200 
random samplings of the dataset
24 CEL files from  
Affymetrix Latin Square Dataset
r
Analyse CEL files using MAS 4.0, MAS 5.0, 
dChip PMMM or dChip PM-Only model 
(single analysis run of 24 files)
— text file—
Sample expression metric results according to 
index and store matrices into indexed array
200 element array containing 
matrices of expression values
Figure 9.2 — Overview data analysis using Microarray Suite and dChip expression 
metrics.
2 3 7
The multi-chip normalisation undertaken in RMA and gcRMA required the individual 
analysis for each sampling. For each sample, the CEL file data was imported into R 
using the a f  fy  module, prior to the application of the RMA or gcRMA analysis (Figure 
9.3). The results of each analysis were saved into a master array containing all the 
expression results for each sampling in a format comparable with that from Microarray 
Suite and dChip analysis.
F igure 9.3
Index of CEL filesnames for each of 200 24 CEL files from
random samplings of the dataset Affymetrix Latin Square Dataset
For each sampling import relevant CEL files 
and apply RMA or gcRMA analysis
Save expression results as 
matrix into indexed array
200 element array containing 
matrices of expression values
Figure 9.3 -  Overview data analysis using RMA and gcRMA expression metrics.
9.3.5.3 Application of tests to determine differential gene expression and 
calculate power
Analysis of the power of each combination of expression metric and test for differential 
gene expression was undertaken using the array of matrices for each metric produced 
in section 9.3.5.2. For each sample, the control probe sets (AFFX prefix) were removed 
prior to the application of a test for differential gene expression (Section 9-3-6).
The output for each test was fed into an FDR function which extracted the location of 
the spikes from the ordered p-values and calculated the area under the FDR curve as 
previously described. The output for each test was exported into a summary matrix 
containing each of the 200 AUC values calculated, grouped by sample size. Summary 
plots were produced charting the average area under the curve (with standard error, 
error bars), across the range of sample size under consideration.
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By combining the results from different combinations of expression metric and test for 
differential gene expression difference in power can be observed by the relative 
positioning of the lines on the plot. By implementation of error bars using the standard 
error of the mean, the presence of a gap between error bars at a chosen sample size is 
equivalent to a significance value of p < 0.05 for a standard paired t-test on the same 
data (Motulsky, 1999).
F igure 9.4
Matrix of expression values for 200 
samplings for single expression metric
Plot graph of sample size versus AUC  
for each expression metric, with SEM error 
bars for each point
Apply test for differential gene expression
Note position of spiked in probe sets
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Filter control probe sets
Order test results by significance
For each sampling apply statistical test and 
calculate area under FDR curve
Store AUC values in matrix 
indexed by sample size
Figure 9.3 -  Overview of FDR analysis for each expression metric and test for 
differential gene expression.
9.3.6 Statistical testing
Fold change analysis was undertaken using a custom function which calculated the 
absolute value of the ratio between the logs of the means of each group of data. 
Analysis of data using the Welch t-test and unpaired t-test were initially undertaken 
using the R t . t e s t  function, however testing identified a performance advantage 
when using customised code for the calculation values for t and degrees of freedom and 
using the p f  function to calculate p-values. The non-parametric Mann-Whitney test 
was implemented using options of the w ilco x  . t e s t  function.
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9.4 Approaches to data normalisation
The following information supports the work undertaken in Chapter Four investigating 
the effect of differing data normalisation techniques to improve the power to detect 
“truth” in detection of the spiked-in transcripts within the Affymetrix Latin Square 
dataset.
9.4.1 Examination of data distributions following normalisation
The distributions of data following the application of QQ normalisation, VSN and a 
rank based normalisation method were compared to those from the untransformed 
data using the Shapiro-Wilks test (Section 9.2.4.1) and correlation to normality 
(Section 9.2.4.2) prior to the assessment of detection power using a FDR curve analysis 
framework.
9.4.2 Refinement of the analysis framework
Adaptation analysis framework introduced in Section 9.3.5 to was adapted to 
incorporate an additional normalisation stage prior to the application of statistical 
testing (Figure 9.5). The same array of sampled expression metrics was employed to 
enable data to be directly comparable to that from Section 9.3.
9.4.3 Implementation of normalisation techniques
QQ normalisation (Bolstad, et al., 2003) was implemented using a custom function 
with R. The function was written to accept a matrix of expression data, apply the QQ 
normalisation and then return the revised expression values in an identical format.
Data was normalised using the VSN method (Huber, et al., 2002) as provided as part of 
the bioconductor VSN module. Similarly to the QQ normalisation, the function returns 
a matrix of identical format to the input matrix with revised values following the 
application of variance stabilisation normalisation.
The relative rank of data within each array was calculated by the application of the R 
function rank to each column within the sample under analysis. The resultant matrix 
being of identical format to the input linked to the next stage of analysis, the 
application of statistical testing.
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F igure 9.5
( Matrix of expression values for 200 samplings for single expression metric
Filter control probe sets
-------------------------------------------------
Plot graph of sample size versus AUC 
for each expression metric, with SEM error 
bars for each point
Order test results by significance
Apply normalisation technique
Apply test for differential gene expression
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Note position of spiked in probe sets
Store AUC values in matrix 
indexed by sample size
Figure 9.5 -  Overview of FDR analysis for each expression metric and test for  
differential gene expression following the additional application of a normalisation 
technique.
9.4.4 Implementation of statistical testing
FDR analysis of data following the application of QQ normalisation and VSN were 
assessed using the Welch t-test implemented in the customised code identified in 
Section 9.3.6. Rank transformed data was assess using both the Welch-t test and the 
non-parametric Mann-Whitney test implemented using options of the w ilco x . t e s t  
function.
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For each sampling apply statistical test and 
calculate area under FDR curve
9.5 Application of robust statistical testing
The following information supports the work undertaken in Chapter Five investigating 
the effect on the power to detect “truth” in detection of the spiked-in transcripts within 
the Affymetrix Latin Square dataset using statistical tests that are more robust against 
the effect of outliers in the dataset.
9.5.1 Refinem ent of the analysis fram ework
The analysis framework introduced in Section 9.3.5 to was adapted to incorporate 
differing statistical tests as part of the overall procedure to assess the area under the 
FDR curves following the application of an expression metric in combination with a 
robust statistical test (Figure 9.6). The same array of sampled expression metrics was 
employed to enable data to be directly comparable to that from Section 9.3.
F igure 9 .6
( Matrix of expression values for 200 samplings for single expression metric
Plot graph of sample size versus AUC  
for each expression metric, with SEM error 
bars for each point
Order test results by significance
Filter control probe sets
Apply robust statistical test to detect 
differential gene expression
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Note position of spiked in probe sets
Store AUC values in matrix 
indexed by sample size
For each sampling apply statistical test and 
calculate area under FDR curve
F igure 9 . 6 -  O verview  o f  FDR a n a lys is  f o r  each expression  m etric  incorpora ting  m ore
robust s ta tistica l tests  f o r  d ifferen tia l gene expression.
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9.5.2 Implementation of robust statistical tests
Four alternatives to the t-test incorporating a combination of mean/median and 
standard deviation/median absolute deviation were implemented by alterations to tbe 
Welch t-test function identified in Section 9.2.4. The R functions of m e a n  and s d  were 
replaced by those of m e d i a n  and m a d  at appropriate points of the t-test formulae.
The trimmed t-test, Winsorised t-test and Yuen t-test were all implemented using 
variations of the Welch t-test function with alterations made to the data inputted to the 
function before application of the standard Welch t formulae. Modifications were made 
accordingly to the degrees of freedom before the calculation of a p-value using the p f  
function.
9.5.3 Randomisation testing
Because of the issues of computational intensity and speed of execution, it was not 
possible to fully implement randomisation testing within the R environment (although 
an R implementation was used for testing an exploration of the technique). Data 
matrices from the first 10 samples with each expression metric array were exported to 
text file for the application of randomisation testing using an external program.
The core randomisation code was implemented using the Microsoft C programming 
language and comprised an executable program which accepted an expression data 
matrix as its input. The error modelling and stepwise approach to assessment of the 
number of randomisation steps required was achieved by the use of a Perl wrapper 
script which formed the appropriate input for the C program and recorded the results 
to another text file.
FDR curve testing and the calculation of the area under the curve was undertaken using 
code produced using Microsoft Excel, before the results of the AUC for the range of 
sample sizes were formatted to be accepted into the R framework for the production of 
summary graphs. The results were combined with those from Section 9.3.4 to facilitate 
comparison between the standard statistical test and the randomisation technique.
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9.6 Application of a Bayesian Framework
The following information supports the work undertaken in Chapter Six investigating 
the effect on the power to detect “truth” in detection of the spiked-in transcripts within 
the Affymetrix Latin Square dataset using the Baldi and Long (Baldi and Long, 2001) 
framework for Bayesian testing.
9.6.1 Refinem ent of the analysis fram ework
The analysis framework introduced in Section 9.3.5 to was adapted to incorporate the 
Bayesian framework for detection of differential gene expression as part of the overall 
procedure to assess the area under the FDR curves following the application of an 
expression metric in combination with a statistical test (Figure 9.7. The same array of 
sampled expression metrics was employed to enable data to be directly comparable to 
that from Section 9.3.
F igure  9 .7
Matrix of expression values for 200 
samplings for single expression metric
Plot graph of sample size versus AUC  
for each expression metric, with SEM error 
bars for each point
Filter control probe sets
Application of bayesian testing framework
Note position of spiked in probe sets
Calculate area under FDR curve (AUC) for first 
200 genes using spike probe set ranks
Order test results by significance
For each sampling apply statistical test and 
calculate area under FDR curve
Store AUC values in matrix 
indexed by sample size
F igure 9 .7  -  O verview  o f  FD R a n a lys is  f o r  each expression  m e tr ic  incorpora ting  m ore
v a ria tio n s  o f  the B a ld i a n d  L ong  B ayesian  fr a m e w o r k  f o r  d ifferen tia l gene
expression.
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9.6.2 Implementation of a Bayesian framework
The base code for the execution of Bayesian testing in the R environment was 
downloaded from the author’s website (http://visitor.ics.uci.edu/genex/cybert/). 
Review of the code identified many sections that could be parsed from the script and a 
refined and simplified version was produced which would enable simple integration 
within the FDR framework.
Additional options were added to the function to allow for variations in the window size 
and blending options as well as alterations in the algorithm utilised from the FDR 
script (see Section 9.5.2). The results of the Bayesian analysis were returned into the 
script for summarisation and analysis of detection power.
9.7 Approaches to annotation and exploration of 
Affymetrix microarray data
The following technical information underpins the work undertaken in Chapter Seven 
investigating approaches for the annotation and exploration of data following the 
application of techniques to identify differential gene expression and introduces some 
of the technical issues and solutions implemented in the MADRAS system.
9.7.1 Implementation of the software platform
MADRAS is principally written in the PHP programming language. PHP is deployed as 
a module within a web server which is, in turn, accessed via a web browser on a client 
computer. Implementation of modules within PHP allows the code to interact directly 
with a variety of external data sources, a mySQL database in the case of the MADRAS 
system (Figure 9.8).
Statistical functions were utilised within the R language. To implement this 
functionality the PHP script exports both a data file and R script file to a temporary 
directory on the server, before the automated execution of the R code from within PHP. 
The results of the R script are returned to another text file, for re-import to PHP, 
formatting and rendering onto the user’s screen.
In development, the MADRAS software was deployed on a PC running Windows XP 
using the phpdev423 package (http://www.firepages.com.au/). phpdev is a package 
which deploys a ready-configured server setup comprising Apache, PHP and mySQL 
and allows for simplified system installation. The software platform for MADRAS can 
be implemented on a variety of operating systems using differing platform releases of 
the open source tools.
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Figure g.8
ApachemySQL
Service
-Workstation
INTERNET
Figure 9.8 -  Overview o f softw are im plem entation fo r  the M ADRAS system
9.7.2 MADRAS database design and implementation
The MADRAS database is principally designed around two modules, an annotation 
database, and user data and exploratory information database. Addition information is 
required to separate the users information, and allow sharing of data between research 
groups. This information is stored in additional database tables for user information.
The user data tables store the uploaded GeneChip array information, along with 
information to format individual chips into groups termed *e x p e r im e n ts Key to the 
exploration of data in manageable segments is the provision of “probelists” which store 
lists of linked probe set identifiers, which can be combined along with annotation 
information and actual user data from an “experim ent” to form the rapid exploration 
environment that MADRAS forms.
The annotation database is formed from a variety of text files downloaded from the 
following sources:
Locuslink from NCBI (ftp://ftp.ncbi.nlm.nih.gov/refseq/LocusLink/ARCHIVE/)
Array specific annotation from Affymetrix (http://www.netaffx.com)
Homologene from NCBI (ftp://ftp.ncbi.nih.gov/pub/HomoloGene/)
Taxonomy from NCBI (ftp://ftp.ncbi.nih.gov/pub/taxonomy/)
OMIM from NCBI (ftp://ftp.ncbi.nih.gov/repository/OMIM/)
GenMAPP pathways from GENMAPP 
(http: / / www.genmapp.org/ download-MAPPs.asp)
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KEGG data from GenomeNet (ftp://ftp.genome.ad.jp/pub/kegg/)
Data from BioCarta was spidered using a PHP script to download each linked html 
file, extract the relevant pathways linked to a Locuslink information and form a 
resultant master file of Locuslink indexed biocarta information.
The text files obtained from each download were uploaded into the database starting 
from the key Locuslink information allowing indexing of the links to be formed 
between tables. An overview of the resultant ddatabase schema is shown in Figure 9.9.
9.7.4 Data upload to MADRAS
Data is read from a tab delimited text file into the database for browsing and storage. 
The data formats are based on saving the pivot table view into a tab-delimited text file 
from within MAS 5.0. However the user has a variety of options as to the data columns 
they supply to the database.
9.7.4.1 Uploadable data formats (examples)
MAS 5.0 -  Signal, Detection and Detection p-value
ProbelD Chipl_Signal Chipl_Detection Chipl_Detection p-value
1554526_at 453.7297434 P 0.942
1564251_at 53.4 M 0.042
213779 at 3.7 A 0.028
MAS 5.0 -  Signal and Detection
ProbelD Chipl_Signal Chipl_Detection
1554526_at 453.7297434 P
1564251_at 53.4 M
213779 at 3.7 A
MAS 5.0 -  Signal only
ProbelD Chipl_Signal
1554526_at 453.7297434
1564251_at 53.4
213779 at 3.7
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9.7.4.2 Upload of other data formats
At present the system only accepts MAS 5.0 data formats (other data may be uploaded 
if forced into this format). To force other data into the required format the key th ings to 
note are the fact that the ProbelD column is optional and column labels must end with 
MAS 5.0 suffixes ( _Signal, _Detection, _Detection p-value) and must be present in the 
combinations indicated above (Section 9.7.4.1).
9.7.3 Technical implementation of analysis features
9.7.3.1 Bar chart and heatmap graphics
The bar chart and heatmap graphics integrated into the explore view (Section 7.4.1) are 
formed following the extraction of relevant data from the database and then converted 
into graphics using the jpgraph PHP library (http://www.aditus.nu/jpgraph/ ). 
jpGraph is a fully 0 0  (Object-Oriented) graph creating class library which can produce 
dynamic graphics for inclusion into the web-page output, eliminating the requirement 
generate fixed graphic files on the server.
A variety of options are passed to the jpgraph code describing the graphing options 
required and include options for a linear or logarithmic scale, display or non-display of 
data values for graphs, the size of the graph and information for the colouration of the 
bars according to detection call and background according to user defined parameters.
9.7.3.2 Experimental data heatmap
The experimental heatmap function plots an image of the clustered data for all probe 
sets in the current probelist. The data is subject to average linkage hierarchical 
clustering after the application of a log transformation and median centring step.
The clustering is undertaken using customised R code which accepts a text file in a 
similar to the “MAS 5.0 signal only” data upload format (Section 9.7.4.1). The script 
outputs two files, a graphical file for inclusion in the returned web-page (png file) and 
an Adobe Acrobat file available for download. The clustering is applied to the probe 
sets only and not the experiments.
9.7.3.3 Dendrogram
Experimental clustering for data for a selected probelist is undertaken using a modified 
version of the heatmap function (Section 9.7.3.2). However, clustering is applied to the 
experiment columns only, and data returned as a dendrogram graphic.
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9.7.3.4 Over-representation analysis
The key function used in the execution of over representation analysis is the p . hyper 
function within the R environment. However, the computationally intensive process of 
an over-representation analysis is the generation of the four figures the hypergeometric 
p-value function requires. The analysis can review the terms contained within the Gene 
Ontology, BioCarta, KEGG and GenMAPP fields as well as the text based gene name 
and summary fields. For the text based fields, these are split into individual and word- 
pairs for individual over-representation analysis for each word/word pair.
First the probe lists is reduced to a list of unique probes by reference to the LocsuLink 
database and array design information tables. Next, data for the field under 
investigation (e.g. BioCarta pathways) is extracted and counts made within the list of 
unique loci for each different term encountered within the field of interest (e.g. list and 
counts of all matches to BioCarta pathways).
For each resultant term, a search is then undertaken against the full corpus of data for 
that field in relevant Locus Link database entries for the GeneChip under examination, 
resulting in the four pieces of information required from application of the 
hypergeometric test; number of hits against the unique loci in the probelists under 
examination, the number of unique loci in the probelist, the number unique Locus Link 
loci represented on the current array, and the number of these loci which contain the 
term under analysis.
As an example, a list of DNA repair genes containing 276 probe sets on a HG-U133A 
array can be reduced to 134 loci in the LocusLink database. Examination of the Gene 
Ontology field indicates that 13 of these 134 loci match the annotation “Molecular 
Function : Damaged DNA Binding”. Review of the relevant LocusLink data for the 
array shows that 22 out of 12726 loci match the annotation. These four figures are 
those forwarded to the p . hyper function in R.
This process is repeated against all identified terms for the field of interest (e.g. all 
Gene Ontology terms represented in the list), with each one returning a separate p- 
value from the analysis. The user is provided with the option of applying a Bonferonni 
correction for multiple testing on each of these analysis results. The results are 
returned as a table to the user with columns indicating the search term, probe list loci 
counts, global loci counts and the resultant p-value from hypergeometric probability 
analysis.
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Appendix One 
Overview of R functions created for distribution 
and FDR investigations
File: boxcox.r
Function: box.cox
Returns a dataset following the application of a Box-Cox power transform according to 
the supplied lambda value.
Usage
b o x . c o x ( x ,  l a m )
Details
x  vector of data values 
l a m  lambda value
Function: box.cox.norm
Returns a lambda value reflecting the Box-Cox transformation correlating most closely 
to normality. The Box-Cox transformation is applied between l m i n  and l m a x  with a 
step value of o .i.
Usage
b o x . c o x . n o r m ( x ,  n o r m = n N A " ,  l m i n = - 3 ,  l m a x = 3 )
Details
x  vector of data values
n o r m  array of normal distribution values Qength must equal length of x )  
if none supplied, the array is filled using the r n o r m  function
l m i n  minimum value of lambda value
l m a x  maximum value of lambda value
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File: basic tests.r
Function: foldchange
Returns the fold-change between two groups of data, calculated as the absolute value of 
the log (base two) transformed ratio of the means of the two groups of data.
Usage
f o l d c h a n g e ( x ,  n g l = " N A " ,  n g 2 = " N A " )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A ". If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
Function: ttest.p
Returns the p-value resulting from an unpaired t-test assuming homogeneity of 
variance between the two groups of data.
Usage
t t e s t . p  ( x ,  n g l = //N A / / / n g 2 = / ,NA/ / )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2 are "NA ". If no parameters are passed,
values are calculated by dividing the dataset into two equal groups.
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Function: welch.p
Returns the p-value resulting from the unpaired Welch t-test assuming heterogeneity of 
variance between the two groups of data.
Usage
w e l c h . p  ( x ,  n g l = " N A " ,  n g 2 = " N A " )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A ". If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
Function: mwu.p
Returns the p-value resulting from the Mann-Whitney test (non-parametric equivalent 
to the unpaired t-test)
Usage
m w u . p ( x ,  n g l = " N A " ,  n g 2 = //NA/ / )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " . If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
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File: robust_tests.r
Function: med_mad.p
Returns the p-value resulting from a robust implementation of the Welch t-test, with 
substitution of the median and median absolute deviation of each group of data for the 
mean and standard deviation respectively.
Usage
m e d _ m a d . p  ( x ,  n g l = " N A " ,  n g 2 = " N A " )
Details
x  vector of data values - group one data should proceed group two data
n g l  number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " . If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
Function: med_sd.p
Returns the p-value resulting from a robust implementation of the Welch t-test, with 
substitution of the median of each group of data for the mean.
Usage
m e d _ s d . p ( x ,  n g l = " N A " ,  n g 2 = " N A " )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2 are "N A ". If no parameters are passed,
values are calculated by dividing the dataset into two equal groups.
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Function: mean__mad.p
Returns the p-value resulting from a robust implementation of the Welch t-test, with 
substitution of the median absolute deviation of each group of data for the standard 
deviation.
Usage
m e a n _ m a d . p ( x ,  n g l = " N A " ,  n g 2 = " N A " )
Details
x  vector of data values - group one data should proceed group two data
n g l  number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " . If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
Function: trimmed.p
Returns the p-value resulting from a trimmed version of the Welch t-test, with the tails 
of the data trimmed.
Usage
t r i m m e d . p ( x ,  n g l = " N A " ,  n g 2 = " N A " ,  d e g = l )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " . If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
d e g  number of data elements to remove from each end of the ordered
dataset for each group. Note: if more elements are to be removed than
exist in the dataset the function returns a p-value of 1.
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Function: windsor.p
Returns the p-value resulting from a Windsorised version of the Welch t-test, with the 
tails of the data substituted according to Windsor’s principle.
Usage
w i n d s o r . p ( x ,  n g l = " N A " ,  n g 2 = " N A " ,  d e g = l )
Details
x  vector of data values - group one data should proceed group two data
n g l  number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " . If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
d e g  number of data elements to Windsorise at each end of the ordered
dataset for each group. Note: if more elements are to be removed than
exist in the dataset the function returns a p-value of 1.
Function: yuen.p
Returns the p-value resulting from a Yuen’s version of the Welch t-test, implementing a 
trimmed mean and Windsorised variance for each group of data.
Usage
w i n d s o r . p ( x ,  n g l = " N A " ,  n g 2 = //NA/ / / d e g = l )
Details
x  vector of data values - group one data should proceed group two data
n g l  number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2 are "NA ". If no parameters are passed,
values are calculated by dividing the dataset into two equal groups.
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d e g  number of data elements to trimmer of Windsorise at each end of the 
ordered dataset for each group. Note: if more elements are to be 
removed than exist in the dataset the function returns a p-value of 1.
File: bayesian_tests.r
Function: bayesian.t
Returns the p-value resulting from Bayesian implementation of the Welch t-test 
utilising a localised estimate of the dataset’s variance to improve detection. The 
function returns a vector contain the p-values for all probe sets in the dataset with 
Affymetrix identifiers as the element names.
Usage
b a y e s i a n . t ( h ,  w i n s i z e ,  r u n n i n g  =  " m e a n " ,  
v a r i a n c e = " u n e q u a l " ,  c o n f = 3 ,  m a d = F A L S E ,  f i x e d = F A L S E )
Details
h matrix of data values (rows containing probe set identifiers, and 
columns GeneChip array names )
w i n s  i  z e  window size in which to calculate the local variance
r u n n i n g  options of " m e a n "  or " m e d i a n "  reflect the calculation of the 
mean or median of values in the current window of variances
v a r i a n c e  window size in which to calculate the local variance
c o n f blending constant, if f i x e d  =  FA L S E  then blending is 
implemented using c o n f  times the sample size in each group
m a d implementation of median/MAD version of t-test
f i x e d  fixed blending constant independent of sample size
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File: Iatin2testing.r
Function: makeRTindex
Generates an index of file names representing samplings of a subset of the Afiymetrix 
HG-U95A Latin square dataset over a range of sample sizes between three and twelve. 
The returned file R T i n d e x . R D a t a  contains an array with 10 times r u n s  elements, 
each containing the CEL file name for that sampling.
Usage
m a k e R T i n d e x ( r u n s = 5 )
Details
r u n s  number of samplings to lake over the full range of sample sizes
Function: makeRTdata
Applies expression metrics to the samplings extracted from the R T i n d e x . R D a t a  file 
created using m a k e R T i n d e x .  The function has a number of dependences according to 
the expression metric applied and outputs an R data object containing an array of 
expression matrices according to each of the samplings.
Usage
m a k e R T d a t a  ( e x p s u m = nm a s 5 " , c e l f i l e . p a t h  =  g e t w d O )
Additional Files Required
I a t i n 2 4 _ m a s 4 _ e x a f f y . c s v  
I a t i n 2 4 _ m a s 5 _ e x a f f y . c s v
1 5 3 2 o 9 9 h p p _ a v 0 4 . CEL  
1 5 3 2 p 9 9 h p p _ a v 0 4 . CEL
l a t i n 2 4 _ M B E I _ P M M M _ e x d c h i p l 3 . c s v  1 5 3 2 q 9 9 h p p _ a v 0 4 . CEL  
l a t i n 2 4 _ M B E I _ P M _ e x d c h i p ! 3 . c s v  1 5 3 2 r 9 9 h p p _ a v 0 4 . CEL
1 5 2 1 m 9 9 h p p _ a v 0 6 . CEL  
1 5 2 1 n 9 9 h p p _ a v 0 6 . C E L  
1 5 2 1 o 9 9 h p p _ a v 0 6 . CEL  
1 5 2 l p  9 9 h p p _ a v 0  6 . CEL  
1 5 2 1 q 9 9 h p p _ a v 0 6 . CEL  
1 5 2 1 r 9 9 h p p _ a v 0 6 . CEL  
1 5 2 1 s 9 9 h p p _ a v 0 6 . CEL  
1 5 2 1 t 9 9 h p p _ a v 0 6 . CEL  
1 5 3 2 m 9 9 h p p _ a v 0 4 . CEL  
1 5 3 2 n 9 9 h p p _ a v 0 4 . CEL
1 5  3 2  s  9  9 h p p _ a v 0 4 . CEL  
1 5 3 2 t 9 9 h p p _ a v 0 4 r . CEL  
2 3 5  3m 9  9 h p p _ a v O  8 . CEL  
2 3 5 3 n 9 9 h p p _ a v 0 8 . CEL 
2 3 5 3 o 9 9 h p p _ a v 0 8 . C E L  
2 3 5 3 p 9 9 h p p _ a v 0 8 . C E L  
2 3 5 3 q 9 9 h p p _ a v 0 8 . C E L  
2  3  5  3  r  9  9 h p p _ a v O  8 . CEL  
2 3 5 3 s 9 9 h p p _ a v 0 8 . CEL  
2 3 5 3 t 9 9 h p p _ a v 0 8 . CEL
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Details
e x p s u m  choice of expression metric to apply, options of r m a a l l ,  
r m a s e p ,  g c r m a a l l ,  g c r m a s e p ,  d c h i p p m ,  d c h ip p m m m ,  m a s 5  
and m a s  4
c e l  f i l e . p a t h  Path information to access additional required files
Function: fdr.test
Undertakes comparative analysis of the power of differing combinations of statistical 
testing to identify the spiked-in transcripts within the Affymetrix Latin square dataset. 
Combinations of tests can be applied to the series of data samplings derived using 
m a k e R T i n d e x  and m a k e R T d a t a .  Following analysis the positions of the spikes is 
determined and used to output a matrix of area under the FDR curves according to 
sample size.
Usage
f d r . t e s t  ( e x p s u m = nm a s 5 " ,  t e s t = " w e l c h ” / d o . q q = F A L S E ,  
d o . r a n k = F A L S E / l o g . i t = F A L S E ,  p o w e r . i t = F A L S E ,  
l o g l O . i t = F A L S E ,  d o . v s n = F A L S E ,  g r a p h . o u t = T R U E )
Additional Files Required
d c h ip P M M M R T . R D a t a  
d c h i p P M R T . R D a t a  
g c r m a A U R T . R D a t a  
g c r m a S e p R T . R D a t a  
m a s 4 R T . R D a t a  
m a s 5 R T . R D a t a  
r m a A U R T . R D a t a  
r m a S e p R T . R D a t a
e x c l u d e . t x t  (list of Affymetrix identifiers to be excluded from analysis) 
Details
e x p s u m  choice of expression metric to apply, options of r m a a l l ,
r m a s e p ,  g c r m a a l l ,  gcrm asep , d c h i p p m ,  d c h i p p m m m ,  m a s 4 and 
m a s  5
t e s t  statistical test to apply to each dataset:
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fo ldchan ge Absolute value of the log ratios of the mean expression level 
t t e  s t  Unpaired t-test
we 1 ch Welch t-test
mwu Non-parametric Mann-Whitney test
meds d Robust Welch t-test using median of the dataset in formulae.
meanmad Robust Welch t-test using mean and median absolute deviation
(MAD) in formulae.
medmad Robust Welch t-test using median and median absolute deviation
(MAD) in formulae.
trim m edl Trimmed t-test (1 degree trimming)
trimmed2 Trimmed t-test (2 degree trimming)
wins or 1 Winsorised t-test (1 degree trimming)
winsor2 Winsorised t-test (2 degree trimming)
yuen 1 Yuen’s t-test (1 degree trimming)
yuen2 Yuen’s t-test (2 degree trimming)
bayes_welch_m ean Apply Bayesian framework utilising the Welch t-test, 
running mean of local variance with a window size of 500
bayes_w elch_m edian Apply Bayesian framework utilising the Welch t-test, 
running median of local variance with a window size of 500
bayes_ttest_m ean  Apply Bayesian framework utilising the impaired t-test, 
running mean of local variance with a window size of 500
b ayes_ttest_m ed ian  Apply Bayesian framework utilising the unpaired t- 
test, running median of local variance with a window size of 500
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b a y e s  m a d  m e a n  Apply Bayesian framework utilising the Welch t-test, 
running mean of local median absolute deviation, with a window 
size of 500
b a y e s _ m a d _ m e d i a n  Apply Bayesian framework utilising the Welch t-test, 
running median of local median absolute deviation, with a 
window size of 500
d o . q q  Apply Quantile-Quantile normalisation to datasets
d o . r a n k  Transform data to ranks within each array
l o g . i t  Apply log2 transform data to each dataset
p o w e r . i t  Apply 2A transform data to each dataset
l o g l O . i t  Apply logio transform data to each dataset
d o . vsn Apply VSN normalisation to datasets
g r a p h . o u t  Display FDR graph upon completion of analysis (uses 
f d r . p l o t )
Function: fdr.plot
Draws a line graph of the output from f d r  . t e s t ,  plotting the sample size on the x- 
axis, with area under the FDR curve. Where multiple values exist in the input matrix at 
each sample size, the mean of values is plotted, together with error bars representing 
the standard error of the mean.
Usage
f d r . p l o t ( x ,  a d d i t = F A L S E / c o l ^ ' b l a c k ” , t e s t = " N A n , 
m e t r i c = " N A " / t r a n s f o r m = " N A n , a d d . t e x t = T R U E ,  t i t l e = n " ,  
l t y - 1 )
Details
a d d i t  add line to existing f d r . p l o t
c o l  line colour
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t e s t text to add to plot (line 1)
m e t r i c text to add to plot (line 2)
t r a n s f o r m text to add to plot (line 3)
a d d . t e x t display text fields
t i t l e plot title
l t y line type (standard R p a r  values)
File: randomised.r
Function: randomised.p
Returns a p-value resulting from the application of a randomised t-test to a dataset 
following a number of random samplings of the data.
Usage
r a n d o m i s e d . p ( x ,  n g l = " N A " ,  n g 2 = " N A " ,  i t s = 1 0 0 0 0 )
Details
x  vector of data values - group one data should proceed group two data
n g l  number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A ".  If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
i t s  number of random samplings to take to derive a p-value
Function: randomised.p.error
Returns a p-value resulting from the application of a randomised t-test to a dataset 
following a number of random samplings of the data derived using an error model 
based on binomial theory.
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Usage
r a n d o m i s e d . p . e r r o r ( x ,  n g l = " N A " ,  n g 2 = " N A " ,  i m a x = 1 0 0 0 0 ,  
k = 0 . 0 5 )
Details
x  vector of data values - group one data should proceed group two data
n g  1 number of values in group one
n g 2  number of values in group two
default values for n g l  and n g 2  are " N A " .  If no parameters are passed, 
values are calculated by dividing the dataset into two equal groups.
i m a x  number of random samplings to take to derive a p-value
k confidence required in the resultant p-value
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Appendix Two 
Overview of script and code to implement the 
randomisation t-test 
File: wrapper.pl
Implements the randomised t-test utilising a bionomical error model using a p er i 
script and the randc2. exe executable. For efficiency data is subjected to 
randomisation testing for a set number of cycles, the data is then reviewed according to 
the model, before data being deemed to have reached an acceptable p-value is excluded. 
The remaining data is then subject to repeated stepped analysis until the maximum 
number of permutations is achieved.
Usage
w rapper.pl inp ut output rows c o ls l  c o ls2  ste p  max conf
Details
inp ut input filename (tab delimited text file, with ID’s as column one
and no header information
output output filename
rows number of data rows
c o ls l number of columns for group 1 data
c o ls2 number of columns for group 2 data
step permutation step between error modelling
max m a x i m u m  number of permutations to perform
conf confidence required (o.i = 10%)
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File: randc2.exe
Implements the randomised t-test in a C code executable. 
Usage
r a n d c 2  i n p u t  o u t p u t  r o w s  c o l s l  c o l s 2  p e r m s
Details
i n p u t  input filename (tab delimited text file, with ID’s as column one
and no header information
o u t p u t  output filename
r o w s  number of data rows
c o l  s  1 number of columns for group 1 data
c o l s 2  number of columns for group 2 data
p e  r m s  number of randomisation steps to apply
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